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Rheumatoid arthritis is a debilitating disease for which there is no cure.   Copper has been 
used for centuries to alleviate the inflammation associated with the disease.   The aim of this 
research was to design and test new ligands which are able to promote the percutaneous 
absorption of copper and/or mobilize endogenous copper reserves.   Formation constants of H+, 
Cu(II), Ni(II) and Zn(II) with five low molecular ligands 2-((2-aminoethyl)amino)-N-(pyridin-2-
ylmethyl)acetamide) [H(555)NH2], 2-((2-dimethyl-amino)ethyl)amino)-N-(pyridin-2-ylmethyl) 
acetamide [H(555)NMe2],  N-(2-aminoethyl)-N'-(pyridin-2-ylmethyl)ethanediamide 
[H2(555)NH2], 3-(2-aminoacetamido)-N-(pyridin-2-ylmethyl)propanamide [H2(565)NH2],  
3-amino-N-(pyridin-2-lmethyl)-propanamide [H(56)NH2] were measured at 25±0.01oC and at an 
ionic strength of 0.15M (NaCl) using glass electrode potentiometry.  
 
The structures of the different Cu(II) species formed with these ligands were investigated 
using ultraviolet-visible (Uv-visible), nuclear magnetic resonance (NMR) spectroscopy and  
X-ray crystallography as well as molecular mechanics calculations.   The Uv-visible spectra 
obtained for the different species in solution were typical of tetragonally distorted Cu(II) 
complexes.   The active binding sites were identified as the pyridine nitrogen, the amide nitrogen 
and the terminal amino group.   The pyridine nitrogen was involved in coordination first, 
followed by the amide and then the terminal amine groups.   The X-ray crystal structure of two 
of the Cu(II) complexes were solved; one formed a rectangular pyramidal geometry and the 
other a distorted square planar geometry.   Molecular mechanics was used to determine the 
lowest energy conformation of different possible geometries.  
 
Since the preferred route of administration is through the skin, the rate of dermal 
absorption and the bioavailability of copper are important.   For this reason, the drugs were 
designed so that they could be administered dermally and be selective for Cu(II) so that they do 
not affect the speciation of other metal ions in blood plasma.   Speciation calculations using a 
blood plasma model were used to estimate the complexing ability of the ligands in vivo.   This 







This study also considered dermal absorption studies.   Octanol/water partition 
coefficients and Franz cell permeation studies showed that the Cu(II) complexes are hydrophilic 
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1. Rheumatoid Arthritis 
1.1 Background of the Disease 
Rheumatoid arthritis (RA) is a chronic, inflammatory, systemic, debilitating disease that 
leads to the destructions of diarthrodial joints1,2 (synovial joints).3  It is considered to be an 
autoimmune disease, although the exact cause is still unknown.1-7  The disease occurs first in 
the knuckle joints and chiefly affects the synovial membranes of multiple joints in the body.8,9  
It is characterized by massive synovial proliferation and subintimal (the underlying tissue 
includes blood and lymphatic vessels)10 infiltration of inflammatory cells, which along with 
angiogenesis (the process for new capillaries from existing blood vessels)11, appears as a slight 
swelling accompanied by stiffness, and leads to the formation of a very aggressive tissue called 
pannus12,13, as shown in Figure 1.1.   Expansion of the pannus induces cartilage thinning and 
bone erosion, leading to the loss of joint function.   The rheumatoid pannus can be considered 
as a local tumor.8,9 
 
 
               Figure 1.1: Chronic Rheumatoid Arthritis. 
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The development of pannus is well represented in Figure 1.2, by a comparison of 
normal joint and one damaged by rheumatoid arthritis as well as swelling and thickening of the 
synovial membrane. 
 
         Figure 1.2: Normal joint (left) and joint affected by RA (right).  
Although RA affects 1–5% of the world’s population, it remains a medical  
challenge.8,14  As the cure for RA has not yet been found, treatment of chronic RA remains 
largely symptomatic.15,16  There is little evidence to suggest that the disease is hereditary.17  It 
can develop at any age, but most commonly starts between the ages of 30 and 50.   It is about 
three times more common in women than in men.18  Why this disease is prevalent among 
women is unknown, but it is presumably related to the hormonal milieu.14,19,20  
The symptoms of RA are weight loss, fatigue, morning stiffness, joint pain, swelling 
and tenderness around the joints, as well as  loss of functioning and mobility of joints.21-24  RA 
can affect many joints in the body, including knees, ankles, elbows and wrists.  
The aetiology of RA is not known.   Clinical evidence suggests that several factors 
together result in the onset of RA.   It is believed to be related to a complex of genetic, 
endogenous (e.g. hormonal, endocrine, or metabolic factors), and exogenous factors  
(e.g. geographic, infectious agents such as viruses, bacteria, and fungi, or occupational 
factors).25,26  All of these have been shown to be implicated in the progression of  RA yet none 
is shown to be its primary cause.27  
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Macrophages, fibroblasts and T-lymphocytes, are three cell populations which are 
found abundantly in the rheumatoid arthritis synovium.28  These cells are shown to play a 
substantial role in the progression and the development of RA.29  However, evidence coming 
from different experimental approaches30-33 strongly supports the hypothesis that RA is a 
disease initiated and driven mostly by T-cells irrespective of its cause.   The chronic 
inflammatory environment in which T-cells operate within the rheumatoid synovium is likely 
to influence their function greatly, although the effector phases responsible for the processes 
that lead to joint destruction involve several different cell types such as cytokines, and also 
catalytic enzymes.30,34-36  
There is no cure for this debilitating disease.   However, the symptoms associated with 
the disease can be alleviated by the use of anti-inflammatory drugs and also controlled by the 
use of immunosuppressive drugs.7,8 
1.2 Drugs used in the Treatment of Rheumatoid Arthritis 
The uses of drug therapy for RA is mainly for the relief of pain, the inhibition of 
inflammation and the restoration of normal immune mechanisms37, as well as, 
multidisciplinary health care to preserve functional capacity of joints.38  An effective treatment 
program for arthritis is reported to consist of drug therapy (steroidal and non-steroidal), 
exercise and rest.39  Highly effective drug treatments exist but early treatment is critical for 
reducing inflammation, relief of pain, slowing or stopping joint damage, and improving patient 
function and wellbeing.40  Furthermore, surgical treatment (joint replacement) is done if the 
joints have been severely deformed.41-43  However, pharmaceutical drugs that are commonly 
given to patients fall into three categories;  
1. Non-steroidal anti-inflammatory drugs (NSAIDs). 
2. Disease-modifying anti-rheumatoid drugs (DMARD). 
3. Glucocorticosteroids. 
1.2.1 NSAIDs  
Non-steroidal anti-inflammatory drugs are usually the first class of drugs prescribed and 
most commonly used because they are well tolerated by patients, and they decrease the 
inflammatory response of the body to disease or injury.44  Examples of these are aspirin, 
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ibuprofen and naproxen.   Non-steroidal anti-inflammatory drugs alleviate inflammation and 
pain by blocking cyclooxygenase (COX) which is an enzyme that is responsible for the 
production of prostaglandins45,46 (Prostaglandins play a key role in the generation of the 
inflammatory response).   Their biosynthesis is significantly increased in inflamed tissue and 
they contribute to the development of the cardinal signs of acute inflammation).47  NSAID’s 
are effective, but they are associated with side-effects, and gastrointestinal side-effects have 
become the most prevalent complication of chronic therapy with NSAIDs.48  As well as 
causing nausea, loss of appetite, vomiting, diarrhoea, constipation, rash, dizziness, drowsiness 
and headache45,46, NSAIDs do not modify the progression of the disease.45,46,49 
1.2.2 DMARDs 
Disease-modifying anti-rheumatoid drugs can be divided further into two classes 
namely:   disease-modifying antirheumatic drugs (DMARDs) and biologic agents; they reduce 
the progression of RA and prevent bone damage.50   Examples of DMARDs include low doses 
of methotrexate, leflunomide, D-penicillamine, sulfasalazine, gold therapy, minocycline, 
azathioprine, hydroxychloroquine (and other antimalarials), and cyclosporine.51,50  DMARDs 
prevent disease progression before it can cause irreparable joint damage.   While DMARDs are 
powerful arthritis fighters, an instant result should not be expected; hence they are also called 
slow acting anti-rheumatic drugs (SAARDs).52  Biological agents are a new type of therapy 
that decreases or stops the progression of RA.   They act as response modifiers that block 
specific immune factors that lead to RA.53  However, prostaglandins (PG’s) have also been 
recognized as an important contributor to the body’s inflammation reaction.   The use of 
DMARD’s is also associated with some side-effects.   These include gastrointestinal 
symptoms, sore and dry mouth, nausea, and skin rash.   Prolonged usage may lead to 
gastrointestinal irritation, renal and liver toxicity.54,55 
1.2.3 Glucocorticosteroids 
Glucocorticosteroids can be taken during the final stage of RA.   These drugs suppress 
inflammation, and they have a high potency compared to NSAID’s and DMARDs but they can 
compromise the immune system.56-58  Examples of corticosteroids are cortisone, prednisone 
and dexamethasone.   They act to reduce heat, swelling and tenderness at the inflamed joint and 
have proved to be the best for combating inflammation.   However, their mode of  
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anti-inflammatory action is unclear.   They are neither antiviral nor antibacterial.44,56,59  These 
drugs work very well but tend to have too many side-effects.   The most feared complication in 
patients with RA has been the effects of steroids on the bone and gastrointestinal tract.52,60,61 
Additional side effects include a puffy face, increase in appetite, weight gain, mood swings, 
water retention and fractures.57,58 
This inefficiency of current drugs against arthritis has challenged scientists to develop 
an anti-inflammatory drug having very few side-effects.   Pharmacological evidence suggests 
the use of copper complexes to be beneficial in alleviation and treatment of RA and that these 
compounds have disease-remitting qualities.62-64  Sorenson in 1987 has discussed the 
physiological basis for pharmacological activities of copper complexes as well as the anti-
arthritic, anti-ulcer and analgesic activities of copper complexes.65  
1.3 Biochemistry and Metabolism of Copper 
Copper, after iron and zinc, is the third most abundant essential trace mineral in the 
body. It has been known as an essential nutrient since the 1920's.66  Copper occurs as the metal 
in oxidation states (0), (I), (II) and unstable (III), but in aqueous solution it occurs only as 
Cu(II) ion.67  Like other essential component such as amino acids, fatty acids, or vitamins, 
copper is not synthesized in the body but must be ingested.   Sources of this essential nutrient 
include dried beans, nuts, animal liver, and crustacean sea food.68,69  It is associated with a 
number of copper-dependent enzymes that are key in mammalian biological processes.   Their 
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Cytochrome C oxidase 
 
Oxygen reducing agent 
Superoxidase dismutase (Cu/Zn-SOD) 
 
Catalyses the dismutation of superoxide in oxygen and 
hydrogen peroxide.   It plays the most important role in 
the antioxidant protection of almost all cells which are 
in contact with oxygen to any extent. 
Tyrosinase (catechol oxidase) 
 
Formation of melanin. 
Dopamine-β-hydroxylase 
 
Hydroxylase of dopamine for catecholamine synthesis. 
α-Amidating enzyme 
 
Modifies C-terminal ends of hypothalamic peptide 
hormones ending in glycine. 
Diamine oxidase Inactivation of histamine and polyamines? (cellular 
and extracellular). 
 
Amine oxidase (extracellular) Inactivation of histamine, tyramine, dopamine, 
serotonin. 
Peptidylglycine monooxygenase Bioactivation of peptide hormones. 
 
Hephaestin Ferroxidase, in trans-golgi of enterocytes; aids iron 
absorption homology to ceruloplasmin. 
Cartilage matrix glycoprotein (CMGP) Ferroxidase/amine oxidase, homologous to 
ceruloplasmin (chondrocytes and eye ciliary 
epithelia). 
β-Amyloid precursor protein Normal function currently unknown. 
 
Prion protein (PrPC) Copper binding properties suggests that it may protect 
against ROS*; has SOD-like activity; may return 
copper to Neurons at synapses (many cells).  
S-Adenosylhomocysteine Sulfur amino acid metabolism hydrolase. 
 
Angiogenin Induction of blood vessel formation. 
 
Blood clotting factors V and VIII Blood clotting. 
 
Ceruloplasmin Accumulation and preservation of iron reserve, iron 
oxydase, copper transport, SOD mimetic 
activity. 
* (ROS) Reactive oxygen species 
The body contains between 50 and 120 milligrams of copper.52,53  Copper from an 
exogenous source enters the body via rapid absorption through the stomach and small intestine 
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(jejunum) by a facilitated diffusion, using transport proteins that transport it to the liver.   It 
then passes through the  phospholipid membranes as a serum albumin complex, and it is finally 
stored in the liver via ligand exchange processes in the form of a metallothionine  
complex52,72,73 or converted into ceuroplasmin that is released into the blood to meet normal 
metabolic needs.59,74,75  It also forms part of important antioxidant enzymes, copper-zinc 
superoxide dismutase.69  Other functions of copper in the body include bone formation, 
keratinisation, reproduction, fertility, development of central and peripheral nervous systems, 
cellular respiration, nerve function, cardiac function, extracellular connective tissue formation, 
pigmentation and regulation of the monoamine concentration.68,69,76  However, excess copper 
in the tissue leads to the production of damaging free radicals and subsequent DNA cleavage.77  
Tissue requirements for copper are considered to be met and controlled in a homeostatic  
fashion  based  on  the  absorption,  storage,  utilization  and excretion of the copper.78   
 In blood plasma, at least 90% of copper is irreversibly bound to ceruloplasmin in a  
non-exchangeable form, while about 10% is reversibly bound to serum albumin and less than 
1% is distributed amongst low molecular weight (l.m.w) complexes, predominantly 
[Cu(histidinate)(cystinate)] as the exchangeable copper fraction in the blood.79,80  
   The medicinal property in the beneficial effects of copper (II) complexes was reviewed 
by Sorenson’s report in 1976, which stated that the active forms of anti-inflammatory drugs are 
the Cu-complexes of such drugs in vivo.   These analogues were also reported to be more active 
than their parent drug or inorganic copper salts.81  In metal-tissue distribution studies of copper 
in individuals with rheumatoid arthritis, elevated levels of serum copper were found during the 
inflammatory stage of the disease.43,81,82  There was a two to three fold increase in endogenous 
copper, mainly serum albumin and ceruloplasmin (CP), returning to normal with remission.52,83 
Furthermore, the accumulation of copper-thionine in the liver decreased on remission with 
inflammation.52,83,84  It has however been shown; that ceruloplasmin is a powerful antioxidant 
and could thus provide protection against cellular destruction, which may be the reason for its 
increased synthesis.  However, this would then bring about decrease in the concentration of 
serum albumin copper, as well as the labile low molecular weight copper complexes.59 
 The l.m.w copper complexes are thought to be involved in the transportation of copper 
between cells in the body; this is because they are formally uncharged.52  Also, it is the 
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decrease of these copper complexes in the body that is thought to increase the progression of 
RA. 
   Two ways have been proposed by which copper concentration can be adjusted; either 
from serum albumin by a direct complexation using a powerful ligand or from the 
ceruloplasmin using destructive chelators (e.g. penicillamine). 
1.4 Copper Inflammation and Arthritis 
Historically copper has been used therapeutically for over 300 years59 and since the 
Middle Ages for the treatment of arthritis.85  The copper bracelet, specifically, has long been 
used as a folk remedy for the treatment of arthritis.   Cupriphores from sweat solubilise the 
copper and promote its dermal absorption into the blood stream,86,87  where it will be 
transported to the affected areas.88  Another traditional treatment, but less common, is by 
wearing stainless steel bracelets with neodymium magnets encapsulated in them.   These 
bracelets do not provide useful chelates (for treatment of RA) but the magnetic field accelerates 
the circulation of blood to all parts of the body89,90, thus distributing copper evenly throughout 
the body. 
L.m.w copper complexes are reported to have superoxide dismutase (SOD) activity by 
controlling the hydroxide and superoxide radical levels in blood serum.72  such radicals have 
been associated with the development of inflammation in tissues.52,69,72  The inflammation is 
characterized by macrophage activation.   Macrophages are phagocytic cells, which produce 
and release reactive oxygen species (ROS).91  The role of SOD, a copper containing enzyme, is 
to remove the highly pro-inflammatory superoxide radical anion O2-.   The superoxide radical 
O2- has been implicated in the promotion of arthritis due to its ability to degrade hyaluronic 
acid (HA) that is an important component of the synovial fluid.59  
In order to improve the bioavailability of copper and hence improve the efficacy of 
complexes, Sorenson62 and Jackson et al.43,80  have investigated Cu(II) complexes and shown 
that they are effective in reducing the inflammation associated with RA, enhancing bio-
availability of copper,  while having reduced toxicity.92,93  Jackson et al.  in 2007, investigated 
Cu(II), Zn(II) and Ca(II), complexes of N1-(2-aminoethyl)-N2-(pyridin-2-ylmethyl)- ethane-
1,2-diamine ([555-N]) and N-(2-(2-aminoethylamino)ethyl)picolinamide ([H(555)-N]), and 
found that these ligands form more stable complexes with Cu(II ) than in vivo competitors, 
Zn(II) and Ca(II).  This is an essential factor in the development of copper-based  
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therapeutics43, i.e., the ligand should not alter the bio-distribution of other metal ions.    
A similar result was found for (1,15-bis(N,N-dimethyl)-5,11-dioxo-8-(N-benzyl)-1,4,8,12,15-
pentaazapentadecane )].84  The high stability of this complex was attributed to the ease with 
which copper deprotonates the donor nitrogen atom of the amide groups.   Although, this 
complex was neutral under physiological conditions, it was reported to be hydrophilic.   Also, 
calculations using a computer model of plasma revealed that the complex dissociates in vivo.84 
This indicated that further work was needed to improve the lipophilicity and the stability of the 
l.m.w. copper(II) complexes. 
1.5 Research Hypothesis 
The hypothesis then is that endogenous l.m.w copper has anti-inflammatory activity and 
should therefore be beneficial in the treatment of RA.   There are two ways in which the blood 
plasma concentration of l.m.w.   Copper can be increased; by release from high molecular mass 
sources, e.g., ceruloplasmin or HSA, or by administration of exogenous copper.   Exogenous 
copper can be administered via intravenous injection or oral absorption.   These two methods 
are natural drug administration routes but injection is painful, and orally the complex would 
have to tolerate the harsh conditions in the stomach.   Therefore, the dermal route is preferred 
as the best route of administration because it is slow (no acute response), tolerable and painless.   
For dermal absorption to be effective, the copper complex must be stable enough to be 
dermally absorbed, but once it enters the blood plasma, the copper must be released to that it 
can exert its pharmacological effect.   Were the copper not to be released, it is likely that the 
complex would be excreted, unchanged, in the urine.   This was found by Jackson et al. in 
2000, for a number of their complexes.8   So, the design of ligand should focus on its role in 
enhancing copper(II) absorption through the skin.   The concentration of all labile copper(II) 
complexes in  plasma will thus be elevated although the percentage distribution of endogenous 
and added copper(II) amongst the l.m.w will remain essentially constant.   As a result, the 
overall concentration of the neutral copper(II) complexes present will be increased.    
1.6 Aim of this Study 
Based on the hypothesis that an increase in endogenous copper will have a beneficial 
anti-inflammatory effect, the aim of this project was to design, synthesize and evaluate new 
ligands that are able to promote the percutaneous absorption of copper. 
 




1. Design a ligand which forms stable, labile copper complexes with a high  
level of specificity for copper binding and which is still able to diffuse       
across a lipid bilayer membrane. 
2. Synthesis of ligands. 
3. Measure equilibrium constant with H+, Cu2+, Zn2+and Ni2+ using glass electrode 
potentiometry in an aqueous solution of 0.15M NaCl over a  
pH range of 2-11. 
4. Investigate the structure of complexes using UV-Visible spectrophotometry and  
NMR spectroscopy. 
5. Study the solubility of the complexes in lipids and in water with  
octanol/water partition coefficients, and the diffusivity with the Franz cell. 
6. Evaluation of the ligands using a blood plasma model. 
7. Verify the postulated solution structures for Cu(II) complexes using 
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2.1 Ligand Design 
2.1.1 Introduction 
  The ligand design for selective complexation of metal ions in solution for therapeutic 
purposes as an alleviation of inflammation associated with RA is of great importance.   
During inflammatory conditions, there is an increase in the total labile low molecular weight 
(l.m.w) concentration of copper in particular compartments of the body such as synovial 
fluid.   The increase is due to the formation of complexes in plasma that can diffuse into 
synovial fluid through the separating membrane.1  Only neutral complexes can pass through 
the membrane separating these compartments whereas charged complexes tend not to, in the 
absence of specific uptake pathways.   However, the endogenous reserve or exogenous 
sources of Cu(II) for this therapeutic activity requires ligands that can successfully mobilize 
the metal ion at the site of inflammation.   However, for this to happen, the ligands must 
possess certain desirable features. 
2.1.2 Ligand Properties and Design 
The design of the ligands that can successfully mobilize Cu(II)  in biofluids depends 
on the stability of  the complexes formed.   They must be strong chelators in order to form 
thermodynamically stable complexes with Cu(II) ion.   The increase in the stability of Cu(II) 
complexes has been associated with an increase in the number of donor atoms.2  The chelate 
effect is observed in Cu(II) complexes of ethylenediamine, [Cu(en)2]2+ which are 107 times 
more stable than copper ammonia complexes [Cu(NH3)4].3   
  In general, the stability of the complexes is affected by the size of the chelate rings 
formed upon coordination.   For example, five-membered chelate rings are more stable than 
six- membered chelate rings.   If more than one chelate ring is formed, then 5,5  is better than 
5,6 which is better than 6,6.   This order of stability has been attributed to entropy changes 
associated with chelate formation.4,5  With three or more contiguous chelate rings, however, 
ring strain or enthalpy also has an effect and so 5,6,5 membered chelate systems are  more 
stable than  5,5,5 chelate analogues.6-9  The low stability in the structure of the 5,5,5 
membered chelate system is  due to steric constraints.10 
The ligands should form bioavailable Cu(II) complexes and at the same time not 
disrupt the homeostasis of other endogenous metal ions.   Therefore, the ligand should 
contain primarily nitrogen donor atoms which will increase the selectivity for copper over 
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most bivalent cations11,12, such as Ca(II) and Zn(II) which are found in large concentrations 
in blood plasma13 and thus can interfere with ligands designed to bind Cu(II)2, since to form a 
neutral Cu(II) complex, the  ligand  has to include  anionic groups or dissociable protons.   
Ligands containing amide groups where amide hydrogen atoms dissociate on complexation 
have been preferred in this study because they are reasonable models of peptide bonds of 
proteins.   Moreover, on loss of amide protons, these ligands can coordinate to a metal ion via 
four nitrogen atoms, giving rise to three chelate rings. 
In addition, the ligands should form kinetically labile complexes to be able to release 
Cu (II) at the biological sites where it is needed.14  The complexes should be lipophilic to 
enable transport across cell membranes and uncharged to prevent urinary excretion.15 
From previous studies, the pyridyl group has a high Cu(II) mobilizing ability and is 
found in most NSAID drugs.16-18  The aromatic ring would increase the rigidity to the ligand 
system and hence the stability and lipophilicity of the metal complex.16  The nitrogen on the 
pyridyl group is envisioned to increase the stability of the complex by the chelate effect. 
Ligands that contain the pyridyl residue that have been studied before are 2-amino-N-
(2-oxo-2-(2-(pyridin-2-yl)ethylamino)ethyl)acetamide [H2(556)-N],a pseudo-mimic of human 
serum albumin, N1-(2-aminoethyl)- N2-(pyridin-2-ylmethyl)ethane-1,2-diamine [555-N] and 
N-(2-(2-aminoethylamino)ethyl)- picolinamide [H(555)-N] see Figure 2.2.   They form stable 
complexes and are more selective for Cu(II) in vivo than Ca(II) and Zn(II).17,19 
In blood plasma, copper is transported by proteins; human serum albumin (HSA) 
being the most effective protein.20,21,22  (HSA) is a major metal-binding protein in the body23,  
Cu(II) binding sites of HSA (shown in Figure 2.1) involves the α-NH2 nitrogen, two peptide 
nitrogens and the imidazole nitrogen of the N-terminal Asp-Ala-His residues.17,24 
Human serum albumin is more selective to Cu(II) than are most proteins.25,26  This  
makes Cu(II) less bioavailable when complexed with HSA than when complexed with other 
protein molecules.26 
 




Figure 2.1:   Structure of Cu(II) binding site.  
 
The designs of the ligands in this study were based on the structure of HSA.   Amines 
are good, selective coordinators of Cu(II)11,12, while especially Ca(II), and Zn(II) do not form 
strong complexes.   However, copper complexes of polyamino ligands like ttda (3,6,9,12-
tetraazatetradecanedioate) and dtda  (-3,6,9-triazaundecanedioate)  as shown in Figure 2.2, 
have been shown to be too stable.27  In animal studies, these complexes were excreted 

































Figure 2.2: Schematic representation of ligands discussed in this chapter 
 
In order to decrease the hydrophilicity and bury the charge of the ligand within the 
complex, the ligands in the present study were designed.   These ligands all have an amide 
group which deprotonates upon metal ion coordination.28  Furthermore, their complexes with 
Cu(II) would be formally neutral.29,30   
Using the criteria outlined above and based on previous studies the following ligand 
have been designed.   The ligands designed (Figure 2.3) in this project have included all three 
design features.   They include the amino group, an amido group and a pyridyl group.  
 
 


























Figure 2.3:   Structures of proposed Ligands. 
Chapter 2: Ligand Design and Synthesis 
21 
 
The above ligands have been carefully designed to achieve successful metal ion 
administration and subsequent mobilization in the body fluids.  
 
2.2 Synthesis of Ligand 
2.2.1 Experimental 
 All solvents and reagents were purchased from either Sigma-Aldrich or Aldrich and 
were used without further purification.   Tetrahydrofuran (THF) was dried using the stand 
Alone SP-1 solvent purification system from LC Technology Solutions Incorporated, USA. 
Reactions were monitored by thin-layer chromatography (TLC) using Merck F254 
aluminium-backed precoated silica gel plates and were visualized by ultraviolet light at 
254nm.   1H and 13C NMR spectra were recorded on a Varian Unity Plus 300/400 MHz or 
Bruker (1H at 400 MHz, 13C at 100.6 MHz) instrument, using tetramethylsilane (TMS) as an 
internal reference.   Mass spectroscopy was carried out on JEOL GCmateII in Electron 
Ionisation mode.    
 
[H(555)NH2],  [H2(565)NH2],  [H(56)NH2], [H2(555)NH2], were purchased from FCH 
group and UORSY/ UKrorgsyntez Ltd. 
 
2.2.2 Synthesis 
H(555)NMe2 ligand was successfully synthesized.   The synthesis of that ligand was 
followed by a complete characterization procedure using nuclear magnetic resonance 
(N.M.R). 
 
2.2.2.1 Synthesis of 2-(2-(dimethylamino)ethylamino)-N-((pyridin-2-yl)methyl)acetamide 
The compound was synthesized according to the literature procedure.31  The first step 
of the synthesis was preparation of 2-chloro-N-(pyridine-2-yl-methyl)acetamide from  
2-aminomethylpyridine and chloroacetylchloride.   The second step of the synthesis involves 
N,N-dimethylethylenediamine, where one nitrogen atom was protected by a methyl group as 
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2.2.2.2 Preparation of 2-chloro-N-(pyridine-2-yl-methyl) acetamide 
2-Aminomethylpyridine (1.90 mL, 18.50 mmol), was dissolved by use of a magnetic 
stirring bar in dry THF (20 mL) after cooling to 0°C in an ice water bath.   TEA 
(Triethylamine) (2.82 mL, 19.50 mmol) as a base and chloroacetylchloride (1.55mL, 
19.5mmol)   was used as the alkylating agent in dry THF (40 mL); the reagents were added 
dropwise to the previous mixture over 1 hour.   The mixture was stirred at room temperature 
for 5 hours under nitrogen.   The reaction was essentially complete as monitored by TLC 
(EtOAc:MeOH; 9:1).  The resulting mixture was filtered, washed with THF and concentrated 
under vacuum.   To the oily residue was added EtOAc (50 mL) and the resulting mixture was 
washed with saturated NaHCO3 solution (3×20 mL).   The organic layers were pooled, dried 
over anhydrous MgSO4, filtered and the solvent was removed under reduced pressure to give 
a residue which was subjected to column chromatography on silica gel using  
(EtoAc:MeOH; 9:1) as eluent to afford the product, as a pale brown oil (2.60g, 76%). 
δH (300MHz, CD3Cl-d) 4.04(2H, S, H1); 4.57(2H, d, J 5.09Hz, H2); 7.16-7.25(2H, m, H3, H5); 
7.62-7.64(1H, m, H4); 7.85(1H, s, NH); 8.53(1H, d, J 4,84Hz, H6). δC (100.6 MHz, CD3Cl-d) 








2.2.2.3 Preparation of (2-(dimethylamino)ethylamino)-N-((pyridin-2-yl)met-hyl)acet-     
              amide 
 A solution of 2-chloro-N-(pyridine-2-yl-methyl)acetamide (2.00 g, 10.83 mmol) in  
dry MeCN (20 mL) was add dropwise over 1hour to a stirred solution of  
N,N-dimethylethylenediamine (53.35 mL, 0.49 mol) in dry MeCN (60 mL) under nitrogen.   
After cooling to 0°C in an ice water bath, the reaction was stirred at room temperature 
overnight.   The reaction was monitored by TLC (EtOAc:MeOH; 9:1).   The resulting 
mixture was filtered and concentrated under reduced pressure. The product was extracted 
with MeOH:CHCl3 (1:4), and washed with saturated NaHCO3 solution (2×10 mL).   The 
combined organic layers were dried over anhydrous MgSO4 and the solvent removed to 
Chapter 2: Ligand Design and Synthesis 
24 
 
afford the product.   The resultant sample was then purified by column chromatography on 
silica gel using MeOH: EtOAc (2:8) followed by MeOH: DCM (4:6) was used to elute.   
Brown oil (0.70g, 27%).  
δH (300MHz, CD3Cl-d) 2.21 (6H, d, J 0.77Hz, H1,2); 2.41 (2H, dd, J 5.40, 6.43Hz, H3); 2.71 
(2H, td, J 0.78,  5.85 Hz, H4); 3.28-3.43 (2H, m, H5); 4.60 (2H, d, J 5.67 Hz, H6); 7.15-7.20 
(1H, m, H9); 7.29 (1H, d, J 7.63 Hz, H7); 7.64 (1H, t, J 7.66 Hz, H8); 8.26 (1H, s, NHb) 8.54 
(1H, dd, J 1.60, 4.77 Hz, H10). δC (100.6 MHz, CD3Cl-d) 44.34 (2C), 45.34, 47.43, 52.76, 
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 3. Potentiometry 
3.1 Introduction 
Formation constants can be determined by techniques such as spectroscopy, 
electrochemistry, potentiometry and calorimetry.   Potentiometry is the most extensively used 
technique in the determination of stability and protonation constants.   Because of the 
availability of electrodes and reproducibility of experimental results, it is considered to be the 
most precise, accurate and non-invasive technique available at present.1,2  Another advantage 
is that it is not subjected to interference from colored samples.3 
Potentiometric titration is a volumetric method in which the potential (E) between two 
electrodes is measured as a function of the added volume of titrant (V).   The indicator 
electrode can be selected to respond to either a reactant or a product.3 
The advantage of potentiometric titration in the measurement of acidity and alkalinity 
is the reliability, dynamic range and selectivity of the glass electrode.   The essence of the 
potentiometric experiment involving glass-electrode potentiometry (GEP) is the monitoring 
of the change in the hydrogen ion concentration, [H+], throughout the experiment.   GEP is 
one of the most frequently used experimental techniques for the study of (de)protonation and 
coordination equilibria in solution4 at constant ionic strength and temperature.5-7  GEP has 
been employed in this study because of its linear Nernstian response, rapid reversibility and 
high sensitivity to aqueous hydrogen ions over a wide concentration range.   However, the pH 
range is usually limited to between 2-12, because below pH 2 and above pH 12, the response 
is no longer linear due to the junction potential and the alkaline error.8 
 
This chapter focuses on the general theory of potentiometry as a measurement method 
applied to complex equilibria, as well as presentation and discussion of experimental results. 
 
3.2 Theory 
The theory of  formation constants and methods used to determine them has been extensively 
covered in the literature.9-12 
 




For a metal M and a ligand L forming a complex ML, the thermodynamic equilibrium 
constant TK1 is defined as follows. 
M + L   ML                                                            
    
      
                                                                                                                                                                                                                                                                                                                            
                                                                                                                                              (3.1) 
where {ML} is the activity of ML, {M} is the activity of M and {L} is the activity of L.   The 
activity of ML can be expressed in terms of its concentration13;  
 
                                                                      
                                                                                                                                              (3.2)     
 
where ϒML is the activity coefficient of the ML species.   Therefore, equation (3.1) can be 
expressed as: 
 
       
          
                  
                                                                 
                                                                                                                                                                    
(3.3) 
 
Equation 3.3 can be rearranged; 
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)                                                                  
                                                                                                                                             (3.4) 
 
The expression (     
       
) is constant at constant ionic strength and temperature so the 
equilibrium constant can be expressed as;  
 
                                                                
    
      
                                                                               
                                                                                                                                            (3.5) 
Hence, the stepwise formation of the parent complexes can be described by the following set 
of formation constants at constant ionic strength.   The charges are omitted for clarity 
 




M + L   ML                                                        K1 = [ML]/ [M] [L]                                
                                                                                                                                                          (3.6)   
ML + L ML2                                                                                              K2 = [ML2]/ [ML] [L]                             
                                                                                                                                                           (3.7)        
MLn-1 + HL MLn + H                                               Kn = [MLn] [H]/ [MLn-1] [HL]                
                                                                                                                                                           (3.8)  
 
The equilibria represented by equations 3.6, 3.7 and 3.8 can also be expressed as overall 
formation constants, denoted by the symbol β, which can be expressed as: 
 
M + L   ML                                   
    
      
                                                   
                                                                                                                                              (3.9)     
                                      
ML + 2L   ML2                                
      
       
                                        
                                                                                                                                               
(3.10)     
 
Therefore, 
MLn-1 + L   MLn                                    
      
            
          
                                                                                                                                              
(3.11)     
  
In general,           
   ∏  
 
   
 
                                                                                                                                            (3.12)  




In any solution containing metal ions M, ligand L and protons/hydroxyl ions H or OH,  
a variety of complexes can be formed.   This phenomenon occurring in solution can be 
described by the following general equilibrium process given by the following expression; 
 
pM + qL + rH   MpLqHr 
                                                                                                                                            (3.13) 
where p, q and r are the stoichiometric coefficients of the components in the complex (metal, 
ligand and proton respectively), while r = -1 refers to the proton being removed or the 
addition of a hydroxyl ion on the complex.   Therefore this equation can take into account the 
formation of mononuclear, binary, protonation or hydroxo, polynuclear as well as 
oligonuclear complexes.14  The formation constant for this reaction is described by the mass 
balance equation as follows; 
         
          
            
 
                                                                                                                                              
(3.14) 
Moreover, the concentrations of MpLqHr from each titration point can be determined and, at 
point k, the concentration of MpLqHr is expressed as; 
 
[MpLqHr]k = βpqr [M]kp[L]kq[H]kr 
                                                                                           
(3.15) 
The total concentration of the metal ion (TM), ligand (TL) and hydrogen ion (TH) can be 
expressed by the law of mass action at k (Tk,M) point: 
 
Tk,M = [M]k + ∑       βpqr [M]k
p [L]kq [H]kr 
                                                                                                                                               
(3.16) 
The total concentration of the free ligand at point k (Tk,L) can be expressed as; 
 
Tk,L = [L]k + ∑       βpqr [M]k
p [L]kq [H]kr    
                                                                                                                                 
(3.17) 




The total concentration of the free hydronium ion at point k (Tk,H) can be expressed as; 
 
Tk,H = [H]k + ∑       βpqr [M]k
p [L]kq [H]kr 
                                                                                                                                  
(3.18) 
where [M]p is the concentration of free aquated metal ions and the summation is over the 
concentration of all the metal-containing species which may be protonated (r > 0) or may not 
 (r = 0), while [L] and [H] represent the concentration of the uncomplexed ligand and proton 
respectively.   The term r can have a negative value if the ligand loses protons upon 
complexation from either a coordinated ligand or a bound water molecule, or if the hydroxide 
ion (OH-) is added to the complex.15,16  If  r = 0 then the complex is not protonated and there 
are no hydroxide ions attached to the complex.    
 
Stability constants depend on temperature, as represented by the Van't Hoff equation;  
 
    
  
  
   
   
          or        
    
      
  
    
 
                                                                
                                                                                                                                                      (3.19) 
 
 
where     is the standard enthalpy change of reaction, T is absolute temperature in Kelvin 
and R is the universal gas constant in J K-1mol-1. 
 
The electrode cell is the centre of any potentiometric investigation.   A typical cell for 
pH glass electrode potentiometry consists of a reference electrode, an indicator electrode and 
a salt bridge.   This cell can be represented as: 
 
reference electrode| salt bridge |analyte solution | indicator electrode 
 
A reference electrode (Eref) is a half-cell having a known potential that remains 
constant at constant temperature and is independent of the composition of the analyte 
solution.17  An indicator electrode (glass electrode, Eg) has a potential that varies with 
variations in the concentration of an analyte.   The liquid junction potential (Ej) is the 
difference between the potential of the internal reference solution and the potential of the 




analyte solution, and is usually small enough to be neglected, if measurements carried out 
well above pH 2 as in the present case.  
 
Ecell can therefore be expressed as: 
 
 Ecell = Eref + Ej + Eg 
                                                                                                                                               
(3.20) 
Since Eg depends on the activity of H+ ions ({H+}), Eg can be expressed in terms of the 
standard electrode potential (E0g) through the Nernst equation; 
 
              (  
  




where Ecell is the measured electromotive force (emf), R is the universal gas constant, T is the 
temperature of the system, and F is Faraday’s constant.   The activity of the hydrogen ion 
{H} ions can be expressed as; 
 
{H}= ϒH [H] 
(3.22) 
where ϒH is the activity coefficient and [H] is the concentration of H+ ions.    





∑      
  
                                                                                                                                            (3.23) 
 
where Ci is the concentration of species i and Zi is the charge of the ion. 
Since the activity coefficient is a constant at constant ionic strength and temperature, equation 
3.21 becomes: 
                
       
 
 
    (3.24) 




Where Econstant is standard electrode potential 
However, the potential depends on temperature and the relationship between the two varies 
with the activity of the hydrogen ion.   The slope (s) of the electrode can be expressed as; 
 
  
       
 
 
      (3.25) 
The dependence of potentials on pH yields a linear curve.   Substituting in the Nernst 
equation; 
 
                         
                            
(3.26) 
Calibration of the electrode requires the determination of both Econst and s. 
 
3.3 Equilibrium Simulation for Titration Analysis 
Equilibrium Simulation for Titration Analysis (ESTA)2 is a computer program used 
for the determination of the protonation/deprotonation constants of the ligand and the stability 
constants of the complexes in aqueous chemical equilibria.   This program has two types of 
program modules, namely, simulation module (ESTA1) which characterises the system on a 
point by point basis, and optimization module (ESTA2) which determines the best values 
based on a least squares procedure over a whole system of titrations.   The simulation unit 
(ESTA1) is used to calculate the complexation functions which help in the interpretation of 
data.   It can also be used to calculate the speciation of a solution.   The other program 
modules are the error propagation module (ESTA3) which performs a Monte Carlo error 
propagation analysis that identifies which parameters need to be refined, and the error 
imposition unit (ESTA7) which is used to examine the effects of random errors on the values 
of the refined parameters.   The plotting unit (ESTA5) is used to put the results calculated by 
ESTA1 in a graphic form.  
There are three tasks from the ESTA program which were used in this study, the formation 
functions (Z-bar), the deprotonation function (Q-bar) and the objective function (OBJE).   




The ZBAR and QBAR were respectively calculated within the ESTA1 module while OBJE 
(optimization with respect to the observed emf) was determined within the ESTA2 module. 
The program ESTA also incorporates the task SPEC within the ESTA1 module, and 
this calculates the distribution of species present in an equilibrium system as a function of the 
pH of the solution. 
3.3.1 The Objective Function 
The objective function18,19 of ESTA which optimises titration parameters, is described 
as the summation of all the squared residuals of the real parameter values from the calculated 
values.   The Gauss-Newton least squares method is used to minimize the objective function, 
Uobj which is expressed as: 
           
  ∑   
  
 
   
∑        
    
  
   
   
       
                                                                                                                                            (3.27)  
where N is the number of experimental titration points, np is the total number of points being 
optimised, ne is the total number of electrodes, wnq is the qth residual at the nth titration point, 
yncalc is the calculated variable of the qth residual at the nth titration point and ynobs is the 
observed variable of the qth residual at the nth titration point. 
 
By using Gauss-Newton methods, it is assumed that the objective function is 
quadratic with all the parameters.   Uobj can therefore be expressed as; 
 
         
   
    
 
 
                                                                                                                                            (3.28) 
where a and b are Gauss-Newton quadratic parameter vectors, p is the optimization parameter 
vector, pt is the transpose of p and H is the Hessian, Hsr expressed as; 
    
      
      
 
                                                                                                                                           (3.29) 




A well-defined system with good initial estimates often converges.   The calculations are 
terminated if the resultant shift vectors are large or if the shift vector has an upward gradient. 
 3.3.2 Formation Function (ZM-bar) and Deprotonation Function (QM-bar) 
The ZBAR task calculates the ZH-bar curve for ligand protonation and the ZM-bar 
curve for complex formation titrations.   In the absence of a metal ion the protonation 
function (ZH-bar) is expressed as; 
       
           
     
 
                                                                                                                                               
(3.30) 
where Tlig is the total concentration of the ligand, TH is the total concentration of hydronium 
ions and where TH is defined by; 
 TH = [  ] -       ∑       [L]
q [H] r 
                                                                                                                                              
(3.31) 
  
The ZH-bar function is plotted against pH.   ZH-bar may be described as the average number 
of hydrogen ions bound to the ligand at each pH. 
Figure 3.0A shows a typical ZH-bar curve.   If a ligand has two dissociable protons, ZH-bar 
levels off at two and one.   The pKa values can also be estimated from the ZH-bar curves.   
The pKa’s are given by the pH at the half-bar values.   E.g. log KLH = 8.09 and log KLH2 = 















 Figure 3.0 A: Typical ZH-bar.  
 
The complex formation function, ZM-bar, defines the average number of ligands bound per 
metal ion.   This can be expressed as: 
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(3.32) 
where, TL ,and  TM are the total ligand, and total metal concentration respectively.   And [L] 
is the free-ligand concentration; 
    
       
∑          
 
                                                                                                                                           (3.33) 
ESTA calculates the residual; 
               
 
      
 
     
                                                                                                                                                                
(3.34) 
where Z0-bar is the observed Z-bar and ZC-bar is the calculated Z-bar.   A low residual means 
that there is good agreement between the observed and calculated Z-bar curves, i.e. they are 
















representation of the equilibria.   It is noted however that the ZM-bar function applies only to 
mononuclear binary complexes.  
ZM-bar can be used to express the speciation of species such as ML, ML2, …MLn.   
A typical ZM curve is given in Figure 3.0B.   If ML is the most predominant species in 
solution, ZM-bar levels off at 1.   Log KML can be estimated from the pL that makes the  
mid-point of the steepest slope.   If MLH is one of the species in solution, the curve splits at 
high pL as shown by the red plot in Figure 3.0C.   The bending of the plots indicates the 
formation of hydroxo species.   From the ZM-bar graphs, the model of Cu(II)/ligand species 
can be predicted.   The bending of the pink plot in Figure 3.0C shows that the formation of 
MLH-1 species begins to form at very low pH’s.   
 
         
                                B         C 
   Figure 3.0: Typical ZM-bar curve when (B) ML is only species. (C) MLH and MLH-1 are present.  
 
The deprotonation function, QM-bar, is the average number of protons released per metal ion 
upon complexation.   Q-bar is expressed as; 
        
  
     
  
 





























where TH is the total proton concentration and T*H is the calculated total concentration of 
protons that would be necessary to give rise to the observed pH in the absence of metal ions 
or rather if no complexation took place.  
The mass balance equations for T*H and TL can be expressed as; 
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      (3.36) 
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  (3.37) 
 
where NJ is the total number of titration points.   When QM-bar has been calculated, it can be 
plotted as a function of pH.   ESTA plots QM-bar on the same graph with n-bar.    
 
For binary systems, a formation function for a ligand subsystem is defined as follows; 
       
  
      
  
  
                                                                                                                                            (3.38) 
The average number of dissociable protons in a complex would be represented as: 
F = qnbar - Qbarp                                                                                                                                                    
  (3.39) 
where p and q are the stoichiometric coefficients of the metal and the ligand respectively, and 
nbar is the average number of protons which would be bound to the ligand in the absence of 
metal complexation.   The agreement between the experimental plot and the theoretical plot is 
an indication of the validity of the proposed chemical model, a process termed pseudo-
plotting.20 
A typical QM-bar graph is given in Figures 3.0 D and E.   The pink plot is the n-bar 
and the blue plot is QM-bar.   The n-bar levels off at 1 indicating there is one dissociable 




proton on the ligand.   At pH 4.4 in Figure 3.0 D, there is crossover of n-bar and QM-bar 
curves.   This indicates that the proton on the ligand has been displaced due to complexation; 
therefore the species formed is ML.   At pH 6.13, the ligand lost two protons due to 
complexation (QM-bar = 1.6), the complex species formed here is the MLH-1.   Between pH 
8.6 and 11.0, n-bar and QM-bar are parallel indicating that there are no more protons being 
displaced by the metal ion.   The QM-bar curve can be also show the formation of hydroxol 
species if the curve goes-up as shown in Figure 3.0 E.  
 
    
                                     D             E 
Figure 3.0: D & E: Typical QM-bar curve when (D) ML is only species. (E) ML and MLH-1 are         
                                    present.  
 
3.3.3 Standard Deviation and Hamilton R-factor 
The standard deviations18,19are errors estimated for the parameters being optimized by 
the method of least-squares.   The standard deviation (σ) can be expressed as; 
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where G is the reciprocal of the Hessian, G = H-1. 
The agreement between the observed and calculated values of the refined data is determined 
by the Hamilton R-factor (   ).
18  It is represented as: 
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)     
                                                                                                                                            (3.41) 
(   ) depends on random errors and the number of variables optimised.   The limiting value 
of R (     ) is expressed as; 
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)     
                                                                                                                                          (3.42) 
 
The lowest value of R that is statistically significant based on the number of variables 
and the random errors in the analytical data.   The closer     is to       the better the 
agreement between the experimental and theoretical data.   If     is less than       the model 




3.4.1 Materials and Sample Preparation 
All solutions, at ionic strength 0.15M with (Cl-) Na+ as the background electrode, 
were prepared in glass-distilled water which had been passed through a Milli-Q water 
purification system (Millipore Corp.) and boiled to remove dissolved carbon dioxide.   Other 
reagents such as, CuCl2.2H2O, NiCl2.6H2O, ZnCl2, NaCl, HCl, NaOH, and EDTA (Merck) 
were bought commercially and were of analytical grade.   These were used without any 
further purification.   Standard divalent metal solutions of Cu(II), Ni(II), and Zn(II) were 
prepared in calibrated volumetric flasks according to Vogel's method21 for metal standard 
solution preparation.   The metal ion solutions were standardized by direct titration against 
EDTA16 using a Metrohm 765 Dosimat automated burette.   All weighing was done to 5 
decimal places on an A&D GH-202 analytical scale balance.   The concentrations of the 




metal ions ranged between 0.010 and 0.012 mol dm-3.   A solution of NaOH (0.1 mol dm-3) 
was prepared under a nitrogen atmosphere from Merck (1.09959-Titrisol) ampoules and 
standardized by titrating against potassium hydrogen phthalate (KHP) using the method of 
Gran.22  Ligand solutions were prepared in standard HCl solution and standardised by acid-
base titration according to Gran's method.22  
 
3.4.2 Potentiometric Measurements and Data Analysis  
Potentiometric titrations were performed under an inert atmosphere of purified 
nitrogen at 25oC and at a constant ionic strength of 0.15 mol dm-3 (NaCl) using a Metrohm 
848 Titrin plus.   The pH meter was equipped with a Metrohm 6.0259.100 glass electrode. 
The electrode slope was calibrated using three buffers.   The strong acid-strong base titrations 
were performed in order to calculate the values of the response intercept Eo, slope (s) and the 
dissociation constant of water (pKw) by introducing titration data into an ESTA file template. 
The value of the Nernstian slope varied between 58.40 and 58.71 over the pH range of  
2.00-11.00.   The values of  Eo varied from 397.87 to 409.71 millivolts,  while the average 
pKw value was 13.67.   The metal to ligand molar ratios varied between 1:1 and 1:2.   The 
metal ion/ligand system was then titrated with standard solutions of NaOH.  
 
The potentiometric titration data were analysed using the ESTA suite of computer 
programs.   The collected data were imported into a preformatted data file for the purpose of 
calculating the electrode parameters, protonation and formation constants.   The task BETA 
of the ESTA programs was used to evaluate the estimated complex species and their 
formation constants.   The output of this task was introduced into the task OBJE within the 
ESTA2 module to give optimised values of the stability constants and the ligand 
concentration describing the system.   Complex formation and deprotonation functions were 
calculated from stability constants obtained using the tasks ZBAR and QBAR within the 
ESTA1 module to find out if the model fitted the system.   After the completion of the model, 
the calculated β values from Equation 3.32 were used in the calculation of protons.   The 
validity of the model was checked by the comparison of the resulting calculated formation 
and the experimental curves.  
 
 




3.5 Results and Discussion 
3.5.1 Protonation Formation Function 
The overall protonation constants, as logβpqr for five ligands [H(555)NH2], 
[H(555)NMe2], [H2(555)NH2], [H2(565)NH2]  and [H(56)NH2] are given in the Table 3.1.   
The protonation constants for H+- L equilibria were evaluated in the pH range 2 - 11.   In 
order to examine the experimental data, the protonation curves of the ligands and species 
distribution graphs have been calculated and the results are presented in Figures 3.1 - 3.10 
below. 
3.5.1.1 H+ -[H(555)NH2] System 
The ZH-bar function, given in Figure 3.1, represents the variation of the mean number 
of protons bound to the ligand as a function of pH.   The blue markers represent the 
experimental data points while the pink markers are the theoretical curve calculated using the 
model given in Table 3.1.   At pH 10.90, ZH-bar is 0, and the ligand is fully deprotonated. 
From pH 10.6 to 8.5 ZH-bar rises.   In this pH range, the ligand is being protonated from the 
L-form to the LH-form.   From pH 8.1 to 6.1, ZH-bar was fairly constant (ZH-bar ≈ 1) 
indicating that no further protonation was occurring.   From pH 6 to 2 the curve rises to  
ZH-bar = 3, indicating the addition of two protons with similar pKa’s.    
 
 




















The excellent agreement between the theoretical and experimental curves in Figure 
3.1, at different total ligand concentrations, the low standard deviations in the log βpqr, as well 
as the Hamilton R factor lends confidence to the model.    
 
                   Table 3.1: Stability constants (log βpqr) for [H(555)NH2]. βpqr = [MpLqHr]/[M]p[L]q[H]r,                                                
                                     I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes standard deviation in          
                                     log βpqr;      is the Hamilton R-factor and        its limit. 























 Figure 3.2 shows the speciation diagrams of [H(555)NH2] from pH 2 to 11.   At  
pH < 10.0 the most predominant species was L.   The species LH dominates at pH 7.   The 
species LH2 and LH3 are predominant, between pH 6.2 and 2.0 and below pH 5.00 
respectively, in aqueous solution. 
 
 



















L LH LH2 LH3




3.5.1.2 H+ -[H(555)NMe2] System 
Figure 3.3 shows ZH-bar as a function of pH for the protonation of [H(555)NMe2].   
The ligand has three pronation sites.   From the half-bar values the first two pKa’s are 
estimated to be 9.2 and 4.8.   Since the curve does not rise to a ZH-bar of 2.5, the last pKa 
cannot be estimated.   The refined beta’s for this system are given in Table 3.2 and the 




   Figure 3.3: ZH-bar for the protonation of [H(555)NMe2]. 
 
The excellent agreement between the theoretical and experimental curves lends 
confidence to the results.   The standard deviations σpqr and RfH are small 
 
                   Table 3.2: Stability constants (log βpqr) for [H(555)NMe2]. βpqr =  [MpLqHr]/[M]p[L]q[H]r,                                  
                                  I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes standard deviation in          











































Figure 3.4 shows the species distribution curves for [H(555)NMe2].   The plots 
indicate that the ligand solution has a mixture of di-protonated and tri-protonated species at 
pH < 4.   At pH = 7 the most predominant species was LH, whereas the neutral form of the 
ligand L predominates at pH > 9.5. 
 
   Figure 3.4: Distribution Curve for the protonation of [H(555)NMe2]. 
 
3.5.1.3 H+-[H2(555)NH2] System 
 Figure 3.5 shows that this ligand contains one measurable protonation site as revealed 
by the levelling off of the ZH-bar function at 1.0. 
 




































 The theoretical and experimental curves are well superimposable, as shown in  
Figure 3.5.   The optimised formation constant is given in Table 3.3. 
              
   Table 3.3: Stability constants (log βpqr) for [H2(555)NH2]. βpqr = [MpLqHr]/[M]p[L]q[H]r,                                                
                     I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes standard deviation in          
                     log βpqr;    
  is the Hamilton R-factor and        its limit. 
p q r log βpqr S.dev            nT(np) 
0 1 1 8.96 0.003 0.008 0.009 3(74) 
 
 The two species of this ligand are shown by the speciation graph in Figure 3.6.   The 
species [H2(555)NH2] and [H2(555)NH2]H+ are the most predominant species above and 
below pH 9.02 respectively in aqueous solutions of the ligand.  
 
                       Figure 3.6: Distribution Curve for the protonation of [H2(555)NH2]. 
 
3.5.1.4 H+-[H2(565)NH2] System 
The ZH-bar as a function of pH is shown in Figure 3.7.   The graph rises from pH 9.04 
to 7.39 indicating that one proton was added to the ligand, resulting in a mono-protonated 
ligand at this pH.   The ZH-bar function levels off on 1 (i.e. ZH-bar = 1) between pH 6.86 and 
5.65, and then it rises until it reaches ZH-bar = 2 below pH 5.65.   This indicates that 






















        Figure 3.7: ZH-bar for the protonation of [H2(565)NH2]. 
 
The theoretical and experimental curves are well superimposable which support the 
[H2(565)NH2] protonation model.   The standard deviations are small and the model is 
accurate since      is less than      .   Optimized log βpqr are given in Table 3.4.    
 
                   Table 3.4: Stability constants (log βpqr) for [H2(565)NH2]. βpqr = [MpLqHr]/[M]p[L]q[H]r,                                           
                                  I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes standard deviation in          
                                  log βpqr;      is the Hamilton R-factor and        its limit. 
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Figure 3.8 shows the distribution of species from pH 2 to 11 for [H2(565)NH2] 
protonation, which confirms that the species [H2(565)NH2]H+ dominates in the pH range  
4.35 – 8.11.   At pH 8.23 there is already more [H2(565)NH2] than [H2(565)NH2]H+  in 
solution.   Below pH 4.24, the most predominant species is [H2(565)NH2]H2+2 in aqueous 





















 Figure 3.8: Distribution Curve for the protonation of [H2(565)NH2]. 
 
3.5.1.5 H+-[H(56)NH2] System 
Figure 3.9 shows the plot of the formation function, ZH-bar as a function of pH for the 
protonation of [H(56)NH2].   The function levels to zero at a high pH of 11.10, afterwards it 
rises up and then levels off at Z-bar value of 1 between pH 8.10 and 6.15.   Below pH 5.31 
the function rises and levels off at a ZH-bar value of 2.0.   That indicating two protons have 
been added to the ligand making it di-protonated at low pH.  
 
 





































Table 3.5 shows log βpqr for the protonation of [H(56)NH2].   The agreement between 
the theoretical and the experimental plot gives us confidence in the model. 
              Table 3.5: Stability constants (log βpqr) for [H(56)NH2]. βpqr = [MpLqHr]/[M]p[L]q[H]r,                                                
                                  I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes standard deviation in          
                                  log βpqr;      is the Hamilton R-factor and        its limit. 


















Figure 3.10 shows the speciation diagrams for [H(56)NH2] protonation from pH 2.0 to 
11.0.   The most predominant species in solution from pH 11.0 to 9.48 is [H(56)NH2] species.   
[H(56)NH2]H+ is the dominating species at physiological pH. From pH 4.13 to 2.07, 
[H(56)NH2]H2+2  is predominant in solution. 
 
 Figure 3.10: Distribution Curve for the protonation of [H(56)NH2]. 
 
3.5.1.6 Discussion – Protonation Constants 
The protonation constants results for the ligands involved in this study are presented 
in Tables 3.1 to 3.5.   These results show low standard deviations while their      values are 
either close or smaller than their corresponding      .   This gives confidence to the chosen 
models.   Protonation or deprotonation constants were measurable for all the available amines 





















are too basic (pKa ≥ 15)23 and outside the pH range 2 – 11 of our glass electrode.   Several 
other workers24-27have also observed that it is not possible to estimate deprotonation of the 
amide nitrogen outside the upper pH limit of our measurements.   However, the deprotonation 
of the amide protons is facilitated by the presence of metal ions such as Cu(II).28,24  So far we 
have always treated equilibrium constant as formation constant while pKa is the equilibrium 
constant when the ligand is acting as an acid i.e deprotonation rather than formation.   The 
measured pKa values are given in Table 3.6. 
             Table 3.6: Stability and Equilibrium constants for [H(555)NH2], [H(555)NMe2],          
                               [H2(555)NH2],  [H2(565)NH2] and  [H(56)NH2]. βpqr = [MpLqHr]/[M]p[L]q[H]r,                       
                               I = 0.15 mol.dm-3 (NaCl), T = 25 ºC. 



























































 The three measurable acid dissociation constants of both [H(555)NMe2] and 
[H(555)NH2] correspond to the pyridyl nitrogen and the two amino groups.   The low values 
of the first protonation constant (pKa1) corresponding to the pyridyl nitrogens are due to the 
electronic repulsion effect and the base weakening effect of the adjacent amide groups.29   
The pKa values of pyridine and 2-methylpyridine are reported as 5.34 and 6.14, 
respectively,30 whereas the introduction of a carbonyl group in 2-methylpyridine results in a 




pKa value of 2.66.23  Therefore, it would be expected that the protonation constant 
corresponding to the pyridyl nitrogen in [H(555)NMe2] and [H(555)NH2], should decrease 
further when an amide group is present.  
The pKa3 for the terminal amino groups of [H(555)NMe2] and [H(555)NH2] is 9.23 
and 9.67 respectively.   This pKa is less than the corresponding pKa of ethylenediamine 
(9.89).31,32  This is attributed to the electron-withdrawing effects of the amide group.31,33  The 
observable reduction in pKa3 in  [H(555)NMe2] compared to that in the analogous 
[H(555)NH2] is due to H-bonding and solvation effects as one moves from primary to tertiary 
amines.34,25  These values are also reasonably close to the first protonation of [H(555)-N]  
(9.40),31 which is an analogous ligand but with the amide carbon adjacent to the pyridine 
ring.   pKa2 of [H(555)NMe2] and [H(555)NH2] are 4.74 and 5.26 respectively and refers to 
protonation of the second amine.   The decrease in basicity is due to electronic repulsion 
when a proton is added to a molecule already containing a proton.   These values are lower 
than the corresponds protonation of  [H(555)-N]31 (6.23).   This is because the secondary 
nitrogen donor atoms of [H(555)NMe2] and [H(555)NH2]  are close to an electron 
withdrawing amide group. 
Two protonation sites are available in [H2(555)-NH2] but only one protonation 
constant was determined by ESTA optimization18 of the potentiometric data.   The pKa = 8.96 
corresponds to the protonation constant of the amino group.   The fact that the protonation 
constant is lower than that of ethylenediamine (pKa = 9.89)32 is due to the electron 
withdrawing effects of the two amide groups31 present in the ligand, capable of drawing 
electrons towards themselves through inductive effects.   S. Odisitse23reported the pKa of the 
pyridyl nitrogen 3.51 in N,N'-bis[2(2-pyridyl)-methyl]pyridine- 2,6-dicarboxamide which is 
quite  similar to the pKa of the pyridyl nitrogen in [H2(555)NH2]. 
[H2(565)NH2]  shows two pKa values arising from the pyridyl nitrogen and the amino 
group, pKa1 = 4.38 and pKa2 = 8.08 respectively.   The chemical environment associated with 
the pyridyl nitrogen is the same as that found in [H(555)NMe2] and [H(555)NH2] thus giving 
very close pKa values differing by only 0.9 and 0.6 log unit respectively.   However, the low 
pKa1 or rather acidity of the pyridyl nitrogen is due to the electronic repulsion effect and also 
the base weakening effect of the CONH group.29  The  amino group is observed to be less 
basic than the nitrogen donor atoms of ethylenediamine (pKa2 = 9.89).35 




A similar protonation scheme is observed for [H(56)NH2] with pKa1 = 4.21 and pKa2 = 
9.39 for the pyridyl nitrogen and amino group  respectively.   The pKa1 is almost equal to that 
of [H2(565)NH2], whereas the pKa2 = 9.39 is observed to be less basic than the nitrogen donor 
atoms of diethylenetriamine (dien) (9.84)35 and higher than [H2(565)NH2] (8.08).   The base 
weakening effect has also been attributed to the same cause as has been mentioned above. 
3.5.2 Complex Formation and Deprotonation Functions 
The ZM-bar and QM-bar functions derived from experimental data were used to 
visualize the data and help with speciation model selection.  
3.5.2.1 Cu(II)-L Systems 
3.5.2.1.1 Cu(II)-[H(555)NH2] System 
ZM-BAR for Cu(II)-[H(555)NH2] as a function of pL is given in Figure 3.11(a).    
ZM-bar should rise and level off towards a ZM-bar limiting value of 1.0 for mononuclear ML 
species formation.   This was not observed in this system.   The ZM-bar function levels off at 
1.39 indicating that ML is not the only species in solution.   The curves rise steeply and fan 
back at pL 8.28, indicating loss of an amide proton upon metal coordination.36,37  The 
deprotonation function in Figure 3.11(b) rises to a maximum value of about 2.61 between pH 
3.71 and 4.76 indicating that approximately three protons have been released from the ligand 
due to complexation.   Between pH 4.6 and pH 7.0, QM-bar runs parallel to n-bar.   This 






















               Figure 3.11 (a): ZM-bar as a function of pL for Cu(II)-[H(555)NH2] Complex. (b): QM-bar       
                                     as a function of pH Cu2+/ [H(555)NH2] Complex. 
 
The reproducibility of repeat titrations and excellent agreement, at different metal to 
ligand ratios, between the theoretical and experimental formation and deprotonation function 
curves.   The analysis of the potentiometric data using the ESTA suite18 of programs yielded 
the results given in Table 3.7.   Furthermore, very low standard deviations and Hamilton  
R-factors were found.   This lends confidence to the model selected.   It is worth noting that 
several possible species were tried but were rejected by the optimization process. 
 
     Table 3.7: Stability constants (log βpqr) for Cu(II) of [H(555)NH2] complexes βpqr =   
                           [MpLqHr]/[M]p[L]q[H]r, I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes   
                           standard deviation in log βpqr;      is the Hamilton R- factor and        its limit.  
Metal p  q r log βpqr S.dev         

























The speciation graphs in Figure 3.12 shows that ML and MLH-l predominate over a 




















formation at pH 3.75 and at pH 7.43 MLH-l species reaches 99.92% formation whereas MLH 
species do not exceed 5% formation.  
 
 
 Figure 3.12: The distribution curve for Cu(II)-[H(555)NH2] Complex. Metal to  
                                        Ligand ratio 1:2. 
 
3.5.2.1.2 Cu(II)-[H(555)NMe2] System 
The complex formation behaviour of the Cu(II)-[H(555)NMe2] system is shown in 
Figure 3.13(a).   like the Cu(II)-[H(555)NH2]  system, the ZM-bar levels off at 1.2, indicating 
that ML is not the predominant species in solution.   The fanning back of the curves at high 
pH is presumably due to the formation of MLH-l and MLH-2 species.   Figure 3.13(b) shows 
the deprotonation function as a function of pH.   When the titration starts at pH of 2.94, the 
function is greater than zero indicating that complexation has already started.   QM-bar then 
increases rapidly in the pH range 2.94 - 3.83 to a maximum value of 2.26.   The n-bar curve 
shows that at pH 3.83 there are essentially two protons to be displaced from the ligand by the 
metal ion.   Complexation was complete between pH 4.55 and pH 8.36. At pH > 9.50 the  
Q-bar curve rises, which indicates hydrolysis of the metal ion forming an MLH-2 species for 
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              Figure 3.13 (a): ZM-bar as a function of pL for Cu(II)-[H(555)NMe2] Complex. (b): QM-bar             
                                         as a function of pH  Cu(II)-[H(555)NMe2] Complex. 
 
Optimised log βpqr are given in Table 3.8.   The standard deviations are small and      
is less than      .   The agreement between the theoretical and experimental complex 
formation curves at different metal to ligand ratios supports the potentiometric model chosen 

































        Table 3.8: Stability constants (log βpqr) for Cu(II) of [H(555)NMe2] complexes. βpqr =   
                          [MpLqHr]/[M]p[L]q[H]r, I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes       
                          standard deviation in log βpqr;      is the Hamilton R-factor and        its limit. 
Metal p  q r log βpqr S.dev         

























The speciation graphs in Figure 3.14 show that ML, MLH-l and MLH-2 are present at 




 Figure 3.14: The distribution curve for Cu(II)-[H(555)NMe2] Complex. Metal to                                                                
                                        Ligand ratio 1:1.5. 
 
3.5.2.1.3 Cu(II)-[H2(555)NH2] System 
The ZM-bar curves in Figure 3.15(a) level off at ~ 0.8, indicating that ML is not the 
predominant species in solution.   The fanning of ZM-bar for higher metal to ligand ratios is 
indicative of loss of an amide proton upon metal coordination.   On the other hand QM-bar in 
Figure 3.15(b) shows that at the start of the titration, at pH of approximately 2.32, Q-bar is 
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rises in the pH range between 2.32 and 3.97.   Between pH 4.45 and 5.94 Q-bar correspond 
with n-bar, indicating that no further complexation takes place in this pH range.   The Q-bar 






                Figure 3.15 (a): ZM-bar as a function of pL for Cu(II)-[H2(555)NH2] Complex. (b): QM-bar   
                                          as a function of pH  Cu(II)-[H2(555)NH2] Complex. 
 
The stability constants are given in Table 3.9.   The standard deviations are small and  
   

































        Table 3.9: Stability constants (log βpqr) for Cu(II) of [H2(555)NH2] complexes. βpqr =  
                           [MpLqHr]/[M]p[L]q[H]r, I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes   
                            standard deviation in log βpqr;      is the Hamilton R-factor and        its limit. 
Metal p  q r log βpqr S.dev         






























The speciation graph for Cu(II)-[H2(555)NH2] is given in Figure 3.16.   Complexation 
begins at pH 2.07 for MLH.   ML is the most predominant in solution in the pH range 3.44 
and 6.75.   MLH-1 is the most predominant in solution between pH 6.76 and 6.89. MLH-2 
species is most predominant at pH > 8.11. 
 
   Figure 3.16 : The distribution curve for Cu(II)-[H2(555)NH2] Complex. Metal to     
                                          Ligand ratio 1:1. 
 
3.5.2.1.4 Cu(II)-[H2(565)NH2] System 
The complexation of [H2(565)NH2]  with Cu(II) seems to be different from that of the 
[H(555)NH2], [H(555)NMe2] and [H2(555)NH2]  systems as observed from the formation and 
deprotonation functions in Figure 3.17(a) and 3.17(b) respectively.   The ZM-bar function 
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Cu(II)-[H2(565)NH2] system is not predominant in solution.   The graph flags back at low 
pL’s corresponding to lower metal to ligand concentration ratios.   This indicates loss of the 
amide protons in this ligand system upon metal ion coordination due to formation of MLH-2 
species at Low pH.   The deprotonation function rises to maximum value of about 3.0 at pH 
5.1 indicating that approximately three protons have been released from the ligand due to 
complexation.   At this pH the ligand has only two protons or rather QM-bar(=3.0) > n-bar 
(=1.5) suggesting the formation of MLH-l species as a result of the release of an amide 






  (b) 
Figure 3.17 (a): ZM-bar as a function of pL for Cu(II)-[H2(565)NH2] Complex. (b): QM-bar as  

































The stability constants for species formed between Cu(II) and [H2(565)NH2]  from pH 
2.0 to pH 11.0 are given in Table 3.10.   The excellent agreement between the theoretical and 
experimental formation as well as small standard deviations and       ≈       .   These show 
that the model is accurate.   Note in this case there is no MLH-1 species.   Different models 
were tried but this species was always rejected. 
 
      Table 3.10: Stability constants (log βpqr) for Cu(II) of [H2(565)NH2] complexes. βpqr =  
                            [MpLqHr]/[M]p[L]q[H]r, I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes    
                             standard deviation in log βpqr;      is the Hamilton R-factor and        its limit. 
Metal p  q r log βpqr S.dev         

























The speciation graphs are given in Figure 3.18.   Mixed species are observed at all pH 
values except at pH below 2.5 where there is about 100 % Cu(II) in solution, and at pH above 
5.3 where almost all Cu(II) ion in solution exist in MLH-2 form. 
 
 
   Figure 3.18: The distribution curve for Cu(II)-[H2(565)NH2] Complex. Metal to                                                           
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3.5.2.1.5 Cu(II)-[H(56)NH2] System 
 A plot of the complex formation function is given in Figure 3.19(a).   From pL 10.44 
to pL 9.00, the ZM-bar is equal to zero.   Then the ZM-bar rises from pL 8.68 to pL 7.36.   
From pH 7.02 to pH 5.02, ZM- bar = 2.   Figure 3.19(b) shows that at pH 3.2 the 
deprotonation function QM-bar of zero indicates that no protons have been displaced due to 
complexation.   For pH values above 3.41, the deprotonation function QM-bar rapidly rises to 
intersect the protonation curve ( n-bar) at a pH of 4.43, reaching a maximum value of about 
2.01 at pH 5.03.   This indicates that metal-assisted deprotonated MLH-l and MLH-2 are being 
formed although ZM-bar shows is not fanning back at pL 5.0.   Above pH 5.03, the QM-bar 





                   Figure 3.19 (a): ZM-bar as a function of pL for Cu(II)-[H(56)NH2] Complex. (b): QM-bar  
































The standard deviations are reasonably low, and the Hamiltonian R-factor is low thus 
giving confidence for the model chosen in Table 3.11. 
         Table 3.11: Stability constants (log βpqr) for Cu(II) of [H2(565)NH2] complexes. βpqr =    
                              [MpLqHr]/[M]p[L]q[H]r, I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes   
                               standard deviation in log βpqr;      is the Hamilton R-factor and       its limit. 
Metal p  q r log βpqr S.dev         

























Figure 3.20 shows the speciation graph for Cu(II)-[H(56)NH2] system.   ML, MLH-1 
and MLH-2 are present in significant levels at different pH values i.e. 11.07% (pH 4.24), 
99.60% (pH 7.09) and 95.45% (pH 10.85) respectively. 
  
                  Figure 3.20: The distribution curve for Cu(II)-[H(56)NH2] Complex. Metal to                                                        
                                         Ligand ratio 1:2. 
3.5.2.2 Ni(II) System 
Several of Ni(II)-systems in this study were kinetically slow.   This was shown by a 
drift in pH and measurements could only be taken after a stable pH was reached.   These data 
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same way as for the Cu(II)-systems and will not be discussed.   The ZM-bar, QM-bar and 
speciation curves are presented in appendix Figure A1-A15.    
        Table 3.12: Stability constants (log βpqr) for Ni(II) of [H(555)NH2], [H(555)NMe2],   
                              [H2(555)NH2], [H2(565)NH2] and [H(56)NH2] complexes. βpqr =    
                              [MpLqHr]/[M]p[L]q[H]r, I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes   
                              standard deviation in log βpqr;      is the Hamilton R-factor and        its limit.   
Ligands p   q r log βpqr S.dev          





















































































































3.5.2.3 Zn(II) System 
 The ZM-bar and QM-bar functions, as well as the speciation graphs, are given in  
Figures B1 – B15.   The data were analysed by using the ESTA suite of programs and the 
results are given in Table 3.13.   The ZM-bar function for Zn(II) with [H2(555)NH2] and  




[H2(565)NH2] systems levelling off  to a value of 1.0, clearly indicates the formation of ML 
as the predominant species.   In the other Zn(II)-ligand systems studied, the ML species is 
never dominant and hence the ZM-bar curves do not level off at 1.0. 
Table 3.13: Stability constants (log βpqr) for Zn(II) of [H(555)NH2], [H(555)NMe2],   
                         [H2(555)NH2], [H2(565)NH2] and [H(56)NH2] complexes. βpqr =        
                         [MpLqHr]/[M]p[L]q[H]r, I = 0.15 mol.dm-3 (NaCl), T = 25 ºC.  S. dev denotes   
                         standard deviation in log βpqr;      is the Hamilton R-factor and        its limit.  
Ligands p   q r log βpqr S.dev          











































































































3.5.2.4 Discussion – Stability and Structure of Complexes 
The five ligands used in this study were chosen to test the effect of the number of 
amide groups and the effect of methyl substitution upon the stability of the metal complexes.   
All five ligands have the same N-((pyridin-2-yl)methyl)acetamide moiety.   The calculated 
equilibrium constants are given in Table 3.14 




Table 3.14: Stability constants (log βpqr) for Cu(II) of [H(555)NH2], [H(555)NMe2], [H2(555)NH2],   
                    [H2(565)NH2] and [H(56)NH2] complexes. βpqr = [MpLqHr]/[M]p[L]q[H]r, I = 0.15   
                    mol.dm-3 (NaCl), T = 25 ºC.     


































































The effect of methyl substitution is shown by a comparison of the formation constants 
for the mononuclear ML species of [H(555)NH2] and [H(555)NMe2], which are the same 
except for the two terminal methyl groups.   Addition of the methyl groups decreases the 
stability of the Cu(II) complex from 11.8 to 10.9.   The reason for this could be inductive or 
steric.   The inductive effect is shown by the protonation constants, as H+ is too small to have 
a steric effect.   The difference in protonation constants (log β011) for these two ligands is 
~0.4, which is too small to account for the difference in the Cu(II) complex stability.   Hence 
the predominant effect must be steric.  




The effect of the amido group is shown by comparing [555-N]31, [H(555)NH2] and 
[H2(555)-NH2].   All three ligands have the same structure but [555-N] has no amide group, 
[H(555)NH2] has one amide group and [H2(555)-NH2]  has two amide groups.   The three 
stability constants are 18.62, 11.81 and 9.39 respectively.   This shows that the amide group 
decreases the stability of the complex substantially.   This result is not unexpected as it is in 
complete accordance with the base-weakening effect of the CONH-group.33  Again this could 
be an inductive effect or the actual structures of the different complexes could be different.   
This is shown by comparing [H2(555)NH2] and [H2(565)-NH2].   When the second amido 
group is moved so that the two carbonyls are no longer adjacent the stability decreases from 
9.39 to 5.93.   Since in [H2(565)-NH2] the carbonyl is closer to the terminal amine, the 
basicity of the amine  decreases from 8.96 to 8.08, a change of 0.9 log units.   This change is 
not big enough to account for the decreased stability of the Cu(II) complex.   Rather there 
must be a change in coordination geometry.   For this reason we need to discuss the possible 
geometries of the different species, remembering however, that thermodynamics tells us 
about the stability of the complex and not its structure.   This structure has to be inferred from 
comparison with related complexes of known structure or determined spectroscopically. 
Ligands used in this study have four main electron donor atoms; amino nitrogen 
(amine-N); amide  nitrogen (amide-N); pyridine  nitrogen (pyridyl-N) ; amide carbonyl 
(amide-O) and hydroxide oxygen (OH-); water oxygen (H2O).    
3.5.2.4.1 The structures of [H(555)NH2] and [H(555)NMe2] 
The MLH formation constants for [H(555)NH2] is 13.89.   Proposed structures of this 
complex are given in Figure 3.21.   They are formed by the coordination of one/two  
amino-N’s with the pyridyl-N protonated or by the pyridyl-N with the amino group 
protonated.   The amide-O is also coordinated.   Of the two structures, a(i) seems a more 
likely coordination geometry than structure a(ii) due to the formation of stable 5,5 membered 
chelate rings rather than 7,5 chelate rings.   In addition the pKa of this species  
(MLH  ML + H) is ~2, which is close to the pKa of the pyridine.   However, 
coordination through the pyridyl-N is also feasible and has been demonstrated for Cu(II) 
N,N'-di(aminoethylene)-2,6-pyridine-dicarbonylamine (Figure 3.31)38, where coordination is 
via one amino-N, the pyridyl-N and the amide-O.   The other amine group is protonated. 










Figure 3.21: Possible structures for MLH of Cu(II)- [H(555)NH2] system. 
The log β110 values for ML in Cu(II)-[H(555)-NH2] and Cu(II)-[H(555)-NMe2] are 
11.81 and 10.90 respectively.   This is much higher than the stability of [Cu(II)(NH3)]2+  
(4.8), suggesting that the ligands are not monodentate.   In fact the log β110 values are similar 
to the log β110 value for the [Cu(II)(en)]2+ (10.5), suggesting that the ligands have a similar 
binding mode.   However, since the basicity of ethylenediamine is less than our two ligands 
one would expect its Cu(II) complexes to be more stable.   In fact they are ~ 1 log unit more 
stable, implying that there is an extra weak binding in these complexes.   Figure 3.22 b(i) and 
b(ii) show possible structures for these complexes.   The weak binding is due to a pyridyl -N 
and an amide-O present in these ligand systems giving these complex species extra stability.   
The formation of three stable membered chelate rings, as shown in structures Figure 3.22 
b(i), are responsible for the increase stability.   Even though both structures 3.22 b(i) and b(ii)  
are  coordinated via 3N they have smaller log β110 than [Cu(II)(dien)]2+  (15.9).   This is 
consistent with the amino (-NH2) group being a stronger base than pyridine.   Of the two 
possible structures, we prefer 3.22b(i) because it has two amine-N’s coordinated giving rise 
to 2 five membered and 1 seven membered chelate rings.   In addition, in structure 3.22b(ii) 
















Figure 3.22: Possible structures for ML of Cu(II)-[H(555)NH2] and  [H(555)NMe2] systems. 
Based on the two possible structures for ML, the transformation to MLH-1 could form 
by deprotonation and coordination of the terminal amine or a swap from O to N coordination 
of the amide.   The pKa for this process (log β110 – log β11-1) is 4.36 and 4.72 for  
Cu(II)-[H(555)-NMe2] and Cu(II)-[H2(555)-NH2] respectively.   This can be compared to the 
same process occurring with 3,5-diaminodiamido-4-oxahexacyclododecane (cageL) (pKa = 5 
for the process log β110 – log β111) where it is known that coordination is accompanied by 
deprotonation of the terminal amine.39  However, this is also the range expected for metal-
assisted deprotonation of the amide proton.24,40,41  Both of these process give the same 
structure for MLH-1 (Figure 3.23 c(i)).   This is the same geometry that was suggested for 




















The pKa value determined for MLH-1 the Cu(II)-[H(555)NMe2] system (CuLH-1   
CuLH-2+H+) is 9.81.   This is higher than the pKa for [Cu(H2O)6] (8.00) and  is presumed to 
be associated with deprotonation of an axially coordinated water molecule.   Note the 
structure for MLH-1 does not have any equatorial waters.  
3.5.2.4.2 The Structures of [H2(555)NH2] 
The postulated structures of the MLH species in [H2(555)NH2] are shown in  
Figure 3.24, where a(i) is more favourable than structure a(ii).   The equilibrium constant of 
the reaction M + LH  MLH is ~ 4.   Given the basicity of the pyridine, this value is too 
high for monodentate coordination (2-methylpyridine, pKa =6.14; 1og β110 = 1.69).23,42  The 
obtained value suggests predominant pyridine coordination (perhaps together with weak 
coordination of the amide-O) in this species.   The terminal amine is still protonated giving 








Figure 3.24: Possible structures for MLH-2 of Cu(II)-[H2(555)NH2] system. 
Loss of a proton from MLH gives rise to the ML complex.   A possible structure of 
ML is depicted in Figure 3.25b.   The complex is formed at pH 6 which means that the amine 
must either be coordinated or protonated.   While this structure has the amine-N and the 
pyridyl-N both coordinated it has a very large chelate ring.   Copper binding constants are 
9.96 for Cu(II) cageL (pKa1= 9.52; pKa2= 8.28) which forms 7 and 8 membered rings; and 8.6 
for 1,4-butylenediamine (pKa1= 10.72; pKa2= 9.44) which form 7 membered chelate rings.39,43  
The increase in basicity of the amines should increase the stability of the complex but this is 
countered by the decrease in chelate effect.  




A possible structure for MLH-1 is depicted in Figure 3.25c.   The pKa of CuL in 
solution, CuL  CuLH-1+H+, is 6.68.   This can be compared to the same process occurring 
with Cu(II) glycinamide (pKa 6.8), where it is known that deprotonation causes exchange 
from the amide-O to the amide-N.44  Similarly, Odisitse et al.39 have proposed a structure in 









Figure 3.25: Possible structures for (b) ML and (c) MLH-1 of Cu(II)-[H2(555)NH2] system. 
 The pKa value corresponding to the deprotonation of MLH-1 is 7.98.   This could be due 
to metal-assisted deprotonation and coordination of the second amide25,45 or loss of a proton 
from a coordinated water molecule.   Even though the hydrolysis constant of Cu(H2O)6 is 8.0 
we believe that deprotonation of the amide has occurred.   The structure of the resulting 







Figure 3.26: Possible structures for MLH-2 of Cu(II)-[H2(555)NH2] system. 
 




3.5.2.4.3 The Structures of [H2(565)NH2] 
The proposed structures of the MLH species for the Cu(II)-[H2(565)-NH2] system is 
given in Figure 3.27a (i and ii).   The species MLH is not very stable and is present in very 
low concentration.   Log K for the equilibrium M + LH  MLH is 1.96.   This is quite 
similar to the stability of 2-methylpyridine, log β110 = 1.69.42  Structures in Figure 3.27  
a (i and ii) have the metal bi- or tri-dentate coordinated to one the pyridyl-N and one/two the 
amide-O.   The terminal amine is still protonated.   In the postulated structure given in Figure 
3.27 a(i), a pyridyl-N and one amide-O donor are coordinated forming a 7 chelate ring 
system.   However, the feasibility of this structure is unlikely based on the low stability of the 
chelate rings.   The structure given in Figure 3.27 a(ii) is favoured because of formation of 
two chelate rings in contrast with the one chelate ring of structure 3.27 a(i).   Further support 
for this conclusion comes from the demonstration that with [Cu(II)en] (log β110 = 10.5) where 
two donors are present, log β110 is 0.46 log units higher than log β111 = 10.04. 
 
 
Figure 3.27: Possible structures for MLH of Cu(II)-[H2(565)NH2] system. 
In the formation of the ML species from MLH, the ML could be formed by 
deprotonation of the terminal amine to give structure 3.28b(ii).   Alternatively, one of the 
amides could deprotonate to give structure 3.28b(i) where the second amide-O is coordinated. 
The pKa for this process CuLH  CuL +H  is 4.36.   Again this can be compared to the 
same process occurring with glycinamide (pKa 6.8) where it is known that coordination 
exchanges from the amide-O to the amide-N.44  For [H2(555)NH2] the pKa was 6.68 while 
here it is  2.4 log units lower.   This could be due to the position of the second amide group 
which changes the size of the chelate ring.   Comparing 1,2-ethylenediamine (pKa1 =9.89; 
pKa2 =7.08), 1,3-propylenediamine (pKa1 = 10.56; pKa2 = 8.76) and 1,4-butylenediamine 




(pKa1 =10.72; pKa2 =9.44), which form 5, 6 and 7 membered chelate rings respectively, the 
copper binding constants are 10.5, 9.7 and 8.6, respectively.43,39  The increasing basicity of 
the amines should increase the stability of the complex but this is countered by the decreased 
chelate effect.   ML of the Cu(II)-[H2(565)NH2] complex starts to form just past pH 3 and 
rapidly reaches a maximum value over a small pH range of less than 1.5 units.   This means 
once the first coordination bond is formed, the chelate effect will aid in formation of the next 
coordination bonds to the central Cu(II) ion.   However, from the potentiometric data we 
cannot distinguish between these structures. 
 
 
Figure 3.28: Possible structures for ML of Cu(II)-[H2(565)NH2] system. 
The MLH-2 is the predominant species of Cu(II)-[H2(565)NH2] with deprotonation 
and coordination of two amide-N’s to give the structure 3.29c.   The logK for the equilibrium  
M + LH2 ↔ MLH-2 is 9.4.   The formation of MLH-2 complex is observed at high pH.   This 
species is formed when all the four nitrogens in the ligand are coordinated to the metal ion 
thus making a 5,6,5 membered ring.   It is reported that an increase in number of chelate rings 
around the metal ion results in large girdle strains, thus influencing the stability of complexes 
formed.46  However the formation constants determined for Cu(II)-[H2(565)NH2]  showed a 
somewhat lower coordination ability of MLH-2 species compared to the analogous ligands 
containing an imidazole ring, a methyl group, or having additional O-donor group(s)     
(amide and/or carboxylate).   For instance glycylglycylhistamine (ggha)47, alanylglycyl- 
histamine (Ala-Gly-Ha)48, and Gly-Gly-His49,50, formation constants have been reported as: 
log β11-2 ~ -2.48; -2.86; and -1.80 respectively.   Also Cu(II)-[H2(565)NH2] has  higher 
coordination with log β11-2 = -3.06 compared to the analogous ligand containing pyridine ring 




[H2(556)-N]27 which has shown log β11-2 = -4.09.   The difference can be attributed to the 
basicity of an imidazole and weak axial coordination of the O-donor group.   The analogous 









Figure 3.29: Possible structures for MLH-2 of Cu(II)-[H2(565)NH2] system. 
3.5.2.4.4 The Structures of [H(56)NH2] 
The log β110 value for an ML in the Cu(II)-[H(56)NH2] (6.83) is observed to be 
similar to the log β110 value for ML of GlyGlyHis (7.60).51  This supports binding of the 
amino-N, a pyridyl-N, and an amide-O to the metal ion.   Thus structure a(i) in Figure 3.30 is 
more likely than a(ii).   The formation of the MLH-1 species could then arise from 
deprotonation of the amide group.   The pKa for this reaction (log β110 – log β11-1) is 3.62,  in 
the range expected for metal-assisted deprotonation of the amide proton24,31,41, rather than a 
water molecule from the coordination sphere of the complex.   The ligand is postulated to 
coordinate to Cu(II) ion through three nitrogen donor atoms leaving two axial sites occupied 
by water molecules.   The structure is given in Figure 3.30b.   The pKa value determined for 
MLH-2 system         (log β11-1 – log β11-2 = 9.53) is assigned to deprotonation of an axial water 
molecule.   This pKa is higher than that [Cu(H2O)6] (8.00), but this is ascribed to the fact that 
in [Cu(H2O)6] an equatorial water proton is deprotonated rather than an axial water.   This 
would therefore suggest the postulated structure shown in Figure 3.30c as the most likely for 
the MLH-2 complex species. 
 
 












Figure 3.30: Possible structures for (a) ML, (b) MLH-1 and (c) MLH-2 of Cu(II)-[H2(565)NH2]    
                       system. 
 
The potentiometric results alone cannot unambiguously predict the correct structure of 
a complex in solution.   To get more evidence of the solution structures formed between 
Cu(II) and these ligand systems, as well as  the coordination geometry of these structures, 
they have also been determined spectroscopically and these will be discussed in detail in 
chapter four. 
 




































3.5.2.4.5 Possible Structures of Ni(II) and Zn(II) Complexes 
The formation equilibria for Ni(II) and Zn(II) show that these metal ions also form 
relatively stable complexes with [H(555)NH2], [H(555)NMe2], [H2(555)-NH2], [H2(565)NH2] 
and [H(56)NH2] although their stability is lower than that of Cu(II).   The equilibrium 
constants for Ni(II) and Zn(II) are shown in Tables 3.12 and 3.13.   Trends in these 
equilibrium constants  are in accordance with the  Irving-Williams stability series.52  
Although Zn(II) is a weaker chelators than Cu(II), the in vivo concentration of this essential 
metal ions is much higher than that of Cu(II) and so could potentially compete for the 
ligands.   For example, the stability constants (log βʼs) of the ML species of [H(555)NH2] 
with Cu(II), Ni(II) and Zn(II) are 11.81, 8.02 and 6.41, respectively.   The difference in 
stability of some 4-5 log units is observed between Cu(II) and the in vivo competitors Ni(II) 
and Zn(II).   This indicates the metal ion’s reduced affinity for complexation and lower 
binding strength of the ligand [H(555)NH2] towards Ni(II) and Zn(II). 
A noticeable feature about the complexation of [H(555)NH2] and [H(555)NMe2] with 
these two metal ions is the prevalence of the ML2, ML, ML-1 and MLH-2 species.   For the 
ML species, the difference in stability observed between Cu(II), Ni(II) and Zn(II) with 
[H(555)NH2] and [H(555)NMe2] were 3 - 5 log units.   The explanation for this observation 
is that the arrangement of the ligand donor atoms is such that the metal ion is constrained to 
adopt the square planar coordination geometry.   Zn(II) prefers a tetrahedral coordination 
geometry as observed in the majority of its simple systems53 and in biological metallo-
enzymes.54   In such enzymes, the Zn(II) ion is coordinated to three nitrogen atoms while a 
water molecule occupies the fourth coordination site constituting the tetrahedral arrangement 
of donor atoms.   On the other hand, Cu(II) and Ni(II) prefers a tetragonally distorted or 
square planar arrangement of ligand(s) donor atoms around the metal ion.55-59  
 
In the deprotonation of ML to form MLH-1 species, the calculated pKa values for the 
complexation of [H(555)NH2] and [H(555)NMe2] with Ni(II) were 8.97 and 6.92, 
respectively and 7.88 and 6.54, respectively for Zn.   For Ni(II), these pKa values were 0.9-2.0 
log units lower than the first hydrolysis constant of Ni(II) (pKM-OH = 9.86).60  Furthermore, 
the pKa values of the formation of MLH-1 species for Zn(II) were 2.3-2.6 log units lower than 
the first hydrolysis constant of Zn(II) (pKM-OH = 9.17).60  This implies that it is the amide that 
is being deprotonated.   While the MLH-1 species could be attributed to deprotonation of the 




amide group, the MLH-2 species are a result of the ionisation of coordinated water molecules.   
We conclude this because the pKa for this process is very similar to the hydrolysis constant of 
the respective metal ions.   For Ni(II) the pKa values are 9.81 and 11.73 for  [H(555)NH2] and 
[H(555)NMe2], respectively.   For Zn(II) the pKa values are 9.95 and 8.80.    
 
The ligands [H2(555)NH2] and [H2(565)NH2] form ML, MLH-1 and MLH-2 species 
with Ni(II) and Zn(II).   Once again the deprotonation constant of ML suggests that it is the 
amide that is deprotonated to form MLH-1.   Similarly, the calculated pKa  (logβ11-1 - logβ11-2 ) 
values for the second deprotonation to form MLH-2 is also lower than the hydrolysis constant 
of the respective metal ions.   This again suggests that it is an amide that is being 
deprotonated.   Note that this is a different conclusion to the one made for [H(555)NH2] and 
[H(555)NMe2].   Here we concluded that the second proton was lost from a coordinated water 
molecule.   The reason for this difference is that [H(555)NH2] and [H(555)NMe2] only have 
one amide group while    [H2(555)NH2] and [H2(565)NH2] have two amide groups.   
 
The coordination of [H(56)NH2]  with Cu(II), Ni(II) and Zn(II) indicates that three 
different mononuclear species are formed in solution.   The ML and MLH-1 species form at 
low pH and the speciation graphs show that there is already complexation at the start of the 
titration.   The calculated pKa (log β110 – log β11-1) values were 7.53 and 7.35 for Ni(II) and 
Zn(II) respectively.   These processes are close to the first deprotonation constants of the 
previous four ligands.   Meanwhile the calculated pKa (log β11-1 – log β11-2) values for the 
second deprotonation were 8.82 and 9.25 log units for Ni(II) and Zn(II), respectively.   These 
values are closer to the hydrolysis constant of the metal ion suggesting that the deprotonation 
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4.1 UV - Visible spectroscopy 
4.1.1 Introduction 
Spectroscopy is a technique that measures the interaction of molecules with 
electromagnetic radiation.1  The UV-visible range of the electromagnetic spectrum covers the 
range 200–800nm (depending on the detector type).2  The interaction of electromagnetic 
radiation of wavelength in the UV-visible region with transition metal chelates gives rise to 
UV-visible spectra of these complexes.   Transition metal complexes give rise to a fascinating 
variety of colours.   These colours come from electronic transitions between energy levels 
whose spacings correspond to the wavelengths of visible light.   Since this spacing of 
transition depends on factors such as the geometry of the complex, the nature of the ligands 
present, and the oxidation state of the central metal atom, electronic spectra of complexes can 
provide valuable information related to bonding and structure.1,3  The ultraviolet and visible 
spectra of coordination compounds of transition metals involve transitions between the d 
orbitals of the metals.   These transitions are frequently referred to as d-d transitions because 
they involve molecular orbitals that are mainly metal d in character.  
Absorption spectroscopy is usually performed with molecules dissolved in a 
transparent solvent.   The absorbance of a solute depends linearly on its concentration and, 
therefore absorption spectroscopy is ideally suited for quantitative measurements.   The 
wavelength of absorption and the strength of absorbance of a molecule depend not only on 
the chemical nature but also on the molecular environment of its chromophores.   Therefore, 
absorption spectroscopy is an excellent technique for following ligand-binding reactions, 
enzyme catalysis and conformational transitions in proteins and nucleic acids.4  As a result, 
UV-visible spectrophotometry is used as a supplementary technique to glass electrode 
potentiometry when ionic equilibria are investigated. 
4.1.2 Theory  
Studies of electronic spectra of metal complexes provide information about structure 
and bonding.   The absorption bands caused by the promotion of an electron from a lower to a 
higher d orbital of the metal ion are labelled as d → d bands.   The relative intensities of 
absorption bands are governed by a series of selection rules.   According to the spin selection 
rule, transitions between states of different spin multiplicity are forbidden.   For example, 
transitions between 4A2 and 4T1 states are "spin-allowed," but between 4A2 and 2A2 are  
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“spin-forbidden”.   The Laporte selection rule states that the only allowed transitions are 
those with a change of parity, gerade to ungerade (g → u) or ungerade to gerade (u → g) but 
not g → g or u → u.   This would mean that all d-d transitions in octahedral complexes are 
Laporte forbidden and therefore many complexes will be colourless.   However, most ions do 
not have perfect symmetry, and are distorted so that the centre of symmetry is destroyed, 
resulting in mixing (hybridization) of d and p orbitals.   This d,p mixing leads to a partial 
break-down of the Laporte selection rule and hence an increase in signal intensity.    
Most Cu(II) complexes and compounds show broad absorption band corresponding to 
the three overlapping transitions 2A2g  ← 2B1g,  2B2g ← 2B1g and 2Eg  ←  2B1g which are spin-
allowed transitions characteristic of a d9 tetragonally distorted Cu(II) complex.5,6  However, 
octahedral complexes of Cu(II) (d9) are appreciably distorted due to the Jahn-Teller effect 
and so there is more than one peak.   These peaks overlap forming a broad and unsymmetrical 
band.   Since this is a d9 system, the crystal-field splitting is in turn affected by the 
coordination sphere of copper into lower energy eg and high energy t2g levels.   The nine d 
electrons are arranged into two levels, i.e. (eg)3 and (t2g)6. Since the eg level is not 
symmetrically filled, Jahn-Teller distortion occurs.   Thus the complex is distorted.7 
 
The Ni(II) ion (d8) exhibits a variety of coordination geometries giving different 
electronic-spectra characteristic of these geometries.   The most common geometry for this 
metal ion is an octahedral arrangement of donor atoms around the central metal ion.   For 
octahedral complexes, three spin-allowed transitions1 are expected which can be assigned in 
order of energies as:  
ν1 = 3T2g (F) ← 3A2g (F), 
ν2 = 3T1g (F) ← 3A2g (F) 
ν3 = 3T1g (P) ← 3A2g (F) 
 
These absorption bands generally fall within the ranges 7, 000 - 13, 000; 11, 000 - 20, 
000 and 19, 000 - 27, 000 cm-1 respectively, with intensities less than 30 dm3 mol-1cm-1 in a 
regular octahedral system.   These three spin-allowed absorption bands, two spin-forbidden 
bands are often observed, and these correspond to transition to the 1Eg and 1T2g.   Generally 
square planar complexes differ from octahedral complexes in the absence of any band below 
10, 000 cm-1 because the ligand field strength in these complexes is very high.1 
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UV-visible spectroscopy commonly obtains spectra as plots of absorbance versus 
wavelength.   The molar absorptivity is characteristic of the species that is absorbing the light 
and is highly dependent on wavelength.   This wavelength is related to the energy of the 
absorbed radiation as shown by the equation (4.1):  
E = hv = hc/λ 
                                                                                                                          (4.1) 
 
Where: 
E = energy 
h = Planck's constant = 6.626 X 10-34 J s 
c = speed of light = 2.998 X 108 m s-1 
v = frequency (s-1) 
λ = wavelength (nm) 
  A measure of the ligand field stabilization energy is given by the equation (4.1).   This 
does not, however, give a direct measure of the strength of bonding, but only the amount by 
which the degenerate d-orbitals of the metal ion have been split due to the crystal field.   
Particularly when the study is performed in solution, the spectra do not depend only on 
structural conditions, but also on environmental elements (nature of the solvent, pH value of 
the aqueous solutions, etc.) which make the acquired spectroscopic data assume a 
“conditional” character.8 
The fraction of light absorbed by a species at a certain wavelength is its absorptivity 
(Ɛ) at that wavelength.   UV-visible spectroscopy is used for quantitative analysis, in terms of 
Beer-Lambert’s law, which states that, for a given ideal solution, there is a linear relationship 
between concentration and absorbance provided that the path length is kept constant. This can 
be expressed in the following form: 
log10   
  
 
   = Ɛcb  
                                                                                                                                                                      
                                                                                                                                              (4.2) 
where I0 and I are the intensities of incident and transmitted radiation respectively, c is the 
molar concentration in  mol dm-3 of the absorbing species, b is the optical path length (cm) 
and Ɛ is the molar absorption coefficient of the absorbing species (dm3 mol-1 cm-1).   The term  
log10   
  
 
    is called the absorbance and is represented by the symbol A, with this law 
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becoming, A = Ɛcb.   If the analyte solution is a mixture of different species, the total 
absorbance at a specific wavelength (Aλ) for each individual species can be expressed as: 
     Ɛ 
    Ɛ 
    Ɛ 
     Ɛ 
     
       (4.3) 
where all the terms are as defined earlier.   The molar absorptivities or extinction coefficients 
are characteristics of the molecular electronic spectra and should be positive and give smooth 
curve when plotted as a function of wavelength.9  Equation 4.3 can be simplified to: 
 
    ∑Ɛ 
    
    (4.4) 
If A, b and C are known at a particular wavelength, then Ɛ can be calculated at that 
wavelength.   Different species absorb light at different wavelengths and the maximum 
wavelengths of absorption can be correlated with the structure of the species.   
Values of λmax can therefore be used to predict structures of complexes.   Billo’s method10 is 
one of the most popular methods of structure determination using values of λmax for a 
tetragonally distorted Cu(II) complex with axially coordinated water molecules.   The λmax of 
the d → d band of the Cu(II) complex in spectra of an aqueous solution can be expressed as 
the sum of individual ligand-field contributions from the four donor atoms which, with 
Cu(II), define the square planar complex.   Calculated λmax is expressed as: 
 
      
   
    
                                                                                                                                               
                                                                                                                                              (4.5) 
where ni is the number of equatorial donor groups and νi is the ligand field of the complex.   
This equation gives the contribution of each of the four coordinating groups to the calculated 
absorption frequency. 
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 Several authors11-15 have used UV-visible to predict the structures of Cu(II) 
complexes with donor groups located only on the equatorial plane of the distorted octahedron 
of copper(II) ion. 
The electron donor groups and their corresponding ligand fields are given in Table 
4.0, according to Billo10,11,16 and subsequently Sigel and Martin.17  










Aqueous solutions of Cu(II) 1:1, 1:1.5 and 1:2 ratio with [H2(555)NH2], 
[H(555)NMe2], [H(555)NH2], [H2(565)NH2], and [H(56)NH2] were prepared over the pH 
range 2-11.   Small amounts of 0.1 mol dm-3 NaOH and 0.02 mol dm-3 HCl were used to 
adjust the pH during the titration.   A CRISONmicro pH meter equipped with a Metrohm 
glass electrode was used to measure the pH.   The exact amount of NaOH/HCl added was 
noted.   The concentrations of the absorbing species were calculated at every pH.   The 
solutions were kept at a temperature of 25 oC.   The electronic spectra in the aqueous 
solutions of Cu(II) and Ni(II) complexes were recorded in 1.00-cm quartz cells using a 
Hewlett Packard 8452A Diode Array Spectrophotometer which was set at 300 -820 nm.    
A blank (water) was used to correct the absorbance.   Since there are different absorbing 
species in solution at the same time, and their concentration changes with pH, it was 
necessary to use known concentration of each species (obtained from potentiometry) to 
deconvolute the spectra.   This was done using UV_SPECTRA.EXE, an in-house computer 
program that uses single value decomposition to solve the set of linear equations.   Note that 
each wavelength is solved independently and so the smoothness of the resultant spectrum of 
Electron donor groups Ligand field (νi 10-3 cm-1) 
amino group νNH 4.60 
amide group νN 4.94 
pyridine  nitrogen - νpy 4.22 
Water νO 2.96 
Carbonyl νO 2.96 
Hydroxide νO 2.96 
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each species can be used to check the method.   In addition, the spectrum of [Cu(H2O)6]2+ is 
calculated and compared to the experimental spectrum of this species.    
4.1.4 Results and Discussion 
4.1.4.1 Cu(II)-L Systems 
Colour changes were noticed during the progression of the potentiometric titrations of 
Cu(II) with all the ligands in this study.   This was due to the changing speciation of the 
solutions with pH, forming different complex species with different absorption spectra.   The 
absorption spectra for these Cu(II)-ligand systems were obtained in the pH range 2-11 and 
wavelength region 400 - 800 nm.  
The wavelengths and molar extinction coefficient values corresponding to maximum 
absorption of the Cu(II) species formed in solution with ligands of this study together with 
those calculated as well as those of [Cu(NH3)n(H2O)6-n]2+ 18are given in Table 4.1.   The 
proposed structures for the various species have already been given in Figures 3.21 and 3.30, 
in Chapter Three.   For convenience, structures of some of the literature ligands used in the 
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 Table 4.1: UV-visible λmax (nm) and Ɛmax (dm3.mol-1.cm-1) for different Cu-Ligand species.   
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Figure 4.1 shows the UV-visible electronic spectra of the Cu(II)-[H(555)NH2] system 
as a function of pH.   At low pH, there is little complex formation and the spectrum is that of 
[Cu(OH2)6]2+ with maximum absorption >800 nm.   As the pH is increased, the absorption 
band increases in intensity and shifts to shorter wavelengths.   From the potentiometric 
results, the species formed between pH 2.53 and 3.44 is MLH.   Further increase in pH, up to 
a value of 3.74, causes the absorption band to increase in intensity and shift to shorter 
wavelengths due to Cu-O to Cu-N bond substitution.   From the potentiometric results, the 
species formed in this region are ML and MLH-1.   No further changes were observed in the 
pH range 7.33 - 8.65. 
 
 
                  Figure 4.1: UV-visible electronic absorption spectra for Cu(II)-[H(555)NH2] with                                                         
                                      [M(0.003 mol dm-3)-L(0.006 mol dm-3)] at different pH values. 
 
Deconvolution of the spectral data leads to the spectra of the individual species  
(Figure 4.2).   The λmax and molar extinction coefficient (Ɛ) are listed in Table 4.1.   
Unfortunately, under the conditions of this experiment, the concentration of the MLH species 
was too low for the spectrum of this species to be calculated.   The ML species exhibits  
λmax = 574 nm and Ɛ = 109.15 dm3 mol-1 cm-1.   Using Billo’s method, and assuming 
coordination by a pyridyl-N, an amide-N and an amine-N, the value of λmax is 574 nm.   A 
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Cu(II)–N,N'-di(aminoethylene)-2,6-pyridine-dicarbonylamine.11  MLH-1 has a λmax of 556 nm 
and Ɛ = 149.92 dm3 mol-1 cm-1.   The shifting in λmax suggests coordination of two  
amino-N’s, a pyridyl-N and an amide-N in a tetragonally distorted arrangement.   The similar 
value was found by Zvimba for the MLH-1 species (550 nm) of Cu(II)-[H(555)-N].12  The 
calculated λmax for this coordination geometry is 545 nm, which is in good agreement with 
the experimental value. 
 
 
    Figure 4.2: Calculated spectra of Cu(II)-[H(555)NH2] individual species. 
 
4.1.4.1.2 Cu(II)-[H(555)NMe2] 
Figure 4.3 shows the UV-visible electronic spectra of the Cu(II)-[H(555)NMe2] 
system as a function of pH.   Before the titration by base, complex formation has already 
taken place at low pH (pH 2.95).   The dominant complex species at this pH is CuN3 with 
maximum absorption at 623 nm, instead of CuO6 with H2O as ligands, which normally forms 
at such low pH.   The band maximum shifts to shorter wavelengths and increases in intensity 
up to a pH value of 9.01. At pH > 9.01, the intensity decreases with the typical blue shift.   
The MLH-2 is the species in this pH range.   From the potentiometric results, we have 
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water molecule.13  It is well known that increased axial coordination decreases the energy of 
the three spin allowed Cu(II) d → d transitions.19 
 
                 Figure 4.3: UV-visible electronic absorption spectra for Cu(II)-[H(555)NMe2] with                                                         
                                     [M(0.004 mol dm-3)-L(0.006 mol dm-3)] at different pH values. 
 
Figure 4.4 and Table 4.2 show the absorption spectra of the experimental species for 
the Cu(II)-[H(555)NMe2] system.   The smooth graphs indicate that the model is appropriate.   
A single absorption band was observed for each species.   The λmax(ɛ) values for the ML is 
623 (101.94) which suggests that Cu(II) coordinates with two amine-N’s, a pyridyl-N and an 
amide-O.   This was the same coordination for ML, where L is Bis-(N,N-dimethylethyl)-2,6-
pyridine-dicarboxamide11 with λmax (600 nm).   λmax 588 (118.51) shifts to a shorter 
wavelength when MLH-1 forms.   This is a result of a Cu-Oamide to Cu-Namide rearrangement.   
The λmax value of 580–590 nm is consistent with 4 nitrogens coordination.12  The alteration of 
MLH−1 to MLH−2 is followed by a significant blue shift of the d–d absorption maximum with 
drop in the molar extinction coefficient.   As well as, the observed λmax (MLH-2) is 63 nm less 
than the calculated maximum wavelength.   A difference of 63 nm between the calculated and 
the observed λmax may be due the fact that coordination to hydroxide (-OH-) is axial while 
coordination to amide-N, two amines-N’s and a pyridyl-N are equatorial.   Billo’s method10,16 













 Wavelength /nm 
pH2.95 PH 3.21 pH 3.8 pH 4.22 pH 4.88 pH 5.47
pH 7.60 pH 8.13 pH 9.01 pH 10.04 pH 11.02






                  Figure 4.4: Calculated spectra of Cu(II)-[H(555)NMe2] individual species. 
 
Two possible structures are suggested by the potentiometric results for the ML with 
[H(555)NH2] and [H(555)NMe2].   The stability constants for both ML are similar with a log 
difference of ~ 1 log units.   The ML of [H(555)NMe2] formed before the titration starts 
between pH range 2.1 - 6.06 while ML of [H(555)NH2] between pH range 2.60 - 5.38. 
Although the two ligands have the same environment, the difference was the two methyl 
groups on the terminal amine.   From the UV-visible spectroscopy it is clear that the 
complexes of these two ligands have different structures.   They have very different λmax 
values; 569 and 623 nm, for [H(555)NH2] and [H(555)NMe2], respectively.   These values 
suggest that ML of [H(555)NH2] has structure in Figure 3.22 b(ii) and [H(555)NMe2] 
structure in Figure 3.22 b(i). 
4.1.4.1.3 Cu(II)-[H2(555)NH2] 
The electronic absorption spectra for the Cu(II)-[H2(555)NH2] system are shown in 
Figure 4.6.   At low pH, the spectrum is the same as that of [Cu(OH2)6]2+.   The red shift in 
λmax when forming MLH from hydrated Cu(II) reflected the increased ligand field splitting in 
the presence of the ligand as opposed to H2O.   As the pH increases, the band maximum 
increases in intensity (curves for pH 2.27 and 3.10).   Further increase in pH (curves for pH 
3.7; 3.65 to 6.24) causes the absorption band to shift to shorter wavelengths due to the Cu-O 
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maximum increases in intensity as Cu(II) complexes of the type CuN4 are formed and the 
deprotonation reaction at the amide site occurs.   The gradual colour changes with changing 
pH are shown in Figure 4.5. 
 
  Figure 4.5: Cu(II)-[H2(555)NH2] showing gradual colour change from pH 1.83 to 10.08. 
 
 
                  Figure 4.6: UV-visible electronic absorption spectra for Cu(II)-[H2(555)NH2] with                                                         
                                      [M(0.005 mol dm-3)-L(0.005 mol dm-3)] at different pH values. 
 
The calculated absorption spectra for the individual species are shown in Figure 4.7. 













pH 1.83  pH 2.07 pH 2.72 pH 3.1 pH 3.75
pH 4.23 pH 5.26 pH 5.99 pH 6.24 pH 6.83
pH 7.29 pH 7.71 pH 8.35 pH 9.1 pH 10.08
pH 10.89 pH 11.21
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that between pH 6.8 and 7.7 there appears to be an isosbestic point at λ 584 nm (Figure 4.6).   
In this pH range ML, MLH-1 and MLH-2 are in equilibrium (see Figure 3.16).   Normally an 
isobestic point is only seen when two species are in equilibrium.   Looking at Figure 4.7, we 
see that these three species have very similar extinction coefficient at λ 599 nm and hence the 
isobestic point.   The λmax of the MLH species is 741 nm which is close to the calculated λmax 
of 766 nm.   The λmax value obtained for MLH is compatible with the coordination of Cu(II) 
Ala–Gly–Ha (λmax 740 nm).20  The λmax of the ML species is 682 nm.   This is close to 680 
nm for [Cu(NH3)2(H2O)4]2+ which is also coordinated by 2N.    
The λmax 575nm for the MLH-1 species suggests coordination of the pyridyl-N,  
an amide-O, an amide-N and an amino-N.   This value is close to the λmax of 570 nm for the 
ML species of the Cu(II)-N,N'-di(aminoethylene)-2,6-pyridine-dicarbonylamine system.11  
The calculated λmax of MLH-2 species is 534 nm which clearly indicates the presence of four 
nitrogen atoms in the coordination sphere.   The Cu(II) ion coordinated with two amide-N, 
one amine-N and a pyridyl-N in a square-planar arrangement.11  The predicted λmax is close to 
the observed value of 524nm.   A high extinction coefficient value of 121.84 dm3mol-1cm-1 
and a change in colour at this pH range supports such geometry.   Thus, the ligand is 
postulated to coordinate the metal ion as shown in the structure given in Figure 3.26 as 
suggested by the potentiometric data. 
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 The UV-visible electronic absorption spectra detected for the Cu(II)-[H2(565)NH2] 
system are shown in Figure 4.8.   At low pH 2.22 and 3.07, the spectrum is the same as that 
of [Cu(OH2)6]2+.   As the base concentration increased, the absorption bands shift towards 
shorter wavelength with an increase in intensity (curves for pH 4.33, 4.75 and 5.03).   A 
noticeable feature about the absorption bands is that they remain the same in the pH range 
5.79 – 8.19 when deprotonation of the second amide occurs to form the MLH-2 species.   This 




                   Figure 4.8: UV-visible electronic absorption spectra for Cu(II)-[H2(565)NH2] with                                                         
                                     [M(0.003  mol dm-3)-L(0.006 mol dm-3)] at different pH values. 
 
 The calculated absorption spectra for the individual species are shown in Figure 4.9. 
The λmax and molar extinction coefficient (ε) for the three [H2(565)NH2] species  are given in 
Table 4.1.   At pH 3.07, the formation of MLH species has already begun, this is in support of 
the speciation curves in Figure 3.18.   The values of  λmax and Ɛmax for CuLH are (746 nm, 
19.78 dm3mol-1cm-1) which is in good agreement with one nitrogen donor atom in the 
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coordinated with  Ala–Gly–Ha20 (λmax = 740 nm) and [Cu(NH3)(H2O)5]2+ (λmax = 745 nm).12  
The coordinating groups are the pyridyl-N and two amide-O groups.   The individually 
calculated d–d spectrum for the CuL species shows a band with λmax at 747 nm (Ɛmax = 47.45 
dm3 mol-1cm-1).   The d-d electronic absorption bands of MLH and ML (Figure 4.9) have the 
same λmax (~746 nm) but different extinction coefficients.   This suggests that there is no 
change in the coordination of the ligand.   However, there is a substantial change in extinction 
coefficient which indicates some change in the symmetry of the molecule.   The bands are 
also slightly asymmetric at the low-frequency side.   In general, the more distorted the 
molecule, the higher the extinction coefficient.   Therefore, a CuN type of coordination is 
most likely to be formed in this speciation range.21  However, λmax of 532 nm for the MLH-2 
species indicates the presence of four nitrogen atoms in the coordination sphere of the Cu(II) 
ion in a square-planar arrangement.   Calculated absorption spectra of 534 nm, as given in 
Table 4.1, confirm the experimental results which are consistent with the presence of an 
amine-N, a pyridyl-N and two amide-N’s in the coordination sphere of the Cu(II) ion.11  
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 The UV-visible electronic absorption spectra for the Cu(II)-[H(56)NH2] system are 
shown in Figure 4.10.   As the pH is increased, the band maximum increases in intensity and 
shifts to shorter wavelength.   This indicates the presence of different species in solution at 
different pH values.   A noticeable feature about the absorption bands is that they remained 
the same in the pH range 5.51 – 9.18.   Above pH 9.18, a drop in the absorbance value was 
found after the formation of the MLH-2 species.   This result suggests that there is no further 
reaction between this species and the base above pH 9.18.   However, this proton could come 
from a coordinated water molecule. 
 
 
                   Figure 4.10: UV-visible electronic absorption spectra for Cu(II)-[H(56)NH2] with                                                         
                                       [ M(0.003 mol dm-3)-L(0.006  mol dm-3)] at different pH values. 
 
 The CuL species were not detected spectroscopically due to very low concentration as 
shown in Figure 3.20.   The values of λmax= 608 nm and Ɛmax = 70.37 dm3 mol-1 cm-1 of 
CuLH-1 are in very good agreement with MLH-1 of glycyl-L-histidine22 (λmax= 606 nm) and 
glycyl-L-histidylglycine23 (λmax= 605 nm).   The calculated λmax 598 nm shows that the 
coordinating groups are an amino-N, an amide-N and a pyridyl-N in addition to a water 
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the molar extinction coefficient when an MLH-2 species was formed.   This observation 
support a mechanism of water hydrolysis11  since, for CuLH-2, water is the only possible 
source of protons.24  However, a drop in the extinction coefficient value suggests that the loss 
of this proton is from an axially coordinated water molecule, an observation consistent with 
the potentiometric results. 
 
 
                   Figure 4.11:  Calculated spectra of Cu(II)-[H(56)NH2] individual species. 
 
 Any slight discrepancy between the calculated and the experimental λmax values given 
above could be due to failure of Billo's method10 for solution mixtures containing axially 
coordinating solvent molecules such as water.   Previous studies showed that the 
rearrangement of donor atoms in the coordination sphere results in the splitting or significant 
shift of the absorption bands.25,26  The predicted results indicate the same structures as 
proposed by the potentiometric results and are in good agreement with the observed λmax. 
4.1.4.2 Ni(II)-L Systems 
The colour changes were only observed for the Ni(II)-[H(555)NH2] and  
Ni(II)-[H2(565)NH2] systems, while the Ni(II)-[H(555)NMe2], Ni(II)-[H2(555)NH2] and 
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absorption spectra and electronic spectra, as a function of pH, for individual species of the  
Ni(II)-[H(555)NH2] and Ni(II)-[H2(565)NH2] are shown in Figure 4.12 and 4.13 respectively.   
The wavelength and molar extinction coefficient values corresponding to maximum 
absorption of the Ni(II) species formed in solution with these two ligands are given in Table 
4.2.   These values were obtained as a result of the changing speciation of the solution with 
pH, forming different complex species with different absorption spectra.   The absorption 
spectra were obtained in the pH range 2-11.   In this study, the Ni(II) spectrophotometric 
spectra are less informative than the Cu(II) spectra. 
 
 Table 4.2: UV-visible spectra λmax (nm) and Ɛmax (dm3.mol-1.cm-1) experimental values with  
                     possible donor groups for Ni(II) with [H(555)NH2] and [H2(565)NH2] complexes. 
 
4.1.4.2.1 Ni(II)-[H(555)NH2] 
At low pH values, the solution is made up of the hydrated [Ni(OH2)6] species.   As the 
base concentration is increased, the intensity of the absorption band at 425 nm increases 
(curves from pH 5.59 to 10.95).   The NiL2, NiL, NiLH−1 and NiLH−2 species presented 
similar spectroscopic parameters, supporting the same coordination in all modes of Ni(II) 
ions.   At pH 5.59, the solution colour starts to change from light green to yellow.   This 
change in colour, which can be attributed to a single absorption band (λmax = 425 nm), 
strongly suggests the formation of square-planar complexes.   The analysis of the data 
suggests that the bonding mode of NiL formed with [H(555)NH2] is the same as that for 
NiLH-2 of Gly-Gly-Gly, but the amino group is still protonated.27  Most Ni(II) complexes 
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coordinated with deprotonated amide nitrogen atoms have been reported to be diamagnetic 
and square-planar.28-31  Furthermore, similar behaviour was observed for the  
Ni(II)-Gly-His complex, which is formed below pH 8, and where the most stable 
coordination mode occurred via the terminal amino-N, amide-N and imidazole-N donors.32  
As a consequence, the latter coordination mode can be suggested for the high stability, planar 
complex-NiLH-2, for which the individually calculated spectrum has a λmax at 425 nm and  




           (a) 
 
(b)                        
               Figure 4.12: UV-visible electronic absorption spectra for (a): Ni(II)-[H(555)NH2] 
                                     with [M(0.003 mol dm-3)-L(0.006 mol dm-3)] and (b): calculated  
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Above pH 6.55, the previously colourless sample turns yellow.   At pH value around 
6.12, the first complex formed is probably NiL.   As can be seen from species distribution 
diagrams in Figure A12, the NiL complex with [H2(565)NH2] was not detected 




        (a) 
 
(b) 
           Figure 4.13: UV-visible electronic absorption spectra for (a): Ni(II)-[H2(565)NH2] 
                                  with [M(0.003 mol dm-3)-L(0.006 mol dm-3)] and (b): calculated  
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Table 4.2 shows the wavelength and molar extinction coefficient values corresponding to 
maximum absorption of the Ni(II) species formed in solution with possible donor groups for 
this ligand.   The deprotonation of two or more amide nitrogens in Ni(II) peptide complexes 
is often followed by fundamental changes of UV-visible spectra, representing a geometry 
shift of the complexes from octahedral (light green) to square planar (yellow) structures.33-35  
λmax band of NiLH-1 (λmax = 445 nm, Ɛ = 110.51 dm3.mol-1.cm-1) unambiguously supports the 
amino-N, amide-N, pyridyl-N and water in the coordination sphere.34  As a consequence, the 
latter coordination mode found in the high stability planar complex of NiLH-2, for which the 
individually calculated spectrum has a λmax at 445 nm and Ɛ = 50.46 dm3.mol-1.cm-1, suggests 
the coordination of a deprotonated amide-N20 at the fourth equatorial site.   The two 
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4.2 1H-NMR Spectroscopy 
4.2.1 Introduction 
NMR spectroscopy is one of the most important analytical tools available today.   It is 
a flexible technique with many applications.37-40  1H-NMR observation yields structures of 
organic molecules, organometallic complexes, proteins, peptides, and nucleic acid oligomers.   
It is also widely used in medicine where it is often called magnetic resonance imaging (MRI).   
Furthermore, it gives detailed information for selected nuclei, information about the chemical 
bonding, the local electronic structure and the local site dynamics.   Small changes to the 
environment at an NMR-active nucleus can be detected and identified.  
In this study 1H-NMR has been used to gain insights in to the site of metal 
coordination upon complexation by Cu(II).   The presence of the metal ion is expected to 
broaden and shift the signals arising from protons attached to the neighbouring carbons most 
affected.41  Cu(II) is  paramagnetic which can affect both the chemical shift and relaxation 
time of the protons.11,41  This manifests in a broadening and shifting of the 1H-NMR signals.   
The broadening effect of the metal is attenuated by 1/r6 where r is the internuclear distance 
between the Cu(II) and the observed proton.   Cu(II) exchange is usually very rapid and so 
only average spectra are seen.   The differential effect of the metal ion on the ligand can then 
be used to determine the structure of the complex. 
 
4.2.2 Experimental 
 All solutions between 0.009 and 0.017 mol dm-3 of ligands were prepared in D2O at 
25°C.   The 1H-NMR spectra were recorded on a Bruker Avance 400MHz spectrometer.   
The comparison of shifting and broadening of the spectra from the ligand protonation and 
copper complexes were determined using the Mestre Nova version 9.1 program.   The pD of 
the solutions was adjusted using concentrated NaOD and DCl.   A CRISONmicro pH meter 
equipped with a Metrohm glass electrode was used to measure the pH.   The spectra were 
recorded from pH 2 to pH 11.   Tertiary butyl alcohol was used as an internal reference.   
Small aliquots of dilute Cu(II) solution were added into the ligand solution.   Since a pH 
electrode was used to measure pD, corrections were made as described by Popov42 and 
Glasoe43;   
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pD = pH meter reading + 0.44 
                      (4.6) 
4.2.3 Results and Discussion 
4.2.3.1 Protonation Titrations 
A spectrum for 1H-NMR is a plot of signal intensity against chemical shift.   If D2O is 
used as solvent, the amine protons are not observed as they exchange with the deuterium of 
the water.   It is possible to record spectra in H2O/D2O and observe the amide protons below 
a pH of ~6.   Above this pH the amide proton are in rapid exchange and so cannot be 
observed.   Since we were interested in the pH range 2- 11 the spectra were all run in D2O, 
which is technically much easier and does not require solvent suppression.  
In this study NMR has been used to determine the sequence of protonation of the 
ligands.   Thus, a plot of chemical shift vs. pH can be used to determine the site of 
protonation42,44, while the inflection point in the chemical shift curves can be used to estimate 
pKa values.   Many authors have used 1H-NMR to determine the sequence of protonation of 
the ligands, to estimate the protonation constants and to predict the structures of metal to 
ligand complexes.45-52   
4.2.3.1.1 Protonation of [H(555)NH2] 
The assignments of the spectra are indicated and follow the numbering in Figure 4.14.   
Figure 4.15 shows the proton 1H-NMR spectra for [H(555)NH2] as a function of pH.   From 
pH 1.94 – 6.29, the signals d, e, f, g and h were the first to shift from low to high field.   This 







Figure 4.14: The structure of the [H(555)NH2] showing the proton labels in Figures 4.15 and 4.16. 
 




Figure 4.15: 1H-NMR spectra of [H(555)NH2] as a function of pH. Note the break in the f1 dimension 
at 5.0 ppm.  The assignments are given under the pH11.44 spectrum and follow the 
numbering scheme given in Figure 4.14. 
 
Also, the signal c shifts between pH 1.94 and 6.29.   This indicates that the secondary 
amine is being protonated in this pH range.   At pH 5.12, the signal b crossover the signal a, 
with shifting to high field for all signals.   From pH 6.29 to high pH the most significant 
shifting to high field were signals a and b.   This indicates protonation of the terminal amine.   
The change in chemical shifts as a function of pH of protons near to possible coordination 
sites is shown in Figure 4.16.   The plots of change in proton chemical shift show 
approximate pKa values of about 3.59, 5.10 and 9.10, corresponded to the protonation of the 
pyridine nitrogen, the secondary amine and the terminal amine respectively.   These are in 
good agreement with the values obtained from potentiometric results. 
 
 
Figure 4.16: Change of chemical shifts of selected protons of [H(555)NH2] as a function of pH.                 
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4.2.3.1.2 Protonation of [H(555)NMe2] 
The numbering of the protons is given in Figure 4.17 and their assignment in Figure 
4.18 which shows the 1H-NMR spectra obtained at different pH values.   Note the crossover 
of the b and c signals at pH 9.69.   The changes of chemical shifts of selected protons are 
given in Figure 4.19.   Between pH 3.35 and 6.07, the aromatic signals f, h, g and i shift 







Figure 4.17: The structure of the [H(555)NMe2] showing the proton labels in Figures 4.18 and 4.19. 
 
 
Signal b, c and d shifted from pH 3.35 to pH 6.07.   This is due to the protonation of the 
secondary amino group.   At high pH, the methyl signals, a1 and a2, undergo a big shift to 
high field.  This indicates protonation of the terminal amine.   
 
 
Figure 4.18: 1H-NMR spectra of [H(555)NMe2] as a function of pH. Note the break in the f1 
dimension at 4.5 ppm.  The assignments are given under the pH10.96 spectrum  
 and follow the numbering scheme given in Figure 4.17. 
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The inflection is seen in Figure 4.19, with significant change in the chemical shift of 
protons.   The inflection point in the chemical shift curves can be used to estimate the pKa 
values of the three protonation sites.   The pKa values of 3.35, 4.04 and 8.79, confirm that it is 
the pyridyl nitrogen and two amino groups are being protonated.   The observed result agree 
with those from the potentiometric results.   Note, in this case the spectra were recorded with 
water suppression in 90:10 D2O/H2O in order to see the amide protons.   The signal for 
proton e is close to the water signal and so was also suppressed.   However the amide protons 




Figure 4.19: Change of chemical shifts of selected protons of [H(555)NMe2] as a function of pH. 
The assignment is given in Figure 4.17. 
 
4.2.3.1.3 Protonation of [H2(555)NH2] 
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Figure 4.21 shows the 1H-NMR spectra.   Change of chemical shifts of protons near the 
possible coordination sites of the free [H2(555)NH2]  as a function of pH are shown in Figure 
4.22.   Going from pH 2.03 to 6.51, the signals c, d, f, e, and g were the first to shift to high 
field.   This is due to the protonation of the pyridine nitrogen.   Signals a and b shifted from 
pH 8.08 to pH 11.21.   This is due to the protonation of the N-terminal amino group. 
 
 
  Figure 4.21: 1H-NMR spectra of [H2(555)NH2] as a function of pH. Note the break in the f1  
 dimension at 5.0 ppm. The assignments are given under the pH11.21 spectrum and  
 follow the number in scheme given in Figure 4.20. 
   
Figure 4.22 shows the plots of chemical shifts as a function of pH.   The inflection 
point in the chemical shift curve can be used to estimate the average pKa of the two 
protonation sites.   From potentiometric data, [H2(555)NH2] has a pKa value of 8.96, and this 
is in very good agreement with the pKa value of 9.00 determined from the NMR data given in 
Figure 4.22.   The protonation constant for the pyridyl nitrogen donor as determined from 
NMR data was 3.11.   Odisitse53 reported the pKa of the pyridyl nitrogen as 3.51 in N,N'-
bis[2(2-pyridyl)-methyl]pyridine- 2,6-dicarboxamide which is quite  similar to the pKa of the 
pyridyl nitrogen in [H2(555)NH2]. 




        Figure 4.22: Change of chemical shifts of selected protons of [H2(555)NH2] as a function of pH. 
The assignment is given in Figure 4.20. 
 
 
4.2.3.1.4 Protonation of [H2(565)NH2] 
Figure 4.24 shows the 1H-NMR spectra obtained at different pH values.   The 









Figure 4.23: The structure of the [H2(565)NH2] showing the proton labels in Figures 4.24 and 4.25. 
 
From pH 3.74 to 5.79, the signals d, e,g, f and h are shifting to high field.   That was due to 
the protonation of the pyridine nitrogen.   At pH 7.47 the signal a start shifts to high field and 
then, crossover the signal b at pH 8.06 going to high field.   This was due to the protonation 
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   Figure 4.24: 1H-NMR spectra of [H2(565)NH2] as a function of pH. Note the break in the f1  
dimension at 5.0 ppm. The assignments are given under the pH11.05 spectrum and  
follow the number in scheme given in Figure 4.23. 
 Figure 4.25 shows plots of proton chemical shifts as a function of pH.   This plots 
given the approximate pKa values of the first protonation (4.60) and the second protonation 
step (8.06).   That value is very similar to those for the protonation of the pyridine nitrogen 
and the amine group from the potentiometric results. 
 
 
         Figure 4.25: Change of chemical shifts of selected protons of [H2(565)NH2] as a function of pH.                          





















c b d e&g f a g
Chapter 4: Ancillary Studies and Molecular Mechanism 
111 
 
4.2.3.1.5 Protonation of the [H(56)NH2] 








Figure 4.26: The structure of the [H(56)NH2] showing the proton labels in Figures 4.27 and 4.28 
 
The 1H-NMR spectra obtained at different pH values are shown in Figure 4.27.   The changes 
of chemical shifts of selected protons are given in Figure 4.28.   From the potentiometric 
results, [H(56)NH2] has two dissociable protons; the pyridine proton and the terminal amine 
proton.   The signals c, d, f, e and g were the first to shift from low to high field from pH 3.12 
to 6.35, which indicates the protonation of the the pyridine nitrogen (pKa = 4.31).   
Protonation of the terminal amine occurs from pH 8.38 to 11.46 where signals a and b start 
shifting substantially.   The pKa value of 8.38 agrees with that from the potentiometric results.    
 
     Figure 4.27: 1H-NMR spectra of [H(56)NH2] as a function of pH. Note the break in the f1 
dimension at 5.0 ppm. The assignments are given under the pH11.46 spectrum       
and follow the number in scheme given in Figure 4.26. 




            Figure 4.28: Change of chemical shifts of selected protons of [H(56)NH2] as a function of pH. 
The assignment is given in Figure 4.26. 
 
4.2.3.2 Complex Formation Titrations 
1H-NMR was used to study the structure of Cu(II) complexes with [H(555)NH2], 
[H(555)NMe2], [H2(555)NH2], [H2(565)NH2], and [H(56)NH2].   The active binding sites for 
these ligands are the pyridyl-N, the amide-N and the amine-N’s.   The 1H-NMR spectra in 
D2O were investigated at different pH values, where the maximum concentrations of the 
various species are observed, as deduced from the speciation diagrams in Chapter 3.   
Gradual addition of Cu(II) ions to solutions of ligand causes important paramagnetic 
perturbations and produces considerable changes in the 1H-NMR spectrum. 
4.2.3.2.1 Cu(II)-[H(555)NH2] complexes 
Figure 4.29 shows the effect of Cu(II) upon the spectra of [H(555)NH2]  as a function 
of pH.   Since Cu(II) is paramagnetic, it tends to broaden the signals arising from protons 
attached to neighbouring carbons as observed in Figure 4.29.   From the speciation graphs in 
Figure 3.12, complexation starts at pH 2.76 and therefore a change in NMR spectra signals is 
expected at pH > 2.76.   The signals in Figure 4.29 broaden with the addition of Cu(II).   The 
very broad peak for the aromatic protons of the pyridyl group (δ = 8) indicates that at pH 3.59 
the pyridyl-N is coordinated to the Cu(II).   At the same pH, c and d are also very broad 
indicating that the amide-N and secondary amine-N are also coordinated.   There is some 
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coordinated.   The results are not unambiguous; however, as more than one species may be 
present at the same time.   Since Cu(II) exchange is fast on the NMR time scale only average 
signals would be observed.   Similarly, at pH 4.02 and 6.26, all the protons broaden 
indicating that all four nitrogens are coordinated.   Note the broadening cannot be due to a 
change in the magnetic susceptibility of the solution as the reference peak does not broaden. 
 
Figure 4.29: 1H-NMR titration for the complexation of [H(555)NH2] (0.099 M) in D2O. Note the 
break in the f1 dimension at 5.0 to 7.0 ppm. The proton assignments are according to  
Figure 4.14. 
 
4.2.3.2.2 Cu(II)-[H(555)NMe2] complexes 
1H-NMR results for the complexation of [H(555)NMe2]  with Cu(II) are given in 
Figure 4.30.   The small amounts of Cu(II) used in the 1H-NMR study should enable the 
observation of significant differential broadening of the resonances of protons close to the 
copper binding.   At pH 3.49, ML is the most predominant species in solution.   Signals from 
b to i were already broadened at the beginning of the Cu(II)/ligand titration.   Signal a1 and a2 
broadened upon further titration with Cu(II).   The broadening of signals h, f, g and i indicate 
coordination to the pyridyl-N.   The broadening of signals a1, a2, b and c indicate 
coordination to the two amino-N’s.   The broadening of d and e indicate coordination to the 
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amide-N or the amide-O.   The stoichiometry supports coordination to the two amino-N’s, a 
pyridyl-N and the amide-O for this species.   When the pH was increased from 3.49 to higher, 
signals d and i disappeared.   The stoichiometry supports coordination to the two amino-N’s, 
a pyridyl-N and the amide-N when MLH-1 forms.   The change in 1H-NMR spectra signals is 
similar to that of the Cu(II)-[H(555)NH2]  system, indicating that indeed complexation takes 
place at all the nitrogen donor.   Further coordination at pH 10.67 to deprotonation of water 
when MLH-2 forms due to is not a change in coordination mode. 
Figure 4.30: 1H-NMR titration for the complexation of [H(555)NMe2] (0.170 M) in D2O. Note the 
break in the f1 dimension at 5.5 ppm. The proton assignments are according to Figure 
4.17. 
 
4.2.3.2.3 Cu(II)-[H2(555)NH2] complexes 
Figure 4.31 shows the effect of Cu(II) on the spectrum of [H2(555)NH2].   At pH 3.11, 
MLH is the most predominant species in solution.   At this pH, signals f, d, and e are   
substantially broadened.   The g signal has broadened so much that it has virtually 
disappeared into the baseline.   The broadening of c indicates coordination to the amide-N or 
the amide-O.   Since the other proton signals are not substantially broadening, this implies 
that the terminal amine is not coordinated.   This is a clear indication that Cu(II) binds to the 
pyridyl-N and the amide-O for this species.   However, in a more basic solution at pH 5.02, 
the signals for protons a and b also broaden, indicating that the terminal amine also 
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coordinates to the Cu(II).   At this pH the ML species predominates.   At pH 7 and 10, all the 
peaks are broadening.   This is consistent with the structures postulated for MLH-1 and MLH-2 
from potentiometry, where the two amide-N’s are coordinated.   
 
Figure 4.31: 1H-NMR titration for the complexation of [H2(555)NH2] (0.100 M) in D2O. Note the 
break in the f1 dimension at 5.0 ppm. The proton assignments are according to Figure 
4.20. 
 
4.2.3.2.4 Cu(II)-[H2(565)NH2] complexes 
Figure 4.32 shows the spectra for complexation of Cu(II) with [H2(565)NH2] as a 
function of pH.   The interpretation of these spectra is difficult as, from the potentiometric 
studies, the formation of MLH, ML and MLH-2 overlap.   Since the different species are 
likely to be in rapid chemical exchange only average effects will be seen.   When the amount 
of Cu(II) titrated into the [H2(565)NH2] solution increased, the signals broadened extensively.   
At pH 4.15, with the exception of h, all the proton signals are broaden the same.   For the 
MLH species we postulate that the Cu(II) is coordinated to the pyrdyl-N, and the two  
amide-O’s.   This structure is consistent with the UV-visible results.   At pH 4.69, the a 
proton signal preferentially broadens, indicating that the terminal amine is now coordinated.   
This is also consistent with the structure postulated for ML from potentiometry, but is not 
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consistent with the UV-visible results where the same λmax was found for ML and MLH.   At 
pH 7.5 the most predominant species is MLH-2.   Here the same broadening of signals was 
seen  as that observed at pH 4.69.   From potentiometry and UV-visible we postulated that for 
this species  the coordination swapped from amide-O to amid-N.   Since this should not have 
an effect on the Cu(II)-proton distances the same broadening would be expected.   Note, in 
strongly basic conditions, the signals appear again and sharpen when the amount of Cu(II) 
was increased.   Since, in solution the concentration of the ligand is very much greater than 
that of Cu(II),  the effect of Cu(II) coordination is transferred to the bulk free ligand via 
chemical exchange.   The sharpening of the signals with increasing pH is explained by the 
slowing down of the exchange.54-56  Similar observations have been made on the  
Cu(II)- glycylglycylhistamine (GlyGlyHa) system.57 
 
 
Figure 4.32: 1H-NMR titration for the complexation of [H2(565)NH2] (0.099 M) in D2O. Note the 
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4.2.3.2.5 Cu(II)-[H(56)NH2] complexes 
The effects of Cu(II) addition on the 1H-NMR spectrum of [H(56)NH2]  are shown in 
Figure 4.33.   The addition of small amounts of Cu(II) to [H(56)NH2] caused differential 
broadening of resonances, which provided an indication of the location of Cu(II) binding.   At 
pH 4.31, the most predominant species is ML.   Only signals c, d, f, e and g are broadening at 
this pH.   This implies that Cu(II) binds to the pyridyl-N and the amide-O in this species.  
This is interesting, particularly as ML was not detected spectroscopically due to its very low 
concentration.   At pH 7.39, the CuLH-1 species predominates.   The signal of proton g 
broadens so much that it disappears into the baseline while those for the a and b protons also 
broaden substantially.   The stoichiometry supports coordination to the pyridyl-N, an  
amino-N and the amide-N when CuLH-1 forms.   Above pH 7.39, all the resonances were 
observed to broaden.   However, the signals a and g disappeared completely.   These results 
indicate that coordination of CuLH-2 is the same as CuLH-1.   MLH-2 forms from the 
deprotonation of a coordinated water molecule. 
 
 
Figure 4.33: 1H-NMR titration for the complexation of [H(56)NH2] (0.099 M) in D2O. Note the break 
in the f1 dimension at 5.0 ppm. The proton assignments are according to Figure 4.26. 
 




4. 3.1 Introduction 
 Single-crystal X-ray diffraction, is a study of crystal structure through X-ray 
diffraction techniques which may lead to an understanding of the molecular and crystal 
structure of a substance.   X-ray crystallography gives information on the structure and 
properties of the crystalline state by determining the arrangement of atoms within a crystal.   
It can be applied to a wide range of sizes of structures ranging from very small molecules and 
simple salts to complex minerals and synthetically prepared inorganic and organometallic 
complexes.   X-ray crystallography is the only technique capable of providing detailed 
information on interatomic distances, bond angles, molecular architecture, absolute 
configuration, thermal vibration parameters and crystal packing, as well as possible order-
disorder and/or non-stoichiometry from the same experiment.58  The solid state structure only 
provides an indication of the solution speciation as one cannot guarantee that the species that 
crystalizes survive in solution. 
4.3.2 Experimental 
4.3.2.1 Single-crystal data collection for Cu(II)-[H(56)NH2Cl]H-1  
 A single crystal of  Cu(II)-[H(56)NH2Cl]H-1, suitable for X-ray structure 
determination was grown by slow evaporation of a 1:1 mixture of EtOH:ClHCl3 and  an 
aqueous solution of the title compound at pH 11.03.   X-ray single crystal intensity data were 
collected on a Nonius Kappa-CCD diffractometer using graphite monochromated  MoK𝛼 
radiation ( λ = 0.71073 Å).   The temperature was controlled by an Oxford Cryostream 
cooling system (Oxford Cryostat).   The strategy for the data collections was evaluated using 
the Bruker Nonius "Collect” program. Data were scaled and reduced using DENZO-SMN 
software.59  Absorption correction was performed using SADABS.60  The structure was 
solved by direct methods and refined employing full-matrix least-squares with the program 
SHELXL-9761 refining on F2.   The program PovRay in the X-seed interface was used to 
generate pictures.62  
4.3.2.2 Single-crystal data collection for Cu(II)-[H2(565)NH2]H-2   
A single crystal of  Cu(II)-[H2(565)NH2]H-2, suitable for X-ray structure 
determination was grown by slow evaporation of a 1:1 mixture of MetOH:ClHCl3 and  an 
aqueous solution of the title compound at pH 11.06.   Single-crystal X-ray diffraction data 
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were collected on a Bruker KAPPA APEX II DUO diffractometer using graphite-
monochromated Mo-K𝛼 radiation (χ = 0.71073 Å).   Data collection was carried out at 173(2) 
K.   Temperature was controlled by an Oxford Cryostream cooling system (Oxford Cryostat).   
Cell refinement and data reduction were performed using the program SAINT1.   The data 
were scaled and absorption correction performed using SADABS.63  The structure was solved 
by direct methods and refined by full-matrix least-squares methods based on F2 using 
SHELXL version 2014/761 and using the graphics interface program X-Seed.62,64  Diagram 
were produced using the program Pov-Ray.65 
 The structure was refined to an R factor of 0.0267 and 0.0309 for [H(56)NH2]H-1 and 
[H2(565)NH2]H-2 respectively.   The crystallographic data and refinement parameters for both 
copper complexes are given in Table 4.3.    
Table 4.3: Details of data collection and structure refinement for the crystal analysis of the  
                   Cu(II)-[H(56)NH2Cl]H-1 and  Cu(II)-[H2(565)NH2]H-2  complexes. 
  
 All non-hydrogen atoms for [H(56)NH2Cl]H-1 and [H2(565)NH2]H-2  were refined 












a ( Å ) 
b ( Å ) 
c ( Å ) 
𝛼 (˚)  
𝛽 (˚)  
𝛾 (˚) 
Volume of unit cell ( Å 3) 
Z 
No. of reflections collected 
No. unique reflections 
Calculated density (g cm-3) 
Absorption coefficient (mm−1) 
F(000) 
Crystal Size (mm) 
Radiation  
theta range for data collection (∘) 
Reflections measured 
R, Rw, goodness-of-fit 
Min and  max residual density (e A˚-3) 


















0.05 x  0.07 x  0.10 
Mo K𝛼   (λ= 0.71073 A˚) 
3.3 - 27.9 
2860 
0.0267, 0.0668, 1.07 
-0.65, 0.43 


















0.13 x  0.14 x  0.17 
Mo K𝛼 (χ= 0.71073) 
2.2,  27.5 
3046 
0.0309, 0.0764, 1.05 
-0.46, 0.30 
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positions and refined in riding models with Uiso assigned the values 1.2 times those of their 
parent atoms, and the C-H bond distances were constrained to 0.95 Å for aromatic hydrogen 
atoms and 0.99 Å for CH2.   The hydrogen atoms of [H(56)NH2]H-1 (H1C, H1D, H2C, H2D, 
H3A and H3B) and for [H2(565)NH2]H-2 (H3A, H3B, H4A, H4B, H4C and H4D) were 
located in the electron difference maps and refined with simple bond lengths restraints.    
4.3.3 Results and discussion 
4.3.3.1 Crystal structure of Cu(II)-[H(56)NH2Cl]H-1 
 The Cu(II)-[H(56)NH2]H-1 complex crystallises in monoclinic crystal system space 
group P21/c.   The structure and the atom-labeling of the complex are shown in Figure 4.34.   
The structure of the complex consists of a Cu atom surrounded in a pentadentate manner 
through the pyridyl-N, amino-N, and amide-N of the ligand.   One Cl atom in this complex 
occupies an equatorial plane and another chloride atom is in the axial positions, which makes 
the Cu(II) coordination 3+2 as shown in Figure 4.35.   The principal atomic distances and 
angles are summarized in Table 4.4. 
      Table 4.4:  Principal atomic distances and angles in Cu(II)-[H(56)NH2Cl]H-1 complex.  
Distances (Å) 
Cu1    -Cl1        2.6736(5) 
Cu1    -N1         1.9896(17) 
Cu1    -N2         1.9756(15) 
Cu1    -N3         1.9783(16) 
Cu1    Cl1_a      2.3229(5) 
O1      -C3         1.277(3) 
O2     -H2D       0.97(2) 
O2     -H2C       0.968(16) 
O3     -H3A       0.97(2) 
O3     -H3B       0.97(2) 
N1     -C1          1.478(3) 
N2     -C3          1.317(3) 
N2     -C4          1.464(3) 
N3     -C5          1.344(3) 
N3     -C9          1.350(3) 
N1     -H1D       0.879(9) 
N1     -H1C       0.880(11) 
C1     -C2         1.518(3) 
C2     -C3         1.514(3) 
C4     -C5         1.501(3) 
C5     -C6         1.391(3) 
C6     -C7         1.383(3) 
C7     -C8         1.390(3) 
C8     -C9         1.373(3) 
C1     -H1B      0.9900 
C1     -H1A      0.9900 
C2     -H2A      0.9900 
C2     -H2B      0.9900 
C4     -H4A      0.9900 
C4     -H4B      0.9900 
C6     -H6         0.9500 
C7     -H7         0.9500 
C8     -H8           0.9500 
C9     -H9           0.9500 
                                                            Angles(˚)  
Cl1     -Cu1    -N1         88.88(4)    
Cl1     -Cu1    -N2         113.46(4)    
Cl1     -Cu1    -N3         88.98(4)    
Cl1     -Cu1    -Cl1_a   95.55(2)    
N1      -Cu1    -N2        94.12(6)    
N1      -Cu1    -N3        175.17(6)   
O1     -C3     -C2       117.31(17) 
O1     -C3     -N2       124.24(19) 
N2     -C4     -C5       110.32(17) 
C4     -C5     -C6       122.63(19) 
N3     -C5     -C4       116.29(17) 
N3     -C5     -C6       121.08(17) 
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Cl1_a  -Cu1    -N1        91.63(5)    
N2      -Cu1    -N3         82.77(6) 
Cl1_a  -Cu1    -N2        150.49(5)   
Cl1_a  -Cu1    -N3        92.88(5)    
Cu1     -Cl1    -Cu1_b   107.58(2)    
H2C    -O2     -H2D      98.1(19)   
H3A    -O3     -H3B      104.9(19)   
Cu1     -N1     -C1         111.07(12)    
Cu1     -N2     -C3         130.45(14)    
C3       -N2     -C4         115.20(16)    
Cu1     -N2     -C4         113.80(12)    
Cu1     -N3     -C9         124.99(13)  
C5       -N3     -C9         119.50(16)    
Cu1     -N3     -C5         115.51(12)   
H1C    -N1     -H1D      107(2)    
C1       -N1     -H1C      110.5(13)   
C1       -N1     -H1D      107.1(15)    
Cu1     -N1     -H1C      110.4(13)    
Cu1     -N1     -H1D      110.8(16)    
N1       -C1     -C2         112.21(17)    
C1       -C2     -C3         118.80(17)   
N2      -C3      -C2         118.45(18)    
C6      -C7      -H7         120.00    
C7      -C8      -H8         121.00    
C9      -C8      -H8         121.00 
C5     -C6     -C7        119.1(2) 
C6     -C7     -C8       119.53(19) 
C7     -C8     -C9       118.46(19) 
N3     -C9     -C8       122.30(19) 
N1     -C1     -H1A    109.00 
C2     -C1     -H1B     109.00 
H1A  -C1     -H1B     108.00 
N1     -C1     -H1B     109.00 
C2     -C1     -H1A     109.00 
C3     -C2     -H2A     108.00 
C1     -C2     -H2A     108.00 
C1     -C2     -H2B     108.00 
H2A  -C2     -H2B     107.00 
C3     -C2     -H2B     108.00 
N2     -C4     -H4B     110.00 
C5     -C4     -H4A     110.00 
H4A  -C4     -H4B     108.00 
C5     -C4     -H4B     110.00 
N2     -C4     -H4A     110.00 
C5     -C6     -H6        121.00 
C7     -C6     -H6        120.00 
C8     -C7     -H7        120.00 
C8     -C9     -H9        119.00 




                    Figure 4.34: Crystal structure of complex Cu(II)-[H(56)NH2Cl]H-1. 
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              Figure 4.35: View of dimer made of two Cu(II)-[H(56)NH2Cl]H-1 complexes. 
Each chloride atom acts as a bridge and links two Cu atoms as shown in Figure 4.35. 
The coordination has typical Cu–N bond lengths66 as in the case of [Cu(Mepy2)en]2+.67,68    
A geometry parameter τ, which is defined τ = (β - α)/60, is applicable to five-coordinate 
structures within the structural continuum between trigonal bipyramidal and tetragonal or 
rectangular pyramidal.   For perfect tetragonal symmetry, τ is zero, and for perfect trigonal-
bipyramidal geometry τ becomes 1.0.69,70  In this complex, β = 175.11(6)° for N1–Cu1–N3, 
and α = 150.49 (5)° for Cl1_a–Cu1–N2.   Thus, τ is (175.11 – 150.49)/60 = 0.410, indicating 
a 90% rectangular pyramidal geometry.   Furthermore, the bridging chlorine atoms are 
positioned at distances of 2.67(5) Å for Cl(1) and 2.32(5) Å for Cl(1a) and make an angle of 
95.55(2)∘ at each metal centre,  in agreement with previous reports.71-73  However, in this 
complex CuLH-1 has a slightly rectangular pyramidal geometry structure which is essentially 
a D2h symmetric.   In addition, the bond lengths are Cu1–N1 1.98 Å, Cu1–N2 1.97 Å,  
Cu1–N3 1.97 Å and Cu1–Cl1 2.67-2.32Å.   The angles around the copper atom are N1–Cu1–
N2 94.12(∘), N1–Cu1–N3 175.17(∘) and N2–Cu1–N3 82.77(∘).   Thus,  values of bond angles 
and bond distances are in good agreement with those reported for some analogous 
Cu(II)complexes in a rectangular pyramidal geometry.68,70  
4.3.3.2 Crystal structure of Cu(II)-[H2(565)NH2]H-2 
The solid-state structure of Cu(II)-[H2(565)NH2]H-2 determined by single-crystal  
X-ray diffraction, together with atom labelling, is shown in Figure 4.36.   The bond lengths 
and bond angles are presented in Table 4.5. 
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    Table 4.5:  Principal atomic distances and angles in Cu(II)-[H2(565)NH2]H-2 complex. 
Distances (Å) 
 
 Cu1    -N1       2.0007(18)      
 Cu1    -N2       1.9327(18)       
 Cu1    -N3       1.9205(18)     
 Cu1    -N4       2.0083(19)      
 O1      -C7       1.259(3)       
 O2      -C10     1.265(3)       
 O3      -H3B    0.970(14)      
 O3      -H3A    0.969(17)     
 O4      -H4C    0.967(15)    
 O4      -H4D    0.97(2)   
 N1      -C1       1.355(3)      
 N1      -C5       1.344(3)   
 N2      -C7       1.317(3)    
 N2      -C6       1.460(3)      
 N3      -C10     1.307(3)      
 N3      -C9       1.456(3) 
 N4      -C11     1.481(3)    
 N4      -H4B    0.879(17)   
 N4      -H4A    0.880(11)      
 C1      -C2       1.374(3) 
 
C2     -C3         1.386(3) 
C3     -C4         1.379(3)  
C4     -C5         1.393(3) 
C5     -C6         1.497(3)  
C7     -C8         1.516(3)  
C8     -C9         1.528(4)  
C10   -C11       1.513(3)  
C1     -H1         0.9500  
C2     -H2         0.9500  
C3     -H3         0.9500  
C4     -H4         0.9500  
C6     -H6A      0.9900 
C6     -H6B      0.9900  
C8     -H8A      0.9900  
C8     -H8B      0.9900  
C9     -H9B      0.9900  
C9     -H9A      0.9900 
C11   -H11A    0.9900  
C11   -H11B    0.9900 
                                                            Angles(˚)  
 
N1     -Cu1    -N2            83.41(8)     
N1     -Cu1    -N3            168.17(9)  
N1     -Cu1    -N4            100.64(7)    
N2     -Cu1    -N3             94.97(8)    
N2     -Cu1    -N4             167.72(9)    
N3     -Cu1    -N4             83.39(8)   
H3A   -O3     -H3B          109(3)    
H4C   -O4     -H4D          108(3)   
C1      -N1     -C5             118.71(18)   
Cu1    -N1     -C5             113.96(14)     
Cu1    -N1     -C1             127.32(15)    
Cu1    -N2     -C6             115.34(14)  
Cu1    -N2     -C7             128.29(15)   
C6      -N2     -C7             116.08(18)    
Cu1    -N3     -C9             122.32(14)  
C9      -N3     -C10           119.83(18)  
Cu1    -N3     -C10           117.71(15)  
Cu1    -N4     -C11           108.75(14)  
C11    -N4     -H4B          106.6(16)    
Cu1    -N4     -H4B          120.5(17)   
C11    -N4     -H4A          109.5(16)   
Cu1    -N4     -H4A          105.0(17)    
H4A   -N4     -H4B          106(2)    
N1     -C1       -C2            122.2(2)    
C1     -C2       -C3            119.1(2)    
C2     -C3       -C4            119.1(2)    
C3     -C4       -C5            119.2(2)  
 
C4     -C5     -C6       121.4(2) 
N1     -C5     -C6       116.94(18)  
N2     -C6     -C5       110.26(18)  
O1     -C7     -C8       118.44(19)  
N2     -C7     -C8       117.8(2)  
O1     -C7     -N2       123.8(2)  
C7     -C8     -C9       115.9(2) 
 N3    -C9     -C8       111.12(19)  
N3     -C10   -C11     114.74(19) 
 O2    -C10   -N3       127.3(2)  
O2     -C10   -C11      117.94(19)  
N4     -C11   -C10      111.02(19)  
C2     -C1     -H1        119.00 
N1     -C1     -H1        119.00  
C1     -C2     -H2        120.00 
C3     -C2     -H2        120.00  
C4     -C3     -H3        120.00 
C2     -C3     -H3        120.00 
C5     -C4     -H4        120.00  
C3     -C4     -H4        120.00  
N2     -C6     -H6B     110.00  
N2     -C6     -H6A     110.00 
H6A  -C6     -H6B     108.00  
C5     -C6     -H6A     110.00  
C5     -C6     -H6B     110.00  
C9     -C8     -H8A     108.00  
C9     -C8     -H8B     108.00  
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N1     -C5       -C4            121.65(19)    
C7     -C8       -H8A         108.00    
C7     -C8       -H8B         108.00    
C8     -C9       -H9A         109.00    
N3     -C9       -H9A         109.00    
N3     -C9       -H9B         109.00   
H9A  -C9       -H9B         108.00       
H8A    -C8      -H8B          107.00  
C8       -C9      -H9B          109.00 
N4       -C11    -H11B        109.00 
N4       -C11    -H11A        109.00 
H11A  -C11    -H11B        108.00 
C10     -C11    -H11A        109.00 
C10     -C11    -H11B        109.00 
  
 
                  Figure 4.36: Crystal structure of complex Cu(II)-[H2(565)NH2]H-2. 
The crystal structure of the Cu(II)-[H2(565)NH2]H-2 complex consists of a monomer 
of Cu(II) coordinated to the ligand via the  pyridyl-N, the amine-N and the two amide -N.    
In this complex Cu(II) has a slightly distorted square planar geometry, with the two amides in 
cis positions.   The structure is essentially of D4h symmetry.   The Cu-Namine, Cu-Namide and 
Cu-Npy distances fall within the expected ranges of, 1.990– 2.004 Å74, 1.91–1.96 Å75, and 
2.00-2.11 Å76,77, respectively.   The Cu–Namine and Cu–Npy distances are almost equal to each 
other.   Furthermore the bond angles N1-Cu-N2 83.41(8)° and N3-Cu-N4 83.39(8)° deviate 
only slightly from the ideal 90° for regular square planar geometry.   The angle (θ) between 
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the N1-Cu-N2 and N3-Cu-N4 planes is found to be 17.64° rather than 0o for a regular square 
plan.   The trans angles N1-Cu-N3 and N2-Cu-N4 are 168.17(9)◦ and 167.72(9)◦ respectively 
which deviates from the ideal bond angle 180◦.   These results suggest that Cu(II) in this 
complex is located in a geometry much closer to square planar.   The angular distortions in 
the complex are caused by the different bite angles in the five and six membered chelate 
rings. 
In summary, the [H(56)NH2Cl]H-1 ligand was reacted with Cu(II) chloride and the 
resulting complex analysed.   The X-ray single crystal structure revealed that the motif 
consists of a monomeric Cu(II), with the copper bound to the three nitrogens of the ligand, as 
well as two chloride atoms.   The fifth coordination site is occupied by Cu–3N and 2Cl to 
form a rectangular pyramidal geometry.   On the other hand, the [H2(565)NH2]H-2 ligand was 
coordinated with copper by four nitrogens to form distorted square planar geometry.   The  
X-ray results support the structures suggesting by potentiometric and Uv-Vis studies.   In 
particularly the X-ray result show the loss of the amide proton from both ligands.   
Unfortunately, it has not been possible to prepare a single crystal of either CuL or CuLH-1 
suitable for X-ray structure analysis.   Furthermore, we were not able to perform crystal 
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4.4 Molecular Mechanics 
4.4.1 Introduction 
Molecular mechanics (MM) is a very popular tool used to express the structures and 
relative energies of a molecule as a function of its resistance to bond stretching, bond 
bending, and atom crowding.78-81  Advances in computing have greatly increased the interest 
in computer-based molecular modelling.   As such, it is now used as an aid in the 
interpretation of experimental results and design of new materials with desirable properties.   
In this study MM was used to determine the lowest energy conformation of possible 
geometries of the complex species in solution.   These calculations of the strain energy of a 
molecule are done using force fields.   The choice of a force field used in a calculation is 
entirely dependent on the type of complex or molecule (i.e. organic or inorganic) of interest 
and the software program used to run the simulation.82  There are a limited number of reliable 
force fields to use for the MM calculation involving metal ions.   Therefore, MM calculations 
involving transition metal ions are not used to the same extent as those for organic 
molecules.83,15  
4.4.2 Theory 
The basis of the molecular mechanics method is that a good estimate of the geometry 
of a molecule can be obtained by taking into account all the forces between atoms calculated 
using a mechanical approach.78,79  
Molecular mechanics expresses the strain energy Estrain ; meaning that it reflects the 
“strain” inherent to a “real” molecule relative to some idealized form.   However, it arises 
from four principle energy terms78,79,84 the general form of which is given as;  
 
 
        ∑   
       
     
 
 ∑   
    
           
 
 ∑   
       
              
 
 ∑ ∑   
          
 
                
 
 
            (4.7) 
Bond deformation strain is the energy exerted on a bond between atoms, either by 
stretching the bond or compressing it.   Due to a bond’s ability to stretch/compress and the 
ability of the angle between the bonds to bend, the total bond deformation strain can be 
estimated using Hooke’s law. 
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     (4.9) 
where kstretch  and  kbend  are the so-called stretch and bend “force constants” respectively,  
while r and α are the bond distance and angle respectively, and req and αeq are the “ideal” 
(equilibrium) bond length and bond angle respectively, taken either from performing 
experiments or from  accurate quantum chemical calculations. 
 
Proper description of the torsional potential requires a form that reflects its inherent 
periodicity.   However, torsional strain is experienced when a molecule undergoes a complete 
rotation around one bond. 
                      [              ] 
 (4.10) 
ω is the torsion angle, ωeq is the ideal torsion angle and ktorsion3 is treated as a parameter.   
Bond torsion contributions to the overall energy may also need to include terms which are 
one-fold and two-fold periodic. 
                      [             ]            [              ]
          [              ] 
(4.11) 
ktorsion1 and ktorsion2  are additional parameters 
Non-bonded interactions typically involve a sum of van der Waals (VDW) interactions and 
coulombic interactions. 
 
Enon-bonded (r) = EVDW (r) + ECoulombic (r) 
  (4.12) 
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Additional non-bonded terms may be included to account explicitly for interactions such as 
hydrogen bonding. 
Most commonly, van der Waals interactions are represented as a sum of repulsive and 
attractive terms.85  This occurs when the distance between these substituents is less than van 
der Waals radii.86  
          [  
  
 
       
  
 
  ] 
                                                                                                                                                                         (4.13) 
 
r is the non-bonded distance, and ε and ro are parameters.   This functional form provides a 
very steep energy barrier inside the sum of van der Waals radii for the two atoms involved.  
The coulombic term takes account of the interaction of charges. 
 




r is the non-bonded distance, and the atomic charges, q, may either be treated as parameters 
or be taken from quantum chemical calculations. 
Many different kinds of force fields have been developed over the years.   Some 
include additional energy terms that describe other kinds of deformations.   Some force fields 
account for coupling between bending and stretching in adjacent bonds in order to improve 
the accuracy of the mechanical model.   In general force field terms are derived empirically 
with the target of reproducing experimental structures and energy distributions.78,79  The 
extension of MM to inorganic chemistry and especially to transition-metal (TM) systems 
presents greater challenges.82,87,88  A generic force field, Extensible Systematic Force Field 
(ESFF)89 has been developed.   This force field90 attempts to provide the widest possible 
coverage of the periodic table, including transition metals, with reasonable accuracy and has 
been successfully used to model several proteins containing metals.89,91,92  ESFF employs 
semi-empirical rules to translate atomic-based parameters to parameters typically associated 
with a covalent valence force field.   The atomic parameters depend not only on atom type, 
but also on internal type, thus resulting in a more accurate force field.   The force field has 
been applied to molecular simulations of a wide variety of systems including nucleic acids, 
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peptides, hydrocarbons, -porphyrins, transition metal complexes, zeolites, and organometallic 
compounds.89  The agreement with the experimental results indicates that ESFF is a valuable 
tool in molecular simulations for understanding and predicting both crystal and gas phase 
molecular structures.   The valence bond, angle, torsion, and out-of-plane energies in the 
mathematical expression of the ESFF are used to describe the internal interactions, while van 
der Waals and electrostatic energies represent the nonbonded interactions.91  An advantage of 
using the ESFF force field is the ease in automatic parameterization of all atom types.93  The 
ESFF force field has been used extensively to study the geometry of Cu(II) complexes91,92,94, 
including complexes with amide coordination.94-96  However, it should be noted that MM 
does not calculate the absolute energy of a system as it does not take into account bond 
enthalpies or entropy of the system.   Instead, it calculates the energy brought about by 
changes in bond angles and lengths from their idealised (parameterized) values.   When a 
complex forms the ligand has to adopt a conformation that is different from its lowest energy 
structure.   This increased conformational energy is compensated for by the formation of new 
bonds to the metal ion.   For this reason it is not really valid to compare two structures that 
have different bonding.   However, the strain introduced into the ligand as a result of metal 
ion coordination can be used as an indication of stability or likelihood of formation. 
 
4.4.3 Calculations 
The MM calculations were performed using the force field ESFF97 as implemented in 
the InsightII v. 2004.1 package.98  The different chemical species in solution were 
constructed from fragments using the BUILDER module of the Accelrys Biosym/MSI 
software package and were based on the speciation models obtained from UV-visible 
spectroscopy and potentiometry (see Chapter 3 and 4.1).   The energy minimizations of the 
copper speciation complexes were carried out using the Discover_3 program which was run 
as an application in the Insight II package.98 
 
4.4.4 Results and Discussion 
In this study, MM has been used to provide more evidence in support of the solution 
structures postulated from potentiometric and spectroscopic data.   In this regard, structures 
of two sets of species were considered for each Cu(II) ligand system.  
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The energy-minimised structures for the Cu(II)-[H(555)NH2], [H2(565)NH2]  and 
[H(56)NH2] systems are given in Figures 4.37-4.41.   The output data for the deformation 
energies including internal (strain) energy for these structures are given in Tables 4.6 - 4.10.   
The energy-minimised structures are compared in terms of internal energy.   The internal 
energy indicates the strain energy introduced into the ligand when it coordinates to the central 
metal ion.   It is a one of the contributing factor in the overall stability of the complex.    
 
Strain energy elevates the internal energy contribution to the overall potential energy 
of the molecule resulting in low complex stability.   On other hand, the strain contribution to 
the differences in stability is the energy associated with torsion of bonds as the different 
donor atoms are oriented for coordination to the metal ion.   Bond stretching seems to make a 
less significant contribution to the differences in strain energies of these structures.   The 
main differences in internal energy contribution arise from twisting of bonds and bending of 
angles as coordinating atoms are accommodated around the central metal ion. 
 
4.4.4.1 ML of [H(555)NH2] System 
 For the Cu(II)-[H(555)NH2] system, it is possible to propose two structures for the 
ML complex (Figure 4.37).   In one structure (Figure 4.37a), the Cu(II) is coordinated to the 
pyridyl-N, two amine-N and an amide-O.   In the other structure (Figure 4.37b) the Cu(II) is 
bound to the pyridyl-N,  amine-N and amide-N, while the terminal amine is not coordinated.   
In order to maintain the stoichiometry, the amine will have to be protonated as the amide has 
lost a proton.   The optimised, MM structures for these two structures show that the Cu(II) in 
Figure 4.37a is very distorted from an idealised tetragonal geometry, while Figure 4.37b has 
a square planar arrangement of ligands in the equatorial plane.   Figure 4.37a has a much 
higher total internal energy (Eint) (84.58 kcal mol-1) than Figure 4.37b (40.81 kcal mol-1)  
(see Table 4.6).   This is mainly as a result of angular and torsional distortions, which are 27 
and 16 kcal mol-1 higher in Figure 4.37a than Figure 4.37b.   Hence from MM calculations, 
the structure in Figure 4.37b is preferred.   This conclusion supports both the potentiometric 
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Table 4.6: Internal energy (Einternal), bond (Ebond), angle (Eangle), torsion (Etorsion) and out-of-plane   
                   (EOop) deformation energies (kcal mol-1) for (a) 7,5,5 and (b) 5,5 membered chelate rings   







Eint 84.58 40.81 
Bond 11.18 11.03 
Angle 47.90 20.57 
Torsion 24.23 8.35 
Oop 1.26 0.84 
 
  
(a)                                                                           (b) 
Figure 4.37: Two possible energy-minimised structures of Cu(II)-[H(555)NH2] (ML). (a): 7,5,5   
                    membered chelate rings and (b): 5,5 membered chelate rings. For clarity the axial  
                    waters are not displayed. 
 
4.4.4.2 MLH-1 of [H(555)NH2] System 
 Figures 4.38c and 4.38d show the two proposed structure of MLH-1 species for the 
Cu(II)-[H(555)NH2] system.   In Figure 4.38c, the Cu(II) is coordinated to the pyridyl-N, two 
amine-N and amide-N to form 5,5,5 membered chelate rings.   Meanwhile, the Cu(II) in 
Figure 4.38d  is coordinated to the pyridyl-N, an amine-N and an amide-N to form 5,5 
membered chelate rings; the terminal amine is not coordinated.   The 5,5,5 chelate structure 
given in Figure 4.38c has a higher internal energy than the 5,5 chelate structure given in 
Figure 4.38d.   The high strain energy associated with the 5,5,5 chelate structure is mainly 
due to the high angle bending and torsional energies in this structure (Table 4.7).   From the 
MM calculations, the proposed structure with 5,5-membered ring in Figure 4.38d is preferred 
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for  MLH-1.   This conclusion does not support the structure postulated from potentiometric 
and spectroscopic data, which favours 4.38c.   Such a result clearly demonstrates the 
limitations of MM calculations as a computational tool for Cu(II) complexes since it does not 
take into account the bond enthalpy of the extra Cu-N bond, the electronic contributions of 
the metal or entropy effects, both in terms of the chelate effect of the ligand and the solvent. 
Table 4.7: Internal energy (Einternal), bond (Ebond), angle (Eangle), torsion (Etorsion) and out-of-plane  
                   (EOop) deformation energies (kcal mol-1) for (c): 5,5,5 and (d): 5,5 membered chelate rings  







Eint 70.76 26.68 
Bond 15.60 8.98 
Angle 45.60 13.64 
Torsion 8.53 3.87 




                            (c)  (d) 
Figure 4.38: Two possible energy-minimised structures of Cu(II)-[H(555)NH2] (MLH-1). (c): 5,5,5  
                   membered chelate rings and (d): 5,5 membered chelate rings.  For clarity the axial  
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4.4.4.3 ML of [H2(565)NH2] System 
 The three proposed structures of ML species for the Cu(II)-[H2(565)NH2] system are 
shown in Figures 4.39 (e, f and g).   In Figure 4.39e, Cu(II) is coordinated to the pyridyl-N, 
an amide-N and an amide-O to form 5,8 membered chelate rings, while the terminal amine is 
still protonated.   In the other two structures, Cu(II) is coordinated to the pyridyl-N and two  
amide-O to form 7,8 membered chelate rings.   However, it could be coordinated as either the 
meridional isomer (Figure 4.39f) or the facial isomer (Figure 4.39g) to form an octahedral 
geometry.   The meridional isomer chelate rings have high internal energy (Table 4.8), 
because it is distorted from an idealised tetragonal geometry.   The two structures e and g 
have similar internal energies (53.87 kcal mol-1) and (52.39 kcalmol-1) respectively.   
However, the structure in Figure 4.39e has a very high angle bending energy.   This energy 
comes from the distortion of the amide geometry.   Ideally the amide with a carbonyl group 
must be planar with sp2 hybridization.   Thus, any distortion of this result leads to loss of 
electron delocalization with the N-amide partial double bond.   From the potentiometric data 
(see section 3.5.2.4.3) we postulated a similar structure to that predicted by these MM 
calculations in Figure 4.39g.   Moreover, the spectroscopic data giving a λmax value of 747 nm 
clearly suggests an octahedral geometry by one nitrogen donor atom. 
Table 4.8: Internal energy (Einternal), bond (Ebond), angle (Eangle), torsion (Etorsion) and out-of-plane  
                 (EOop) deformation energies (kcal mol-1) for (e): 5,8, (f): 7,8 Mer and (g): 7,8 Fac   









Eint 53.87 116.51 52.39 
Bond 12.62 18.82 10.39 
Angle 33.44 85.61 20.03 
Torsion 7.22 11.90 21.22 
Oop 0.57 0.16 0.73 
 
 




 (e)                                                             (f) Mer 
 
(g) Fac 
Figure 4.39: Three possible energy-minimised structures of Cu(II)-[H2(565)NH2] (ML). (e): 5,8 (f):  
                      7,8 Mer and (g): 7,8 membered chelate rings Fac. For clarity in the structure (e) the    
                    axial waters are not displayed. 
 
4.4.4.4 ML of [H(56)NH2] System 
 The two proposed structures of ML species for the Cu(II)-[H(56)NH2] system are 
given in Figures 4.40h and 4.40i with their corresponding energies given in Table 4.9.   The 
Cu(II) in Figure 4.40h is bound to the pyridyl-N, an amide-O and an amine-N to form  
7,6-membered rings.   In Figure 4.40i, the Cu(II) is coordinated by the pyridyl-N and an 
amide-N, while the terminal amine is protonated.   The optimised MM structures for these 
two structures show that the Cu(II) with a 5-membered ring (Figure 4.40i) has a lower strain 
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energy than the 7,6 chelate structure (Figure 4.40h).   This energy difference arises from a 
high angle bending energy (22.60 kcal mol-1) and torsion energy (16.68 kcal mol-1) in the 7,6 
chelate structure as the amine nitrogen donor is forced into the coordination plane of the 
metal.   From the MM calculations, the structure with a 5-membered ring (Figure 4.40i) is 
preferred.   This structure is not consistent with the structure of the ML species determined 
from potentiometric study (Figure 4.40h).   The ML result clearly demonstrates the 
limitations of MM calculations as a computational tool for Cu(II) complexes.   This result is 
in accordance with the established observation that three chelate complexes are more stable 
than complexes with bidentate ligands.99 
Table 4.9: Internal energy (Einternal), bond (Ebond), angle (Eangle), torsion (Etorsion) and out-of-plane  
                   (EOop) deformation energies (kcal mol-1) for (h): 7,6 and (i): 5 membered chelate rings of  







Eint 59.40 36.68 
Bond 19.07 12.06 
Angle 22.60 21.62 
Torsion 16.68 2.80 
Oop 1.03 0.19 
 
 
                                                                                               
 (h) (i) 
Figure 4.40: Two possible energy-minimised structures of Cu(II)-[H(56)NH2] (ML). (h): 7,6 and                       
                    (i): 5 membered chelate rings. For clarity the axial waters are not displayed. 
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4.4.4.5 MLH-1 of [H(56)NH2] System 
 The two possible structures for MLH-1 of the Cu(II)-[H(56)NH2] system, are shown in 
Figures 4.41j and 4.41k.   In one structure (Figure 4.41j), Cu(II) is coordinated to the  
pyridyl-N and an amide-N.   In the other structure (Figure 4.41k), Cu(II) is bound to the  
pyridyl-N, an amine-N, and an amide-N.   From the MM optimisation of these two structures, 
the 5,6 chelate structure (Figure 4.41k)  had a slightly higher strain energy (Table 4.10) than 
the 5 chelate structure (Figure 4.41j).    
Table 4.10: Internal energy (Einternal), bond (Ebond), angle (Eangle), torsion (Etorsion) and out-of-plane  
                     (EOop)  deformation energies (kcal mol-1) for (j): 5 and (i): 5,6 membered chelate rings   







Eint 26.57 33.11 
Bond 10.49 12.31 
Angle 12.47 16.64 
Torsion 3.36 4.13 
Oop 0.24 0.02 
 
  
 (j)                                                            (k)  
Figure 4.41: Two possible energy-minimised structures of Cu(II)-[H(56)NH2] (MLH-1). (j): 5 and                       
                   (k): 5,6  membered chelate rings For clarity the axial waters are not displayed. 
 
 For both structures, the major contributions to the internal strain energy come from 
the angle bend and bond stretch energies.   However, it is not much different in comparison to 
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the 5 membered ring in Figure 4.41j.   The 5,6 chelate ring systems in this study seem to be 
stabilized as compared to the 5 chelate ring system due to the pre-organization of the ligand.   
The MM calculations were not able to distinguish between the two structures.   However, the 
potentiometric, UV-visible spectroscopy and X–ray studies favour the structure with 5,6 
membered rings (Figure 4.41k) for MLH-1.  
 
4.4.5 Conclusion 
 In this study molecular mechanics has been used as a simple computational tool to 
provide more information about the possible structures for the different complexes.   These 
results were used to support the potentiometric and spectroscopic (NMR, UV-visible) studies.   
In all calculations, no account is taken of the electronic contribution, Jahn-Teller distortion of 
Cu(II), entropy effects, the chelate effect of the ligand and solvent effects.   This might 


















              
 
 






















Figure 4.42: Some of the literature ligands used in the discussion. 
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5.1 Blood Plasma Model 
5.1.1   Introduction 
Cu(II) complexes are effective in treating inflammation associated with rheumatoid 
arthritis.   This pharmacological effect was first associated with the free labile copper (II) 
concentration in the body by Sorenson et al. in 1976.1  The main objective of the present 
study was to produce a drug that is able to mobilize Cu(II) in blood plasma.   Although the 
ligands designed in this study form more stable complexes with Cu(II) than with Zn(II) and 
Ni(II), this is no guarantee that the Cu(II) complex will form in vivo.   Furthermore, the 
concentrations of Zn(II) and Ni(II) are much higher than the Cu(II) concentration in the body 
and there are a myriad of other ligands that bind Cu(II).   For example, a small fraction of 
these metal ions are bound to low molecular weight (l.m.w) compounds, mainly amino acids.   
The metals bound to l.m.w compounds play a major role in many biological and 
physiological processes like intestinal absorption, cell absorption and renal excretion.2  The 
complexing ability of the ligands in vivo was estimated by calculating, their plasma-
mobilizing indices (p.m.i).  
 Most complexes in blood plasma are charged and therefore need a neutral transport 
molecule that will help them to cross the lipid bilayer found in cell membranes.   The May 
model uses a program called Evaluation of Constituent Concentrations in Large Equilibrium 
Systems (ECCLES)3,4 which calculates the p.m.i.   Thus, p.m.i defines the ability of a ligand 
to move Cu(II) from a protein-bound form to a l.m.w form.   This means that a strong specific 
Cu(II) chelator would have high p.m.i. values at low drug concentrations, indicating a 
potentially useful therapeutic agent. 
5.1.2 Blood Plasma Simulations 
The present study was carried out to investigate the in vivo Cu(II) speciation  of the 
studied ligands using the program ECCLES.5  This program has a list of species that are 
found in blood plasma with their cumulative stability constants.6-9  ECCLES simulates the 
speciation of species of interest at the physiological pH of 7.4 in blood plasma so as to 
calculate the plasma-mobilizing indices.   This calculation takes into account the competition 
of species with some 7 metal ions and 40 ligands that generate more than 5000 species 
present in blood plasma.   The total ligand concentration was varied over a range  
10-1 - 10-10 M.  
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The plasma mobilizing index was defined for Cu(II)10,11 as;  
      
                                                                                        





Figure 5.1 shows p.m.i curves for Cu(II), Ni(II), and Zn(II) with [H(555)NH2] plotted 
against logarithms of the concentration of the ligand.   The curves indicate that the mobilizing 
ability of [H(555)NH2]  in vivo was in the order Cu(II) > Ni(II) > Zn(II).   The ligand was 
selective for Cu(II) in vivo relative to other metal ions.   The remarkably high mobilizing 
ability of this ligand is related to the stable complexes it forms with Cu(II).   In addition, the 
predominant CuLH-1 species of this ligand was present at physiological pH at a total ligand 
concentration of 10-5 and 10-4 mol dm-3 for [H(555)NH2] with Ni(II) and Zn(II), respectively. 
In spite of the higher concentrations of these in vivo competitors and the predominance of the 
MLH-2 species for both Ni and Zn metal ions, their weak binding strength with [H(555)NH2]   
made them less important competitors of Cu(II) in vivo. 
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The blood plasma index curves for Cu(II), Ni(II), and Zn(II) as a logarithmic function 
of concentration of the ligand is given in Figure 5.2.   Despite the high in vivo concentration 
of Zn(II), [H(555)NMe2] is able to mobilize Cu(II) to a greater extent.   At low ligand 
concentrations 10-5 M, [H(555)NMe2] mobilized Cu(II) but not Ni(II), and the p.m.i of the 




        Figure 5.2: Log p.m.i as a function of log [H(555)NMe2] for Cu(II), Ni(II) and Zn(II) complexes. 
 
5.1.3.3 [H2(555)NH2] 
Figure 5.3 shows the log p.m.i curves vs log of ligand concentration for [H2(555)NH2] 
with Cu(II), Ni(II) and Zn(II) complexes.   The curves indicate that the mobilizing ability of 
[H2(555)NH2]  in vivo is in the order Zn(II) > Cu(II) > Ni(II).   Therefore, Zn(II) is a good 
competitor of Cu(II) for [H2(555)NH2] in blood plasma.   This ligand mobilized Zn(II) over 
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   Figure 5.3: Log p.m.i as a function of log [H2(555)NH2] for Cu(II), Ni(II) and Zn(II) complexes. 
 
5.1.3.4 [H2(565)NH2] 
The p.m.i curve for [H2(565)NH2] is given in Figure 5.4.   [H2(565)NH2] mobilized 
Cu(II) at ligand concentrations above 10-4 M, while Ni(II) and Zn(II) are mobilized only at 
ligand concentrations above 10-2 M. 
 






































The p.m.i curves for [H(56)NH2] are given in Figure 5.5.   [H(56)NH2] mobilized 
Cu(II) almost exclusively over Ni(II) and Zn(II) in blood plasma.   Cu(II) is mobilized by 
[H(56)NH2] from a ligand concentration of 0.01 M whereas, Zn(II) is mobilized only at 











           Figure 5.5: Log p.m.i as a function of log [H(56)NH2] for Cu(II), Ni(II) and Zn(II) complexes. 
 
5.1.4 Discussion 
 Figure 5.6 shows the Cu(II) p.m.i curves for [555-N], [H(555)NH2], [H(555)NMe2], 
[H2(555)NH2], [H2(565)NH2] and [H(56)NH2].   The ligands [H2(555)NH2] and [H(56)NH2] 
were observed to give a log p.m.i value of ~ 0.46 only at high concentration (0.01 M).   This 
indicates that [H2(555)NH2] and [H(56)NH2] have low mobilizing ability in blood plasma and 
thus cannot effectively increase the l.m.w Cu(II) fraction.   The reason for the low mobilizing 
ability of these two ligands is the stability of their complexes with Zn(II) and Ni(II).   The 
mobilizing ability of the other ligands for Cu(II) in vivo is in the order [H(555)NH2] > 
[H(555)NMe2] > [H2(565)NH2] at a total ligand concentration range of  
10-6-10-2 M.   This means that [H(555)NH2] and [H(555)NMe2] have the highest ability to 
mobilize copper in vivo in comparison with the other ligands covered in this study.   The 
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[H(555)NMe2] is related to the stable three chelate rings formed with Cu(II) as well as the 
presence of methyl groups in terminal amine moiety in [H(555)NMe2].  
Zvimba and Jackson7 reported that a [555-N] ligand containing a pyridine residue and an 
amine nitrogen is a high mobilizer of Cu(II) in vivo.   However, better mobilization of 
 [555-N] compared to [H(555)NH2] and [H(555)NMe2] could be as a result of stronger 
coordination of the amino groups as opposed to amidic groups.   Such results are not 
unexpected because the electron withdrawing nature of such a group has been reported12 to 
reduce the basicity of the donor atoms for these complex systems.   Thus the in vivo 
mobilization of Cu(II) was observed to decrease as amide groups are introduced into the 
ligand.  
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5.2 Dermal Absorption Study 
Another objective of this work was to establish if the different ligands were able to 
promote the dermal absorption of Cu(II).   This was done by measuring the effect of the 
ligands on the rate of diffusion of Cu(II) through a Cerasome membrane as a model for skin 
and determining the  partition coefficients in 1-octanol.   
5.2.1 Octanol / Water Partition Coefficients 
5.2.1.1 Introduction 
The partition coefficient between octanol and water (log Poct/aq) is an important 
physicochemical parameter for characterizing the lipophilicity or hydrophobicity of a 
compound.   It is used in many fields, especially in the environmental and pharmaceutical 
sciences.13  The octanol/water partition coefficient is a key parameter in the mathematical 
prediction of percutaneous penetration of chemicals.14,15  It is  widely accepted as the best  
two-phase system to model the partitioning between biomass and water.16  Log P expresses 
the partitioning of a chemical between an aqueous (e.g., vehicle) and a lipid phase  
(e.g., stratum corneum).   Octanol is often used as a simplified model of the lipid barrier of 
the stratum corneum to predict the penetration of chemicals into the skin.17  One important 
aspect upon which biological activity depends is the ability of the drug to reach the target 
area.   In general, dermal absorption transport across the skin and bio-membranes is a process 
of limited diffusion which is governed by the drug’s chemical and physical properties such as 
lipophilicity and protein binding.18,19  Although Cu(II) complexes, when administered orally 
and intravenously do increase the availability of copper, it is difficult to move this 
coordinated metal ion through a series of body compartments without protein binding.20  In 
comparison to the classical methods of drug administration such as orally, by injection 
intravenously, intraperitoneally etc., percutaneous absorption offer one obvious advantage of 
being less painful and hence tolerable to the patient.20  Accordingly, in this study we have 
investigated the octanol/water partition coefficients of Cu(II) complexes with a view to 
establishing whether these species can be administered transdermally.   Partition coefficient 
(log Poct/aq) is expressed as; 
              (
                
          
) 
(5.2) 
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where [Cu(II)]oct is concentrations of Cu(II) in the organic phase, [Cu(II)]aq is concentrations 
of Cu(ll) in the aqueous phase. 
An investigation of a biphasic system at varying pH values interestingly shows that 
speciation changes with pH and the different species have different partition coefficients.   
The skin permeabilities of chemicals are directly proportional to their partition coefficients22, 
and therefore this observation is relevant here.   
5.2.1.2 Experimental 
 The classical method for measuring partition coefficients is the shake flask method, 
which has been adopted as the standard Organisation for Economic Cooperation and 
Development (OECD) method.23  However, this technique is not suitable for compounds 
having higher hydrophobicity because of the formation of octanol emulsions in water.13 
 In this study, partition coefficients were measured using the shake flask method where 
the organic phase was 1-octanol pre-saturated with water.23,24  Solutions of Cu(II) (0.005 M) 
with ligand in ratios of 1:1, 1:2 and 1:1.5 were prepared in distilled/deionised water.   5 ml of 
Cu(II) complex solutions were dispersed into 10 glass vials in the pH range between pH 2.0 
to 11.0 and these solutions were mixed with 6 ml of 1-octanol (99 %).   The mixture was 
shaken for two minutes and left for 5 minutes for the two phases to separate at a constant 
temperature of 25 °C.   The organic layer could not be analysed directly using Microwave 
Plasma-Atomic Emission Spectrometer (MP-AES) and so the copper had to be back-
extracted into an aqueous phase.   This was done using 6 ml of 5% HNO3. 4 ml aliquots were 
withdrawn from the new aqueous phase (5 % HNO3).   The concentration of copper in each 
phase does not determine the concentration of the complex species.   The total concentration 
of Cu(II) in each phase was measured using MP-AES.   The partition coefficients of Cu(II)-
complex as a drug were calculated using Equation 5.2. 
5.2.1.3 Results 
5.2.1.3.1 Cu(II)-[H(555)NH2] 
Figure 5.7 shows the partition coefficients (log Poct/aq) and the speciation graph of 
Cu(II)-[H(555)NH2] systems plotted as a function of pH.   It is evident that complexes of 
Cu(II) and Cu(II)-[H(555)NH2]  were more soluble in water than in 1-octanol, since the  
log Poct/aq values were negative (Figure 5.7).   The distribution coefficients did not change 
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much with pH (from pH 2 to 11).   The distribution curves showed that mixed species were 
observed at some pH values therefore, the log Poct/aq values obtained were not for a single 
species.   All three species (MLH, ML, and MLH-1) had about the same log Poct/aq value.   
MLH was formed in very small amounts due to the limited amount of Cu(II).   The log Poct/aq 
at pH 7.4 (physiological pH) was -3.3. 
 
           Figure 5.7: Log Poct\aq as a function of pH and speciation graph for 1:2 Cu(II)-[H (555)NH2]. 
 
5.2.1.3.2 Cu(II)-[H(555)NMe2] 
The distribution coefficient curve and the speciation graph for Cu(II)-[H(555)NMe2] 
are given in Figure 5.8.   The distribution coefficient curve shows that the solubility in  
1-octanol increased with an increase in pH (from pH 2 to 11).   Figure 5.8 also shows that all 
log Poct/aq values were negative, indicating that these complexes are largely hydrophilic.   The 
low log Poct/aq values in the acidic pH range for the complex species in this system indicate 
that the hydrated [Cu(OH2)6]2+ species predominated in this pH region, although complex 
formation in the Cu(II)-[H(555)NMe2] system began at low pH.   In the pH range 2.0-3.6, the 
copper is predominantly present as the ML species.   Since log Poct/aq is constant in this pH 
range we conclude that ML has a distribution coefficient of -2.5.   Log Poct/aq = -2.06 at pH 
10.10 where 91 % of the Cu(II) is present as MLH-2 and so the distribution coefficient was 
assigned to this species.   The log Poct/aq value at physiological pH 7.40 was estimated as  
-2.19 for the most predominant species MLH-1.   There was an increase in log Poct/aq values in 

























Cu(II) MLH ML MLH-1  Log Poct\aq





       Figure 5.8: Log Poct/aq as a function of pH and speciation graph for 1:1.5 Cu(II)-[H(555)NMe2].   
 
5.2.1.3.3 Cu(II)-[H2(555)NH2] 
 Figure 5.9 shows the partition coefficients (log Poct/aq) and the speciation graph as a 
function of pH for the Cu(II)-[H2(555)NH2] system.   From this, it is possible to estimate the 
log Poct/aq values of the individual species.   The MLH species that was formed at the start of 
the titration (pH 2.07) had a log Poct/aq value of -3.39.   The log Poct/aq value is constant in the 
pH range 3.33 – 6.23 for ML species.   At a physiological pH of 7.4, MLH-1 was the 
predominant species and had a log Poct/aq value of -2.8.   However, the MLH-2 species 
predominated at pH 9.2 which corresponded to a log Poct/aq value of -2.6.   The positively 
charged species were expected to result in negative log Poct/aq values due to the ability of 














2 4 6 8 10


















         Figure 5.9: Log Poct/aq as a function of pH and speciation graph for 1:1 Cu(II)-[H2(555)NH2]. 
 
5.2.1.3.4 Cu(II)-[H2(565)NH2] 
 The octanol/water partition coefficients and the speciation graph as a function of pH 
for the Cu(II)-[H2(565)NH2] system are given in Figure 5.10.   A noticeable feature about 
Figure 5.10 is that all log Poct/aq values were negative but increased with pH.   Negative 
values of log Poct/aq suggest that these complexes are largely hydrophilic.   From Figure 5.10, 
the log Poct/aq values for the ligand system at physiological pH (7.40) were estimated as -2.1, 
indicating a 0.78% extraction of copper into the octanol phase.   From the species distribution 
curves, at this pH, the CuLH-2 species predominated and so the partition coefficient was 
assigned to this species.   Above pH 8.00, log Poct/aq was constant. 
 
 





























































Results for Cu(II)-[H(56)NH2] are given in Figure 5.11.   The solubility in 1-octanol 
increased from low pH to high pH.   The log Poct/aq value of -2.4 at pH 4.26 was associated 
with the ML species from the speciation distribution graph in Figure 5.11.   At a 
physiological pH of 7.4, log Poct/aq value of -2.4 is associated with the predominant MLH-1 
species.   At pH 10.1 where 95 % of the Cu(II) was present as MLH-2,  the log Poct/aq value 
was -2.2 and therefore this value was assigned as the distribution coefficient.  
     
      Figure 5.11:  Log Poct/aq as a function of pH and speciation graph for 1:2 Cu(II)-[H(56)NH2]. 
 
5.2.1.4 Discussions 
 Available evidence indicates that compounds having molecular weights less than 
 600 (g.mol−1) are ideally suited for passive diffusion across the skin and other  
biomembranes.23-25 This process has been found to depend on the lipophilicity of the drug 
and the 1-octanol/water partition coefficient of Cu(II).   Log Poct/aq is often used by medicinal 
chemists as a measure of lipophilicity.23,24  Complex species with a net charge of zero are 
more lipophilic, than charged complex species.6-8,16,26-30  The octanol/water partition 
coefficients of the copper complexes studied have been determined in order to ascertain if 
they can be applied as topical agents in the alleviation of the anti-inflammatory process in 
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A summarising table log Poct/aq for complexes of Cu(II) with different ligands at pH 7.4 is 
given below (Table 5.1). 
Table 5.1: Logarithm of partition coefficient -log Poct/aq of Cu(II)  at pH 7.4 in the presence of      
                   different ligands in octanol/water mixtures. 
Ligands 
 
Major Species               - log Poct/aq 
Cu[H(555)NMe2]   
 
MLH-1 2.19 ± 0.001 
Cu[H2(565)NH2]   
 
MLH-2 2.10 ± 0.001 
Cu[H(56)NH2]   
 
MLH-1 2.42 ± 0.001 
Cu[H2(555)NH2]    
 
MLH-1 2.89 ± 0.004 
Cu[H(555)NH2]   
 
MLH-1 3.27 ± 0.01 
 
The negative values of log Poct/aq indicate that these complexes were largely 
hydrophilic.   The relatively hydrophilic nature of these ligands in addition to the charge 
distributions explains the preference of the complexes for the aqueous layer, resulting in 
negative values of log Poct/aq. 
For a drug to be considered lipophilic, the log Poct/aq value should be at least 0.60. 
Octanol/water partition coefficient values for highly hydrophobic (log Poct/aq > 6) and highly 
hydrophilic (log Poct/aq < -2) substances have been reported recently.16,31  Although our 
compounds have log Poct/aq values of less than 0.60, their log Poct/aq values at physiological 
pH indicate that they do have some lipophilic character and that the presence of bulky groups 
plays a role to enhance their lipophilicity.  
  In general, only neutral molecules take part in the partition equilibrium between the 
aqueous and organic phases, while the charged complexes remain in the aqueous phase.   The 
contributing factors to the hydrophilicity of the present complexes are; the presence of 
coordinated water molecules, hydrogen bonding between charged groups in these species and 
the solvent molecules, the overall charge of the MLH, ML, MLH-l , MLH-2 complexes and 
hydrogen bonding between carbonyl oxygen atoms and the bulk of the water molecules. 
Cu(II) complexes with a benzyl moiety have been found to have improved lipophilicity.32   
Thus the presence of pyridyl moieties in the ligand systems in this study is expected to 
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enhance the lipophilicity of their Cu(II) complexes and promote their extraction into the 
organic phase.   Also the N-methyl substituent on the terminal amine increases the 
lipophilicity of the Cu(II) complexes at pH 7.4 as anticipated. 
Positive log Poct/aq values (0.618 - 4.128) of some anti- inflammatory drugs have been 
reported.33  Rothwell and coworkers34 have recently reported the octanol/water partition 
coefficients of quercetin and related flavonoids to be in the range -1.11 to 3.22.   Several 
workers35-37 have studied 64Cu-labeled complexes having log Poct/aq values in the range 
 -1.60 to -3.02 for potential use as attaching copper radionuclides to biological molecules for 
diagnostic imaging and targeted radiotherapy.   Jackson and coworkers38 reported log Poct/aq 
values for related Cu(II) complexes of dioxo N5-donor ligands to be in the range -3.70 to  
-6.63 for the MLH, ML, MLH-l and MLH-2 species.   Nomkoko and coworkers39 also 
reported log Poct/aq value of -1.25 at physiological pH (7.4) for the related dioxo N5-donor 
ligand.   Therefore, the results obtained in this study are encouraging considering that they 
fall in the indicated range.   The Cu[H2(565)NH2] and Cu[H(555)NMe2] complexes were 
reasonably lipophilic at physiological pH (7.4). 
Although partition coefficients are traditionally used as a proxy for dermal absorption, 
these studies have used organic drugs not metal complexes.   In order to evaluate that 
partition coefficients can be used in this way, skin permeability was measured using an 
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5.2.2 Franz Diffusion Cells  
5.2.2.1 Introduction 
Low levels of the bio-available copper in the blood have been associated with the 
development of chronic inflammation and remission of symptoms has been seen with the 
administration of exogenous copper supplements.40,41  The ability of Cu(II) complexes with 
amino acids to penetrate through the stratum corneum and participate in copper ion transport 
processes is the key to their cosmetic and pharmaceutical activities Walker et al., have 
measured the dermal absorption from copper  bracelets and found it to be significant.40    
Despite previous successful designs of various useful copper chelating agents capable of 
enhancing bio-availability of copper in the blood, the challenge remains to develop a system 
that can enhance exogenous dermal absorption.   The topical application of Cu(II)-based 
drugs is desirable because the current therapy for inflammation disorders relies on intra-
articular or intravenous drug injection and causes the patient discomfort.7  A drug can cross a 
membrane either by passive or active diffusion.42  Passive diffusion occurs from a high 
concentration to a low concentration and does not require an external energy source.   In 
percutaneous absorption studies, the potency of penetration of chemical substances is often 
described by the permeability coefficient Kp.44 
For passive molecular diffusion, Fick’s first diffusion law44 is used to calculate the 
permeability coefficient Kp (cm/h) of Cu(II) ions in the lipid membrane.   Kp  depends on 
physiochemical parameters such as solvent temperature, solvent viscosity, nature of substrate 
and mass of substrate.   The relation between the permeability coefficient (Kp) and the steady-
state flux is calculated using the equation45,46; 




                                                                                                                                             (5.3) 
where Ci is the initial permeate concentration in the donor solution and J is the mass of 
permeate that passes through a unit area of the membrane in unit time.   This equation implies 
that in percutaneous absorption studies Kp is theoretically a more reliable parameter than flux, 
when taking the concentration into consideration.   Fick’s first law of diffusion is able to 
describe the distribution of chemicals in fluids and is used in various technical fields.   
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However, it is not able to characterise the effect of vehicle and consequently the effect of 
concentration.44 
When the amounts measured at successive sampling intervals are not significantly 
different, this is considered steady state flux and Ci is the equilibrium concentration of Cu(II) 
in the donor phase.   Then; 
 
(5.4) 
where Q (mg) is the quantity of Cu(II) transported through the membrane in time  
t (hrs), and A is the area of exposed membrane in cm2.   The steady state flux J units are 
mg/(cm2. h).   As stated above the permeability coefficient is more reliable than the flux to 
describe the extent of a dermal absorption potential of chemical substances.  
In the Franz diffusion cell, a biological membrane is normally used to determine the 
diffusion of the metal ion.   However, a biological membrane is dependent on the time they were 
obtained, the conditions of conservation and treatment.   In addition, the age, sex and weight 
have to be specified for a biological membrane.   These considerations are not necessary for 
artificial membranes.   The penetration process can be studied in vitro in a model system using a 
Franz diffusion cell with a liposome membrane as an artificial membrane.44  The artificial 
membrane gives results that are similar to the actual diffusion through human skin.   The Franz 
diffusion is based on vertical diffusion between donor and acceptor phases, where a liquid 
crystalline system with physicochemical properties similar to those of the intercellular of stratum 
corneum is used to model the skin barrier.  
5.2.2.2 Experimental 
A modified Franz cell was designed based on a normal Franz cell.47  The cell 
consisted of two compartments of the same height, diameter and controlled temperature.   
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                      1. Donor phase filled either with 20ml of Cu(II)                 
                              tripeptide  complexes. 
                          2. Receiver phase filled with 20ml blank  
                              solution (distilled/deionised water). 
                          3. The artificial membrane (0.094 g). 
                          4. Passive diffusion direction. 
                          5. Clamp. 
                          6. Stirrer bar. 
                          7. Magnetic stirrer. 
                          8. Burette stand with clamp 
 
 
Figure 5.12:  Modified Franz cells apparatus.  
The experiments were performed using a Franz diffusion cell.   The receiver cell was 
filled with 20 ml of distilled/deionised water, while the donor phase was filled with solutions 
having copper to ligand ratio of 1:2 and 1:1.5.   The solutions of Cu(II) (0.005 M) were 
prepared in 20 ml distilled/deionised water.   A Physiological pH of 7.4 was maintained in the 
acceptor cell in all the experiments, as the lower layer of the stratum corneum.   The acceptor 
liquid was in close contact with the membrane during the experiment and was continuously 
and homogeneously stirred by a rotating magnet placed inside the cell.   Duration of 
experiments (72 h), both cells were covered to prevent water from evaporating.   The 
experiments were maintained at a constant temperature 25°C.   The artificial membrane was 
made using filter paper that was submerged in Cerasome 9005, dried for a few minutes at 
room temperature and then weighed.   The membrane is a lipid solution, which mimics 
human stratum corneum.   The amount of lipid absorbed, determined by mass difference, was 
0.094±0.002 g.   The membrane sizes (i.e. mass and thickness) were kept constant for every 
new diffusion experiment undertaken.   The available diffusion area between cells was  
0.7085 cm2.   Copper concentration (ppm) was determined using a Microwave Plasma-
Atomic Emission Spectrometer (MP-AES Agilent 4100).   The instrumental detection limit of 
Cu(II) at wavelength 327.39 nm was 0.2 ppb.   The samples were prepared by diluting 1:10 
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(volume/volume) using 5% HNO3 immediately prior to analysis.   The standard solutions of 
Cu(II) were prepared as reported.48-50 
5.2.2.3 Results and Discussion 
5.2.2.3.1 Effect of Time on Diffusion  
Table 5.2 and Figure 5.13 show the effect of time on the concentration of copper 
diffusing through the membrane in the presence of  [H(555)NMe2], [H2(565)NH2], 
[H(56)NH2], [H2(555)NH2], [H(555)NH2] and Cl-.   The pure CuCl2.2H2O was determined at 
pH 4.0 because, at pH 7.00 and the concentration used, Cu(OH)2 would precipitate.   From 
Figure 5.13, it is clear that the ligands used can keep Cu(II) in solution at pH 7.0 and promote 
the passage of  Cu(II) through the membrane, and each complex shows the same general 
trend.   The effect of these ligands on the diffusion of Cu(II) was studied for 72h.   From 
Figure 5.13 it can be seen that there was a slow induction period of ~ 4hrs during which time 
equilibrium was set up between the donor phase and the membrane and thereafter a rapid 
increase in diffusion through the Cerasome 9005 membrane is observed.   A steady state flux 
of copper into the receiver phase is shown by the straight line from 6h to 72h.   The observed 
induction period was attributed to the development of equilibrium between the donor phase 
and the membrane as a result of the complex diffusing through it.51,48  After ~50 hrs it can be 
seen that the flux starts to level off as saturation is reached. 
 
Figure 5.13: Variation of copper conc. of complexes as function of a time through Cerasome                      
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Table 5.2:  Concentration (ppm) of Cu(II) in receiver phase in the presence of different ligands  

















0 0 0 0 0 0 
2 
 
4.2 ± 0.1 3.6 ± 0.1 5.7 ± 0.1 2.2 ± 0.1 5.2 ± 0.1 0.2 ± 0.1 
4 
 
8.8 ± 0.1 4.6 ± 0.1 11.4 ± 0.1 3.4 ± 0.1 9.9 ± 0.1 0.6 ± 0.1 
6 
 
14.4 ± 0.1 5.8 ± 0.1 15.4 ± 0.1 4.8 ± 0.1 13.9 ± 0.1 1.1 ± 0.1 
24 
 
43 ± 0.1 25.8 ± 0.1 47.9 ± 0.1 16.7 ± 0.1 44.2 ± 0.1 14.2 ± 0.1 
30 
 
50.5 ± 0.1 32.3 ± 0.1 57.1 ± 0.1 20.2 ± 0.1 52.6 ± 0.1 16.3 ± 0.1 
48 
 
73.9 ± 0.1 53.7 ± 0.1 79.6 ± 0.1 32 ± 0.1 75.7 ± 0.1 25.3 ± 0.1 
54 
 
78.2 ± 0.1 62.1 ± 0.1 85.2 ± 0.1 35.5 ± 0.1 81.6 ± 0.1 27.2 ± 0.1 
72 
 
88.8 ± 0.1 83.5 ± 0.1 99.8 ± 0.2 44.9 ± 0.1 95.7 ± 0.1 35.3 ± 0.2 
 
5.2.2.3.2 The steady state flux J and permeability coefficient Kp calculations 
The flux values J, permeability coefficient Kp and their corresponding standard error 
(SE) for the copper complexes are shown in Table 5.3.   The steady state flux and 
permeability coefficients were calculated from the gradient of the curves46 in Figure 5.13.   
The measurements were done in triplicate.   The flux was calculated from the slope of the 
linear portion of the plot of the cumulative amount of Cu(II) penetrated per square centimetre 
through the membrane as function of a time.44  
Figure 5.14 shows the influence of the different ligand systems on the flux of Cu(II) 
ions through the Cerasome 9005 membrane.   These results suggest that the complexation of 
Cu(II) ions by the different ligands greatly influences the diffusion of Cu(II) ions across the 
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Table 5.3: Flux of diffusion J (mg/cm2h) and permeability coefficient Kp (cm\h) of copper   
                     complexes through Cerasome 9005 membrane. 
Complexes J mg/cm2h Kp cm/h 
Cu[H(555)NMe2] 
 
0.018 ± 0.01 0.082 ± 0.01 
Cu[H2(565)NH2] 
 
0.022 ± 0.01 0.078  ± 0.01 
Cu[H(56)NH2] 
 
0.019 ± 0.01 0.069  ± 0.01 
Cu[H2(555)NH2] 
 
0.011 ± 0.02 0.060  ± 0.02 
Cu[H(555)NH2] 
 
0.02 ± 0.01 0.069 ± 0.01 
CuCl2.2H2O  
*pH 4.0 
0.003 ± 0.05 0.025  ± 0.07 
 
 
              Figure 5.14: Effect of different ligands on the flux of copper through Cerasome 9005  
                                    membrane in modified Franz cell from 24 – 72 hrs at pH 7.00. 
Lena and Kinga (2007) found that complexation of Cu(II) ions greatly increases the 
permeation rate of Cu(II) ions as Kp values for complex species are significantly higher (by as 
much as ten times) than the value for simple Cu(II) ions.   The order for the permeability 
coefficients  Kp of Cu(II) ligand complexes as shown in Figure 5.15, is as follows: 
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obtained results show that different ligands were able to enhance the passage of Cu(II) through 
an artificial membrane.  
 
 
Figure 5.15: Influence of ligands on the permeability of copper complexes through Cerasome 9005    
                      membrane at pH 7.00. 
 
One of the aims of this study was to design ligands that would increase the level of 
endogenous copper through dermal absorption.   This was evaluated using partition 
coefficient and Franz cell.   Partition coefficients are easier to measure than membrane 
permeability using a Franz cell.   For this reason partition coefficients are often used as an 
indication of tissue permeability.   However, for copper complexes it is not known if partition 
coefficients are a good proxy for tissue permeability.   Since in this study we have measured 
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5.2.2.3.3 Relationship between logarithm of permeability coefficient Log Kp and    
                octanol/water partition coefficient Log Poct\aq of copper complexes. 
Table 5.4 shows log Kp, log Poct/aq and the major copper species of different ligands at pH 
7 present in solution.   So it is reasonable to assume that the measured parameters refer to this 
species.     
Table 5.4: The permeability and partition coefficients values of Cu(II) speciation in the presence of  




Major Species               - log Poct/aq  -log Kp 
Cu[H(555)NMe2]   
 
MLH-1 2.19 ± 0.001 1.09± 0.01 
Cu[H2(565)NH2]   
 
MLH-2 2.10 ± 0.001 1.11± 0.01 
Cu[H(56)NH2]   
 
MLH-1 2.42 ± 0.001 1.16± 0.01 
Cu[H2(555)NH2]    
 
MLH-1 2.89 ± 0.004 1.22± 0.04 
Cu[H(555)NH2]   
 
MLH-1 3.27 ± 0.01 1.16± 0.02 
 
Figure 5.16 shows the possible correlation between the logarithm of permeability 
coefficient log Kp and octanol/water partition coefficient log Poct\aq of the Cu(II) complexes.   The 
coefficient of correlation obtained from Figure 5.16 is R2 = 0.487 ± 0.05.   However, it is far 
from 1 demonstrating that, there is no correlation between the logarithm of permeability 
coefficient and the logarithm of octanol/water partition coefficient of all Cu(II) complexes.   The 
48% variability can be explained by octanol/water partition coefficient of the Cu(II) complexes; 
i.e. that permeability coefficient does not linearly depend on octanol/water partition coefficient 
for all copper complexes. 
 




       Figure 5.16: Logarithm of permeability coefficient log Kp plotted against logarithm partition                          
                             coefficient Log Poct\aq of 7 copper complexes. 
 
5.2.2.4 Conclusion 
The amount of Cu(II) transferred from aqueous solution to organic layer changes with 
pH because speciation changes with pH and the different species have different partition 
coefficients.   The results showed that all the Cu(II) complex species studied had log Poct\aq 
valves below zero indicating that complexes were relatively hydrophilic.   However, The 
Cu[H2(565)NH2] and Cu[H(555)NMe2] complexes were reasonably lipophilic at 
physiological pH (7.4).   In addition, the transport of copper through an artificial membrane 
with ligands greatly increased the permeation rate of Cu(II) ions since Kp values for complex 
species were significantly higher than those for simple Cu(II) ions.   The obtained results 
show that the permeability rate of Cu(II) complexes through Cerasome 9005 membrane 
depends on the ligand.   From the partition coefficients results, Cu[H2(565)NH2]  is predicted 
to have the highest dermal absorption but Kp says Cu[H(555)NMe2] should have the highest 
dermal absorption.   A statistical analysis of the results showed that they were no correlation 
was found between logarithm of partition coefficient and permeability coefficient.   This 
means that log Poct\aq is not as good a measure of dermal absorption of Cu(II) as log Kp. 
 
y = 0.0747x + 0.9554 
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 The fundamental role of copper and the recognition of its complexes as important 
bioactive compounds in vitro and in vivo have aroused an ever-increasing interest in these 
agents as potential drugs for therapeutic intervention in various diseases.1  Copper complexes 
have been reported to have anti-inflammatory activities for the alleviation of inflammation 
associated with rheumatoid arthritis (RA).   Several reviews have been published on the anti-
inflammatory activity of copper complexes.2-6  This study was undertaken in order to develop 
better Cu(II)-based anti-inflammatory drugs which can be administered orally, intravenously or 
transdermally.   However, the preferred route of administration is through the skin, because 
percutaneous absorption offers one obvious advantage of being less painful and hence tolerable 
to the patient.7  Therefore, the rate of dermal absorption and bioavailability of the copper is 
important.   In the present study five ligands, were designed with the aim of increasing the low 
molecular weight (l.m.w) copper concentration in vivo. 
In blood plasma, copper is transported by proteins; human serum albumin (HSA) being 
the most effective protein.8-10  The Cu(II) binding site of  HSA is Asp-Ala-His residues (shown 
in Figure 2.1).11,12  The designs of the ligands in this study were based on the structure of HSA.   
All the ligands are peptide mimetics, containing one or more amide groups.   When the copper 
coordinates to the amide-N it displaces the amide proton which decreases the charge of the 
complex.   Amines are good, selective coordinators of Cu(II)13,14 and the pyridyl group has a 
high Cu(II) mobilizing ability and is found in most NSAID drugs.3,11,15  For this reason these 
two groups were incorporated into the ligand design.  The pyridyl aromatic ring increases the 
rigidity of the ligand system and hence the stability and lipophilicity of the metal complex.15  In 
addition, N-methyl substitution was used to increase the lipophilicity of the complex.   Using 
these criteria the ligands in this study have been designed.   
The effect of the number and position of amide groups as well as, the effect of methyl 
substitution upon the stability of the metal complexes was studied using a glass electrode 
potentiometry.   The solution equilibria of H+, Cu2+, Ni2+ and Zn2+ at 25°C and an ionic 
strength of 0.15 mol dm-3 were measured.   The Cu(II) complex species showed significantly 
different coordination behaviour at physiological pH.   The formation equilibria for Ni(II) and 
Zn(II) showed that these metal ions also form relatively stable complexes with these ligands, 
although their stability is lower than that of Cu(II).    
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The CuL species was formed for all the ligands in this study.   The stability of the CuL 
complexes is in the order [H(555)NH2] > [H(555)NMe2]  > [H2(555)NH2] > [H(56)NH2] > 
[H2(565)NH2].   The effect of methyl substitution is shown by comparing [H(555)NH2] and 
[H(555)NMe2] which is a decrease in stability constants by only one log unit.   However, the 
N-methyl substituent on the terminal amine was increased the lipophilicity of the copper 
complexes. 
The effect of the number of amide groups is shown by comparing the CuL species of 
[555-N]2, which has no amide group (Figure 3.31), with [H(555)NH2] and [H(56)NH2], which 
have one amide group and [H2(555)NH2] and [H2(565)NH2], which have two amide groups.   
In this comparison, the obvious conclusion is reached that the stability decreases with the 
introduction of amide groups.   This comparison, however, is not really valid because the 
structure of the different complexes is different.   In [555-N] (log β 18.62) the copper is 
coordinated through all 4 nitrogen donor groups, while in [H(555)NH2] (log β 11.81) only 3 
nitrogens are coordinated, the terminal amine being protonated.   In [H2(555)NH2]  
(log β 9.39) the copper is coordinated through the pyridyl-N, the terminal amine-N and the 
amide-O.   Thus, the difference in stability reflects the different coordination mode as well as 
the number of amide groups.    
The position of the amide group is shown by comparing [H2(555)NH2] and 
[H2(565)NH2].   Here, since the stoichiometry is the same, a comparison of the stability 
constants is valid.   The Cu(II) log β11-2 for these two are -5.27 and -3.06 respectively.   The 
reason for this is most likely steric strain.   [H2(555)NH2] forms three, five membered, chelate 
rings while [H2(565)NH2] forms 5,6,5 chelate rings.   Previous studies4,16-18 have shown that 
three contiguous five membered rings are less stable than when the strain is released by a larger 
6 membered ring in the middle.    
The reason for designing different ligands with different structural features was to see 
which is the best at complexing copper at physiological pH.   Hence, the best way to evaluate 
the different ligands is to compare their speciation, in competition, at different pH.   This would 
take into account the different basicities (pKa’s) of the ligand and also their different 
stoichiometries.   Such a speciation diagram is shown in Figure 6.1, where the concentration of 
Cu(II) and each of the ligands are 1 mM.   These results show that [H(555)NH2] is the best 
ligand between pH 6 to 7.   This ligand has the highest stability with Cu(II) compared to the 
other ligands as it is coordinated with Cu(II) via two amine-N’s, an amide-N and a pyridyl-N.   
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The second ligand binding with Cu(II) in the same pH range is  [H(555)NMe2].    At high pH 
21% of Cu(II) is bond to this ligand  as the MLH-1 and MLH-2 species.   The [H2(565)NH2] 
binds 48% of the Cu(II) at high pH.   This is due to forming MLH-2 by losing two amide 
protons.   Meanwhile, [H2(555)NH2] and [H(56)NH2] are not able to compete with the other 
ligands and so their complexes are not formed. 
 
 
             Figure 6.1: Effect of different ligands on the percentage of Cu(II) as a function of pH. 
 
The above discussion centered on the ability of the different ligands to complex copper 
in vitro.   What is also important is the ability of the ligands to complex copper in vivo.   This 
was evaluated using a computer model of blood plasma, which takes into account competition 
with endogenous metal ions and ligands.   It is particularly important is that the ligands were 
evaluated using the ECCLES program, an in vivo speciation model of blood plasma.   The 
ligands must be selective for Cu(II) over Ca(II) and Zn(II), as these ions are present in plasma 
at much higher concentrations than Cu(II) and hence are potential competitor in vivo.19-21  The 
mobilizing ability of the ligands was in the order [H(555)NH2] > [H(555)NMe2] > 
[H2(565)NH2] > [H2(555)NH2]  > [H(56)NH2].   At a concentration of 10-6 to 10-2 mol dm-3 the 
ligands were able to cause a 10 fold increase in the concentration of low molecular weight 
Cu(II) complexes.   The results showed that the [H2(555)NH2] and [H(56)NH2] have low 
mobilizing ability in blood plasma and thus cannot effectively increase the l.m.w Cu(II) 
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complexes with Zn(II) and Ni(II), i.e. they are not very selective for Cu(II).   [H(555)NH2] and 
[H(555)NMe2] have the highest copper mobilizing capacity as they form the most stable 
complexes and are selective for Cu(II) over Zn(II).     
Figure 6.2 shows the [H(555)NH2] and [H(555)NMe2] p.m.i curves.   For comparison 
results with the terminal amino acid sequence of serum albumin, glycylglycylhistamine 
(GGHA) and L-aspartyl-L-alanyl- L-histidine N-methyl amide (Asp-Ala-His-NHMe) are also 
shown.   From this we see that [H(555)NH2] is better at mobilizing Cu(II) in vivo than GGHA 
and Asp-Ala-His-NHMe.   On the other hand, [H(555)NMe2] has the same Cu(II) mobilizing 
ability as GGHA.   The remarkably high mobilizing ability of [H(555)NH2]  by one log unit 
compared to GGHA and three log unit  compared to Asp-Ala-His-NHMe is related to the 
presence of one electron withdrawing CONH-group.   At these ligand concentrations, the Zn(II) 
p.m.i is insignificant.   Hence, the speciation of this essential metal ion is not disturbed.   In 
spite of the higher concentration of Zn(II) than Cu(II) in vivo, it is unable to compete with 
Cu(II) for [H(555)NH2] and [H(555)NMe2]. 
 
 
    Figure 6.2: Cu(II) plasma mobilizing index for [H(555)NH2], [H(555)NMe2], GGHA  
                           and Asp-Ala-His-NHMe.  
 These ligands are able to coordinate Cu(II) in vivo and in order to understand the 
difference in stability of the different Cu(II) complexes their chemical structures were 
















Chapter 6: Concluding Remarks 
175 
 
by potentiometry, 1H-NMR, UV-visible spectroscopy, X-ray crystallography and Molecular 
Mechanics (MM) calculation studies.   At different pH’s the colours of the Cu(II) complexes 
varied from light blue to purple.   It was expected that as the pH increased, Cu(II) would  
induce ionization of the amide protons22,23, implying a transition from Cu-O to Cu-N in the 
coordination arrangement.24  Since several species existed in solution, deconvolution of the 
spectral data as a function of pH generated extinction coefficient-based data which was used 
successfully to determine the actual spectra of the complexes in solution.   At physiological pH, 
the predominate species is MLH-1 for all the ligands except [H2(565)NH2], which  has MLH-2 
as the predominant species.   The preference of Cu(II) ion for an environment with four 
nitrogen donor atoms with a coordination number of four in a tetragonally distorted 
environment or a square planar geometry were noted.   The UV-visible spectroscopy results 
showed that [H2(555)NH2] and [H2(565)NH2]  formed 4N coordination (NH2, 2N-, Npy) with 
λmax 524 and 532, respectively.   Both complexes have the same colour at high pH and are 
suggested to form a square planar geometry.   The MLH-1 of [H(56)NH2]  and [H2(555)NH2] 
were coordinated by 3N (NH2, N-, Npy), where the fourth equatorial position could be a water 
molecule or carbonyl respectively.   The MLH-1 species of [H(555)NH2] and [H(555)NMe2]  
are suggested to form tetragonally distorted octahedral geometries via 4N coordination (2NH2, 
N-, Npy) with Cu(II).   
 From the 1H-NMR results, it is clear that for some of the complexes, more than one 
species is in solution at the same time.   The 1H-NMR study showed that the pyridyl -N is 
coordinated at the beginning of complexation followed by the amide and terminal amine 
groups.   This is indicated by the broadening of the proton resonances of the 1H-NMR signal 
arising from protons attached to neighbouring carbons upon complexation by Cu(II).   
However, coordination by the carbonyl oxygens rather than the amide nitrogen cannot be ruled 
out.   Unfortunately, the amide proton is in rapid exchange and so cannot be observed.   The  
1H-NMR results confirm the results obtained by potentiometric and UV-visible spectroscopy. 
 While structures are suggested for different species from potentiometry and 
spectroscopy, it is not clear that these structures are physically reasonable.   For this reason, 
molecular mechanics (MM) was used to calculate the strain energies (internal) of the different 
possible geometries for the complexes.   By consideration of the differences in strain energy on 
complexation in various species, the stability of the postulated solution complexes, were 
successfully explained.   Thus, it was shown that molecular mechanics calculations, though not 
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a comprehensive tool, can still be used to rationalize the stability of related complex species in 
solution. 
 Direct evidence for the amide proton dissociation on complexation has been widely 
reported25-27 for Cu(II) complexes in solution.   The two structures, we were able to isolate and 
study by X-ray crystallography were the Cu(II) complexes of [H(56)NH2] and  [H2(565)NH2].   
The Cu(II)[H(56)NH2] complex had an essentially rectangular pyramidal geometry, while 
Cu(II)[H2(565)NH2] formed a distorted square planar geometry.   The results of X-ray 
crystallographic study have shown unequivocally that the amide proton displacement takes 
place in the solid with the coordination of the resulting negative amide groups occurring to the 
metal ion 
One of the objectives of the study was to develop Cu(II) complexes that could be 
administered “trans-dermally”.   This was evaluated by measuring the effect of the ligands on 
the rate of diffusion of Cu(II) through Cerasome, as an artificial membrane mimetic of skin.   
These results were then compared with traditional octanol/water partition coefficient 
measurements. 
Traditionally, octanol/water partition coefficients are used as an indication of 
transdermal absorption.   The results showed that all the Cu(II) complex species studied had 
log Poct\aq values below zero indicating that complexes were relatively hydrophilic.   The 
presence of the pyridyl moieties in the ligand systems, enhanced the lipophilicity of their Cu(II) 
complexes.   The N-methyl substituent on the terminal amine increased the lipophilicity of the 
Cu(II) complexes.   The transport of copper through an artificial membrane with ligands greatly 
increased the permeation rate of Cu(II)  ions since Kp values for complex species were 
significantly higher than those for simple Cu(II) ions.   The order for the permeability 
coefficient Kp  of Cu(II) ligand complexes was as follows: [H(555)NMe2] > [H2(565)NH2] > 
[H(555)NH2] ~ [H(56)NH2] > [H2(555)NH2] > Cl-.    
Partition coefficients are often used as an indication of tissue permeability as they are 
easier to measure than membrane permeability using a Franz cell.   However, the obtained 
results showed that, there was no correlation between partition coefficient and permeability 
coefficient.   This means that log Poct\aq is not as good a measure of dermal absorption of Cu(II) 
as log Kp; this indicates that care must be exercised when using partition coefficients as a proxy 
for tissue permeability.   
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 In the present study, [H(555)NH2] and [H(555)NMe2] have a higher mobilizing 
capacity than all the other ligands.   On the other hand, [H(555)NMe2] and  [H2(565)NH2] have 
the higher Cu(II) permeability.   The best mobilizing ligand is not the best transport ligand and 
so a compromise ligand has to be chosen.   This is [H(555)NMe2], which has a similar 
mobilizing ability as [H(555)NH2]  and also is the best at promoting dermal absorption.   It 
would be interesting to investigate the copper bio-distribution for this ligand in an animal 
model of arthritis using 64Cu(II) as a radiotracer. 
 The overall results in this study are encouraging and merit further evaluation for the use 
of Cu(II) complexes in chemotherapy.   It is therefore hoped that this study has contributed to 
the understanding of some aspects and factors involved in the development of copper-chelating 
agents for alleviation of inflammation associated with RA.   The study has clearly outlined the 
approach that could be followed in future studies for the development of new drugs with the 
aim of introducing Cu(II) into the body.  
 This study has shown that the [H2(555)NH2] system, which has two amide groups next 
to each other forms weak Cu(II) complexes and hence is not able to mobilize the metal ion  
in vivo.   Previous studies have shown that the stability of these complexes can be improved by 
the addition of a carbon spacer between the two amides.   This is certainly something that can 
be investigated in future.   In addition, methyl groups could be added to the terminal amine to 
improve the lipophilicity.   Studies in the future could also focus on a similar system with 
imidazole replacing the pyridine.   Imidazole is a stronger base and is part of the binding 
terminus of HSA.28   Based on these considerations the following ligands can be proposed for 





































Figure 6.3: Schematic representation of structures of ligands for future studies. 
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3.6.2.2 Ni(II) system 
3.6.2.2.1. Ni(II)-[H(555)NH2] system 
Figure A1 shows the ZM-bar plot for Ni(II)-[H(555)NH2].   The QM-bar and the 
distribution graph for Ni(II)-[H(555)NH2]titrations are given in Figure A2 and A3 respectively. 
 
 
  Figure A1: ZM-bar as a function of pL for Ni(II)-[H(555)NH2] Complex. 
 
    
 A2 A3 
Figure A2: QM-bar as a function of pH Ni(II)-[H(555)NH2] Complex. Figure A3: The distribution        
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3.6.2.2.2. Ni(II)-[H(555)NMe2] system 
 ZM-bar for Ni(II)-[H(555)NMe2] is given in Figure A4.   The QM-bar curves shown in 
Figure A4 and the speciation graphs is given in Figure A6.   The Ni(II) complex species were 
not similar to those species obtained from the Cu(II) system. 
 
 
  Figure A4: ZM-bar as a function of pL for Ni(II)-[H(555)NMe2] Complex. 
 
   
 A5                                                               A6 
Figure A5: QM-bar as a function of pH Ni(II)-[H(555)NMe2] Complex.  Figure A6: The distribution     












































Ni+2 ML2 ML MLH-1 MLH-2
Appendix 
Page 3  
 
3.6.2.2.3. Ni(II)-[H2(555)NH2] system 
The ZM-bar is given in Figure A7.   Q-bar and the distribution graph for the Ni(II)- 
[H2(555)NH2]  system are shown in Figure A8 and Figure A9 respectively. 
 
 
                     Figure A7: ZM-bar as a function of pL for Ni(II)-[H2(555)NH2] Complex. 
 
  
 A8              A9 
Figure A8: QM-bar as a function of pH Ni(II)-[H2(555)NH2] Complex. Figure A9: The distribution  
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3.6.2.2.4. Ni(II)-[H2(565)NH2] system 
The formation function for the Ni(II)-[H2(565)NH2] titrations is shown in Figure A10.   
The plot of QM-bar is given in Figure A11.   The distribution curve for Ni(II)-[H2(565)NH2] 
titrations is given in Figure A12.   
 
 
 Figure A10: ZM-bar as a function of pL for Ni(II)-[H2(565)NH2] Complex. 
 
    
 A11 A12 
Figure A11: QM-bar as a function of pH Ni(II)-[H2(565)NH2] Complex. Figure A12: The distribution  
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3.5.2.2.5. Ni(II)-[H(56)NH2] system 
Figure A13 given the ZM-bar for the Ni(II)-[H(56)NH2] titrations.   Figure A14 and 




 Figure A13: ZM-bar as a function of pL for Ni(II)-[H(56)NH2] Complex. 
 
    
 A14 A15 
Figure A14: QM-bar as a function of pH Ni(II)-[H(56)NH2] Complex. Figure A15: The distribution   
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3.5.2.3.1 Zn(II)-[H(555)NH2] system 
The ZM-bar function for the Zn(II)-[H(555)NH2] system shown in Figure B1.   The 
deprotonation function (QM-bar) curves given in Figure B2.   The calculated species 
distribution curves shown in Figure B3. 
 
 
                     Figure B1: ZM-bar as a function of pL for Zn(II)-[H(555)NH2] Complex. 
  
  
 B2 B3 
Figure B2: QM-bar as a function of pH Zn(II)-[H(555)NH2] Complex. Figure B3: The distribution  
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3.5.2.3.2 Zn(II)-[H(555)NMe2] system 
ZM-bar for complex formation titrations between Zn(II) and [H(555)NMe2] is given in 
Figure B4.   QM-bar and the speciation graph for Zn(II)-[H(555)NMe2] titrations are given in 
Figure B5 and Figure B6 respectively.  
 
 
        Figure B4: ZM-bar as a function of pL for Zn(II)-[H(555)NMe2] Complex. 
 
   
   B5 B6 
Figure B5: QM-bar as a function of pH Zn(II)-[H(555)NMe2] Complex. Figure B5: The distribution  
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3.5.2.3.3 Zn(II)-[H2(555)NH2] system 
Figure B7 shown the ZM-bar function for the Zn2+/ [H2(555)NH2] system.   Figure B8 
and Figure B9 show the deprotonation function curves and the distribution graph for the Zn2+/ 
[H2(555)NH2] system respectively. 
 
 
  Figure B7: ZM-bar as a function of pL for Zn(II)-[H2(555)NH2] Complex. 
 
   
 B8 B9 
Figure B8: QM-bar as a function of pH Zn(II)-[H2(555)NH2] Complex. Figure B9: The distribution  
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3.5.2.3.4 Zn(II)-[H2(565)NH2] system 
 ZM-bar was observed for the Zn(II)-[H2(565)NH2] titrations as shown in Figure B10.    
QM-bar for Zn(II)-[H2(565)NH2] titrations is given in Figure B11.   The distribution curve for 
Zn(II)-[H2(565)NH2] is given in Figure B12. 
 
 
      Figure B10: ZM-bar as a function of pL for Zn(II)-[H2(565)NH2] Complex. 
 
   
 B11 B12 
Figure B11: QM-bar as a function of pH Zn(II)-[H2(565)NH2] Complex. Figure B12: The distribution  
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3.5.2.3.5 Zn(II)-[H(56)NH2] system 
The ZM-bar for the titration of Zn with [H(56)NH2] is given in Figure B13.   QM-bar is 
given in Figure B14.   The speciation graphs in Figure B15 show species formed by the 
complexation of [H(56)NH2] with Zn(II).   
                                   
 
   Figure B13: ZM-bar as a function of pL for Zn(II)-[H(56)NH2] Complex. 
 
   
 B14 B15 
Figure B14: QM-bar as a function of pH Zn(II)-[H(56)NH2] Complex. Figure B15: The  
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